Orthopedics

During total knee arthroplasty (TKA), traditionally a thigh tourniquet is used to minimize blood loss. Although intraoperative blood loss is negligible, postoperative blood loss can be extensive, and patients often require blood transfusions. Transfusions expose patients to clinical risks and increase costs. Well-documented transfusion complications include allergic reaction, transfusion-related acute lung injury, transfusion-associated circulatory overload, venous thromboembolism, graft vs host disease, bloodborne infections, and immunomodulation.¹ Although measures are taken to reduce these risks, the costs associated with transfusions continue to escalate.²

Postoperative bleeding is attributed to fibrinolytic system activation. The antifibrinolytic agent aminocaproic acid (ACA), a synthetic analogue of the amino acid lysine, acts by competitively blocking the lysine-binding site of plasminogen, inhibiting fibrinolysis.³ Multiple studies have shown that ACA and a similar drug, tranexamic acid, can reduce postoperative blood loss when used intravenously in unilateral TKA.^4,5 However, more studies are needed to evaluate antifibrinolytic agents with comparative controls using standardized procedures and documented outcome measures. In addition, the majority of studies have used tranexamic acid rather than ACA, despite the lower cost and similar efficacy of ACA.^1,4 ACA is an inexpensive medication with a low risk profile, making it an attractive alternative to historical post-TKA management (which has a higher rate of blood transfusions) and a viable replacement in protocols already implementing tranexamic acid, the more expensive antifibrinolytic.^5,6 It has been proposed that ACA use reduces equipment (drain) costs, blood transfusion costs, exposure to complications of blood loss, and transfusion reactions and reduces or eliminates the need for costly medications, such as erythropoiesis-stimulating agents.

Kagoma and colleagues⁵ reported that antifibrinolytic agents may reduce bleeding by at least 300 mL and may reduce the need for transfusions by 50% or eliminate this need altogether. Other antifibrinolytic agents have been studied in unilateral TKA, with results showing decreased drainage and improved postoperative hemoglobin (Hb) levels.⁶

We conducted a study to evaluate the effectiveness of a single intraoperative dose of ACA in reducing postoperative blood loss and the need for blood transfusions with increased preservation of postoperative Hb levels.

Methods

In October 2011, Dr. Anderson initiated an intraoperative intravenous (IV) ACA protocol for primary unilateral TKA. Given the decreased drain output immediately observed, and patients’ increased postoperative Hb levels, a retrospective study was proposed. After obtaining full Institutional Review Board approval for the study, we retrospectively reviewed the medical charts of 50 consecutive patients who underwent primary unilateral TKA—the last 25 who had the surgery before the IV ACA protocol was initiated (control group) and the first 25 who were given the IV ACA medication during the surgery (antifibrinolytic group). Inclusion criteria were primary unilateral TKA, no bleeding dyscrasia, no history of anaphylactic response to antifibrinolytic agents, no history of deep vein thrombosis, and normal preoperative coagulation parameters, international normalized ratio (INR), and partial thromboplastin time. Exclusion criteria included lateral corner release, lateral retinacular release, combined extensive deep and superficial medial collateral ligament releases, and cardiac or peripheral stent in place.

Each surgery—a standard primary unilateral TKA with an intramedullary femoral component and an extramedullary tibial component—was performed by Dr. Anderson. Each component was cemented. Each patient underwent a posterior cruciate ligament release and/or a deep medial collateral ligament release. A well-padded thigh tourniquet was inflated before surgical incision, and it remained inflated until all postoperative surgical dressings were applied. Each patient in the antifibrinolytic group was given a 10-g dose of IV ACA at the start of implant cementation; the dose was administered over 10 minutes and was completely infused before tourniquet deflation. For each patient in the control group, a suction drain (Constavac, Stryker) was used. As postoperative drainage was so insignificant in the first 12 antifibrinolytic cases, use of the drain was then discontinued.

All patients received standard postoperative deep vein thrombosis prophylaxis in the form of warfarin in accordance with existing practice. Warfarin was given once a day starting the night of surgery and was continued until discharge based on daily INR values with an agreed-on target of 2.0. Thigh-high compression stockings and calf sequential compression devices were used in all cases. No patient in either group predonated blood or was given erythropoietin injections before or after surgery. Postoperative allogeneic transfusions were given to patients who were clinically symptomatic or short of breath; patients with hypotension uncorrectable with IV volume supplementation and an Hb level under 9.0 g/dL; and patients with an Hb level under 7.0 g/dL regardless of symptoms. All patients were monitored for postoperative adverse events and complications.

Postoperative blood loss (drain output), Hb levels on postoperative days 1 and 2 (POD-1, POD-2), blood transfusion amounts, and complications were recorded for all patients. Group means were compared with 2-sample t tests for independent samples. Data are reported as group means and SDs. All significance tests were 2-tailed, and statistical significance was set at P < .05.

Results

Fifty patients enrolled in the study: 25 in the control group and 25 in the antifibrinolytic group. Table 1 compares the main characteristics of the 2 groups. No significant differences were found between these groups for any of the characteristics considered.

There was significantly (P < .0001) more postoperative drainage in the control group: Mean drain output was 410.9 mL for the control group and 155.0 mL for the antifibrinolytic group (Table 2). Patients in the antifibrinolytic group did not receive any blood transfusions, whereas 40% of patients in the control group received transfusions (P = .022). On average, the transfused patients received 0.4 unit of packed red blood cells.

Although there was no statistically significant difference in POD-1 or POD-2 Hb levels between the antifibrinolytic and control groups, the antifibrinolytic group trended higher on POD-1 (11.1 g vs 10.7 g; P = .108) and POD-2 (11.5 g vs 10.2 g; P = .117) (Table 3). Mean Hb level was 8.1 g for control patients transfused on POD-1 and 7.9 g for control patients transfused on POD-2. For control patients who were not transfused, mean Hb level was 10.7 g on POD-1 and 10.2 g on POD-2.

There were no adverse events (eg, anaphylaxis, hypersensitivity) in either group, and there was no difference in incision drainage or returns to operating room between the groups.

Discussion

In TKA, a tourniquet is used to minimize intraoperative blood loss; postoperative bleeding, however, is often extensive. Both surgery and tourniquet use are reported to enhance local fibrinolytic activity within the limb.⁸ The synthetic antifibrinolytic ACA reduces blood loss by clot stabilization rather than by promotion of clot formation.⁸

In the present study, a single intraoperative dose of IV ACA administered in primary unilateral TKA significantly reduced postoperative wound drainage and eliminated the need for postoperative allogeneic blood transfusions. In addition, patients who received ACA had higher Hb levels on POD-1 and POD-2. These results are similar to those of other clinical trials in which external blood losses were measured.^4-7 The postoperative drain output differences (~250 mL) in our study are clinically relevant, as they indicate significant reductions in postoperative blood loss with the implementation of an antifibrinolytic operative protocol.

In a study by Ponnusamy and colleagues,¹ blood transfusion after orthopedic surgery accounted for 10% of all packed red blood cell transfusions, but use varied widely. National TKA transfusion rates vary from 4.3% to 63.8% among surgeons and hospitals.⁹ This evidence calls for standardization and critical review of practices to ensure more efficient use of blood products, effectively protecting patients from unneeded complications and reducing hospital costs. Mounting evidence supporting the efficacy of ACA in reducing perioperative blood loss and lowering postoperative blood transfusion rates points toward including antifibrinolytic therapy in standard TKA protocols. In our study, 40% of control patients and no antifibrinolytic patients required a transfusion—a stark contrast.

Although our antifibrinolytic group’s postoperative Hb levels were not statistically significantly higher, their being elevated illustrates the protective effect of intraoperative use of antifibrinolytics in TKA. This elevation in Hb levels is especially valid given the similarity of the antifibrinolytic and control patients’ preoperative Hb levels (P = .871) (Table 1). Other studies have shown similar upward trends in postoperative Hb levels, many of which were statistically significant.^5-8,10

Conclusion

This study showed that a single intraoperative 10-g dose of IV ACA significantly reduced perioperative blood loss and lowered blood transfusion rates in TKA. In addition, postoperative Hb levels were higher in the patients who received ACA than in patients who did not receive an antifibrinolytic. The positive effects of ACA were obtained without adverse events or complications, making use of this antifibrinolytic a relevant addition to TKA protocols.

During total knee arthroplasty (TKA), traditionally a thigh tourniquet is used to minimize blood loss. Although intraoperative blood loss is negligible, postoperative blood loss can be extensive, and patients often require blood transfusions. Transfusions expose patients to clinical risks and increase costs. Well-documented transfusion complications include allergic reaction, transfusion-related acute lung injury, transfusion-associated circulatory overload, venous thromboembolism, graft vs host disease, bloodborne infections, and immunomodulation.¹ Although measures are taken to reduce these risks, the costs associated with transfusions continue to escalate.²

Postoperative bleeding is attributed to fibrinolytic system activation. The antifibrinolytic agent aminocaproic acid (ACA), a synthetic analogue of the amino acid lysine, acts by competitively blocking the lysine-binding site of plasminogen, inhibiting fibrinolysis.³ Multiple studies have shown that ACA and a similar drug, tranexamic acid, can reduce postoperative blood loss when used intravenously in unilateral TKA.^4,5 However, more studies are needed to evaluate antifibrinolytic agents with comparative controls using standardized procedures and documented outcome measures. In addition, the majority of studies have used tranexamic acid rather than ACA, despite the lower cost and similar efficacy of ACA.^1,4 ACA is an inexpensive medication with a low risk profile, making it an attractive alternative to historical post-TKA management (which has a higher rate of blood transfusions) and a viable replacement in protocols already implementing tranexamic acid, the more expensive antifibrinolytic.^5,6 It has been proposed that ACA use reduces equipment (drain) costs, blood transfusion costs, exposure to complications of blood loss, and transfusion reactions and reduces or eliminates the need for costly medications, such as erythropoiesis-stimulating agents.

Kagoma and colleagues⁵ reported that antifibrinolytic agents may reduce bleeding by at least 300 mL and may reduce the need for transfusions by 50% or eliminate this need altogether. Other antifibrinolytic agents have been studied in unilateral TKA, with results showing decreased drainage and improved postoperative hemoglobin (Hb) levels.⁶

We conducted a study to evaluate the effectiveness of a single intraoperative dose of ACA in reducing postoperative blood loss and the need for blood transfusions with increased preservation of postoperative Hb levels.

Methods

In October 2011, Dr. Anderson initiated an intraoperative intravenous (IV) ACA protocol for primary unilateral TKA. Given the decreased drain output immediately observed, and patients’ increased postoperative Hb levels, a retrospective study was proposed. After obtaining full Institutional Review Board approval for the study, we retrospectively reviewed the medical charts of 50 consecutive patients who underwent primary unilateral TKA—the last 25 who had the surgery before the IV ACA protocol was initiated (control group) and the first 25 who were given the IV ACA medication during the surgery (antifibrinolytic group). Inclusion criteria were primary unilateral TKA, no bleeding dyscrasia, no history of anaphylactic response to antifibrinolytic agents, no history of deep vein thrombosis, and normal preoperative coagulation parameters, international normalized ratio (INR), and partial thromboplastin time. Exclusion criteria included lateral corner release, lateral retinacular release, combined extensive deep and superficial medial collateral ligament releases, and cardiac or peripheral stent in place.

Each surgery—a standard primary unilateral TKA with an intramedullary femoral component and an extramedullary tibial component—was performed by Dr. Anderson. Each component was cemented. Each patient underwent a posterior cruciate ligament release and/or a deep medial collateral ligament release. A well-padded thigh tourniquet was inflated before surgical incision, and it remained inflated until all postoperative surgical dressings were applied. Each patient in the antifibrinolytic group was given a 10-g dose of IV ACA at the start of implant cementation; the dose was administered over 10 minutes and was completely infused before tourniquet deflation. For each patient in the control group, a suction drain (Constavac, Stryker) was used. As postoperative drainage was so insignificant in the first 12 antifibrinolytic cases, use of the drain was then discontinued.

All patients received standard postoperative deep vein thrombosis prophylaxis in the form of warfarin in accordance with existing practice. Warfarin was given once a day starting the night of surgery and was continued until discharge based on daily INR values with an agreed-on target of 2.0. Thigh-high compression stockings and calf sequential compression devices were used in all cases. No patient in either group predonated blood or was given erythropoietin injections before or after surgery. Postoperative allogeneic transfusions were given to patients who were clinically symptomatic or short of breath; patients with hypotension uncorrectable with IV volume supplementation and an Hb level under 9.0 g/dL; and patients with an Hb level under 7.0 g/dL regardless of symptoms. All patients were monitored for postoperative adverse events and complications.

Postoperative blood loss (drain output), Hb levels on postoperative days 1 and 2 (POD-1, POD-2), blood transfusion amounts, and complications were recorded for all patients. Group means were compared with 2-sample t tests for independent samples. Data are reported as group means and SDs. All significance tests were 2-tailed, and statistical significance was set at P < .05.

Results

Fifty patients enrolled in the study: 25 in the control group and 25 in the antifibrinolytic group. Table 1 compares the main characteristics of the 2 groups. No significant differences were found between these groups for any of the characteristics considered.

There was significantly (P < .0001) more postoperative drainage in the control group: Mean drain output was 410.9 mL for the control group and 155.0 mL for the antifibrinolytic group (Table 2). Patients in the antifibrinolytic group did not receive any blood transfusions, whereas 40% of patients in the control group received transfusions (P = .022). On average, the transfused patients received 0.4 unit of packed red blood cells.

Although there was no statistically significant difference in POD-1 or POD-2 Hb levels between the antifibrinolytic and control groups, the antifibrinolytic group trended higher on POD-1 (11.1 g vs 10.7 g; P = .108) and POD-2 (11.5 g vs 10.2 g; P = .117) (Table 3). Mean Hb level was 8.1 g for control patients transfused on POD-1 and 7.9 g for control patients transfused on POD-2. For control patients who were not transfused, mean Hb level was 10.7 g on POD-1 and 10.2 g on POD-2.

There were no adverse events (eg, anaphylaxis, hypersensitivity) in either group, and there was no difference in incision drainage or returns to operating room between the groups.

Discussion

In TKA, a tourniquet is used to minimize intraoperative blood loss; postoperative bleeding, however, is often extensive. Both surgery and tourniquet use are reported to enhance local fibrinolytic activity within the limb.⁸ The synthetic antifibrinolytic ACA reduces blood loss by clot stabilization rather than by promotion of clot formation.⁸

In the present study, a single intraoperative dose of IV ACA administered in primary unilateral TKA significantly reduced postoperative wound drainage and eliminated the need for postoperative allogeneic blood transfusions. In addition, patients who received ACA had higher Hb levels on POD-1 and POD-2. These results are similar to those of other clinical trials in which external blood losses were measured.^4-7 The postoperative drain output differences (~250 mL) in our study are clinically relevant, as they indicate significant reductions in postoperative blood loss with the implementation of an antifibrinolytic operative protocol.

In a study by Ponnusamy and colleagues,¹ blood transfusion after orthopedic surgery accounted for 10% of all packed red blood cell transfusions, but use varied widely. National TKA transfusion rates vary from 4.3% to 63.8% among surgeons and hospitals.⁹ This evidence calls for standardization and critical review of practices to ensure more efficient use of blood products, effectively protecting patients from unneeded complications and reducing hospital costs. Mounting evidence supporting the efficacy of ACA in reducing perioperative blood loss and lowering postoperative blood transfusion rates points toward including antifibrinolytic therapy in standard TKA protocols. In our study, 40% of control patients and no antifibrinolytic patients required a transfusion—a stark contrast.

Although our antifibrinolytic group’s postoperative Hb levels were not statistically significantly higher, their being elevated illustrates the protective effect of intraoperative use of antifibrinolytics in TKA. This elevation in Hb levels is especially valid given the similarity of the antifibrinolytic and control patients’ preoperative Hb levels (P = .871) (Table 1). Other studies have shown similar upward trends in postoperative Hb levels, many of which were statistically significant.^5-8,10

Conclusion

This study showed that a single intraoperative 10-g dose of IV ACA significantly reduced perioperative blood loss and lowered blood transfusion rates in TKA. In addition, postoperative Hb levels were higher in the patients who received ACA than in patients who did not receive an antifibrinolytic. The positive effects of ACA were obtained without adverse events or complications, making use of this antifibrinolytic a relevant addition to TKA protocols.

During total knee arthroplasty (TKA), traditionally a thigh tourniquet is used to minimize blood loss. Although intraoperative blood loss is negligible, postoperative blood loss can be extensive, and patients often require blood transfusions. Transfusions expose patients to clinical risks and increase costs. Well-documented transfusion complications include allergic reaction, transfusion-related acute lung injury, transfusion-associated circulatory overload, venous thromboembolism, graft vs host disease, bloodborne infections, and immunomodulation.¹ Although measures are taken to reduce these risks, the costs associated with transfusions continue to escalate.²

Postoperative bleeding is attributed to fibrinolytic system activation. The antifibrinolytic agent aminocaproic acid (ACA), a synthetic analogue of the amino acid lysine, acts by competitively blocking the lysine-binding site of plasminogen, inhibiting fibrinolysis.³ Multiple studies have shown that ACA and a similar drug, tranexamic acid, can reduce postoperative blood loss when used intravenously in unilateral TKA.^4,5 However, more studies are needed to evaluate antifibrinolytic agents with comparative controls using standardized procedures and documented outcome measures. In addition, the majority of studies have used tranexamic acid rather than ACA, despite the lower cost and similar efficacy of ACA.^1,4 ACA is an inexpensive medication with a low risk profile, making it an attractive alternative to historical post-TKA management (which has a higher rate of blood transfusions) and a viable replacement in protocols already implementing tranexamic acid, the more expensive antifibrinolytic.^5,6 It has been proposed that ACA use reduces equipment (drain) costs, blood transfusion costs, exposure to complications of blood loss, and transfusion reactions and reduces or eliminates the need for costly medications, such as erythropoiesis-stimulating agents.

Kagoma and colleagues⁵ reported that antifibrinolytic agents may reduce bleeding by at least 300 mL and may reduce the need for transfusions by 50% or eliminate this need altogether. Other antifibrinolytic agents have been studied in unilateral TKA, with results showing decreased drainage and improved postoperative hemoglobin (Hb) levels.⁶

We conducted a study to evaluate the effectiveness of a single intraoperative dose of ACA in reducing postoperative blood loss and the need for blood transfusions with increased preservation of postoperative Hb levels.

Methods

In October 2011, Dr. Anderson initiated an intraoperative intravenous (IV) ACA protocol for primary unilateral TKA. Given the decreased drain output immediately observed, and patients’ increased postoperative Hb levels, a retrospective study was proposed. After obtaining full Institutional Review Board approval for the study, we retrospectively reviewed the medical charts of 50 consecutive patients who underwent primary unilateral TKA—the last 25 who had the surgery before the IV ACA protocol was initiated (control group) and the first 25 who were given the IV ACA medication during the surgery (antifibrinolytic group). Inclusion criteria were primary unilateral TKA, no bleeding dyscrasia, no history of anaphylactic response to antifibrinolytic agents, no history of deep vein thrombosis, and normal preoperative coagulation parameters, international normalized ratio (INR), and partial thromboplastin time. Exclusion criteria included lateral corner release, lateral retinacular release, combined extensive deep and superficial medial collateral ligament releases, and cardiac or peripheral stent in place.

Each surgery—a standard primary unilateral TKA with an intramedullary femoral component and an extramedullary tibial component—was performed by Dr. Anderson. Each component was cemented. Each patient underwent a posterior cruciate ligament release and/or a deep medial collateral ligament release. A well-padded thigh tourniquet was inflated before surgical incision, and it remained inflated until all postoperative surgical dressings were applied. Each patient in the antifibrinolytic group was given a 10-g dose of IV ACA at the start of implant cementation; the dose was administered over 10 minutes and was completely infused before tourniquet deflation. For each patient in the control group, a suction drain (Constavac, Stryker) was used. As postoperative drainage was so insignificant in the first 12 antifibrinolytic cases, use of the drain was then discontinued.

All patients received standard postoperative deep vein thrombosis prophylaxis in the form of warfarin in accordance with existing practice. Warfarin was given once a day starting the night of surgery and was continued until discharge based on daily INR values with an agreed-on target of 2.0. Thigh-high compression stockings and calf sequential compression devices were used in all cases. No patient in either group predonated blood or was given erythropoietin injections before or after surgery. Postoperative allogeneic transfusions were given to patients who were clinically symptomatic or short of breath; patients with hypotension uncorrectable with IV volume supplementation and an Hb level under 9.0 g/dL; and patients with an Hb level under 7.0 g/dL regardless of symptoms. All patients were monitored for postoperative adverse events and complications.

Postoperative blood loss (drain output), Hb levels on postoperative days 1 and 2 (POD-1, POD-2), blood transfusion amounts, and complications were recorded for all patients. Group means were compared with 2-sample t tests for independent samples. Data are reported as group means and SDs. All significance tests were 2-tailed, and statistical significance was set at P < .05.

Results

Fifty patients enrolled in the study: 25 in the control group and 25 in the antifibrinolytic group. Table 1 compares the main characteristics of the 2 groups. No significant differences were found between these groups for any of the characteristics considered.

There was significantly (P < .0001) more postoperative drainage in the control group: Mean drain output was 410.9 mL for the control group and 155.0 mL for the antifibrinolytic group (Table 2). Patients in the antifibrinolytic group did not receive any blood transfusions, whereas 40% of patients in the control group received transfusions (P = .022). On average, the transfused patients received 0.4 unit of packed red blood cells.

Although there was no statistically significant difference in POD-1 or POD-2 Hb levels between the antifibrinolytic and control groups, the antifibrinolytic group trended higher on POD-1 (11.1 g vs 10.7 g; P = .108) and POD-2 (11.5 g vs 10.2 g; P = .117) (Table 3). Mean Hb level was 8.1 g for control patients transfused on POD-1 and 7.9 g for control patients transfused on POD-2. For control patients who were not transfused, mean Hb level was 10.7 g on POD-1 and 10.2 g on POD-2.

There were no adverse events (eg, anaphylaxis, hypersensitivity) in either group, and there was no difference in incision drainage or returns to operating room between the groups.

Discussion

In TKA, a tourniquet is used to minimize intraoperative blood loss; postoperative bleeding, however, is often extensive. Both surgery and tourniquet use are reported to enhance local fibrinolytic activity within the limb.⁸ The synthetic antifibrinolytic ACA reduces blood loss by clot stabilization rather than by promotion of clot formation.⁸

In the present study, a single intraoperative dose of IV ACA administered in primary unilateral TKA significantly reduced postoperative wound drainage and eliminated the need for postoperative allogeneic blood transfusions. In addition, patients who received ACA had higher Hb levels on POD-1 and POD-2. These results are similar to those of other clinical trials in which external blood losses were measured.^4-7 The postoperative drain output differences (~250 mL) in our study are clinically relevant, as they indicate significant reductions in postoperative blood loss with the implementation of an antifibrinolytic operative protocol.

In a study by Ponnusamy and colleagues,¹ blood transfusion after orthopedic surgery accounted for 10% of all packed red blood cell transfusions, but use varied widely. National TKA transfusion rates vary from 4.3% to 63.8% among surgeons and hospitals.⁹ This evidence calls for standardization and critical review of practices to ensure more efficient use of blood products, effectively protecting patients from unneeded complications and reducing hospital costs. Mounting evidence supporting the efficacy of ACA in reducing perioperative blood loss and lowering postoperative blood transfusion rates points toward including antifibrinolytic therapy in standard TKA protocols. In our study, 40% of control patients and no antifibrinolytic patients required a transfusion—a stark contrast.

Although our antifibrinolytic group’s postoperative Hb levels were not statistically significantly higher, their being elevated illustrates the protective effect of intraoperative use of antifibrinolytics in TKA. This elevation in Hb levels is especially valid given the similarity of the antifibrinolytic and control patients’ preoperative Hb levels (P = .871) (Table 1). Other studies have shown similar upward trends in postoperative Hb levels, many of which were statistically significant.^5-8,10

Conclusion

This study showed that a single intraoperative 10-g dose of IV ACA significantly reduced perioperative blood loss and lowered blood transfusion rates in TKA. In addition, postoperative Hb levels were higher in the patients who received ACA than in patients who did not receive an antifibrinolytic. The positive effects of ACA were obtained without adverse events or complications, making use of this antifibrinolytic a relevant addition to TKA protocols.

Patients with postoperative delirium have significantly worse preoperative short-term cognitive performance and significantly greater long-term cognitive decline, compared with patients without delirium, according to Sharon K. Inouye, MD, and her associates.

In a prospective cohort study of 560 patients aged 70 years and older, 134 patients were selected for the delirium group and 426 for the nondelirium group. The delirium group had a significantly greater decline (–1.03 points) at 1 month, compared with those without delirium (P = .003). After cognitive function had recovered at 2 months, there were no significant differences between groups (P = 0.99). After 2 months, both groups decline on average; however, the delirium group declined significantly more (–1.07) in adjusted mean scores at 36 months (P =.02).

©Wavebreakmedia Ltd/thinkstockphotos.com

From baseline to 36 months, there was a significant change for the delirium group (–1.30, P less than .01) and no significant change for the group without delirium (–0.23, P = .30). Researchers noted that the effect of delirium remains undiminished after consecutive rehospitalizations, intercurrent illnesses, and major postoperative complications were controlled for.

The patients underwent major noncardiac surgery, such as total hip or knee replacement, open abdominal aortic aneurysm repair, colectomy, and lower-extremity arterial bypass.

“This study provides a novel presentation of the biphasic relationship of delirium and cognitive trajectory, both its well-recognized acute effects but also long-term effects,” the researchers wrote. “Our results suggest that after a period of initial recovery, patients with delirium experience a substantially accelerated trajectory of cognitive aging.”

Read the full study in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association (doi:10.1016/j.jalz.2016.03.005).

[email protected]

Patients with postoperative delirium have significantly worse preoperative short-term cognitive performance and significantly greater long-term cognitive decline, compared with patients without delirium, according to Sharon K. Inouye, MD, and her associates.

In a prospective cohort study of 560 patients aged 70 years and older, 134 patients were selected for the delirium group and 426 for the nondelirium group. The delirium group had a significantly greater decline (–1.03 points) at 1 month, compared with those without delirium (P = .003). After cognitive function had recovered at 2 months, there were no significant differences between groups (P = 0.99). After 2 months, both groups decline on average; however, the delirium group declined significantly more (–1.07) in adjusted mean scores at 36 months (P =.02).

©Wavebreakmedia Ltd/thinkstockphotos.com

From baseline to 36 months, there was a significant change for the delirium group (–1.30, P less than .01) and no significant change for the group without delirium (–0.23, P = .30). Researchers noted that the effect of delirium remains undiminished after consecutive rehospitalizations, intercurrent illnesses, and major postoperative complications were controlled for.

The patients underwent major noncardiac surgery, such as total hip or knee replacement, open abdominal aortic aneurysm repair, colectomy, and lower-extremity arterial bypass.

“This study provides a novel presentation of the biphasic relationship of delirium and cognitive trajectory, both its well-recognized acute effects but also long-term effects,” the researchers wrote. “Our results suggest that after a period of initial recovery, patients with delirium experience a substantially accelerated trajectory of cognitive aging.”

Read the full study in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association (doi:10.1016/j.jalz.2016.03.005).

[email protected]

Patients with postoperative delirium have significantly worse preoperative short-term cognitive performance and significantly greater long-term cognitive decline, compared with patients without delirium, according to Sharon K. Inouye, MD, and her associates.

In a prospective cohort study of 560 patients aged 70 years and older, 134 patients were selected for the delirium group and 426 for the nondelirium group. The delirium group had a significantly greater decline (–1.03 points) at 1 month, compared with those without delirium (P = .003). After cognitive function had recovered at 2 months, there were no significant differences between groups (P = 0.99). After 2 months, both groups decline on average; however, the delirium group declined significantly more (–1.07) in adjusted mean scores at 36 months (P =.02).

©Wavebreakmedia Ltd/thinkstockphotos.com

From baseline to 36 months, there was a significant change for the delirium group (–1.30, P less than .01) and no significant change for the group without delirium (–0.23, P = .30). Researchers noted that the effect of delirium remains undiminished after consecutive rehospitalizations, intercurrent illnesses, and major postoperative complications were controlled for.

The patients underwent major noncardiac surgery, such as total hip or knee replacement, open abdominal aortic aneurysm repair, colectomy, and lower-extremity arterial bypass.

“This study provides a novel presentation of the biphasic relationship of delirium and cognitive trajectory, both its well-recognized acute effects but also long-term effects,” the researchers wrote. “Our results suggest that after a period of initial recovery, patients with delirium experience a substantially accelerated trajectory of cognitive aging.”

Read the full study in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association (doi:10.1016/j.jalz.2016.03.005).

[email protected]

The location of ligament tears within a pitcher’s elbow can be key to predicting the success of non-operative treatment for injuries, according to the results of a study presented at the 2016 annual meeting of the American Orthopedic Society of Sports Medicine.

Researchers examined 38 pitchers from one professional baseball organization (both major and minor league teams) who sustained ulnar collateral ligament (UCL) injuries between 2006 and 2015,. Thirty-two players (84%) received non-operative treatment for partial ligament tears. A proximal tear of the UCL was identified in 81% of the patients who were successfully treated non-operatively. By contrast, a distal tear of the UCL was detected in 90% of patients who failed non-operative treatment and required surgery.

The location of ligament tears within a pitcher’s elbow can be key to predicting the success of non-operative treatment for injuries, according to the results of a study presented at the 2016 annual meeting of the American Orthopedic Society of Sports Medicine.

Researchers examined 38 pitchers from one professional baseball organization (both major and minor league teams) who sustained ulnar collateral ligament (UCL) injuries between 2006 and 2015,. Thirty-two players (84%) received non-operative treatment for partial ligament tears. A proximal tear of the UCL was identified in 81% of the patients who were successfully treated non-operatively. By contrast, a distal tear of the UCL was detected in 90% of patients who failed non-operative treatment and required surgery.

The location of ligament tears within a pitcher’s elbow can be key to predicting the success of non-operative treatment for injuries, according to the results of a study presented at the 2016 annual meeting of the American Orthopedic Society of Sports Medicine.

Researchers examined 38 pitchers from one professional baseball organization (both major and minor league teams) who sustained ulnar collateral ligament (UCL) injuries between 2006 and 2015,. Thirty-two players (84%) received non-operative treatment for partial ligament tears. A proximal tear of the UCL was identified in 81% of the patients who were successfully treated non-operatively. By contrast, a distal tear of the UCL was detected in 90% of patients who failed non-operative treatment and required surgery.

After anterior cruciate ligament (ACL) reconstruction, women younger than age 25 with a graft size of <8 mm have an increased change of re-tearing their ACL, according to the results of a study presented at the 2016 annual meeting of the American Orthopedic Society of Sports Medicine.

Researchers studied 503 athletes (235 women and 268 men; average age 27) undergoing primary, autograft hamstring ACL reconstruction. The surgeries were all performed at a single center by a single surgeon between September through December 2012. Patients were followed for 2 years. Overall, the rate of re-tears was 6% and the mean graft size was 7.9 mm.

Graft size <8 mm and age < 25 years were significantly predictive of re‐tear. Female sex was correlated with re‐tear but was not significant.

After anterior cruciate ligament (ACL) reconstruction, women younger than age 25 with a graft size of <8 mm have an increased change of re-tearing their ACL, according to the results of a study presented at the 2016 annual meeting of the American Orthopedic Society of Sports Medicine.

Researchers studied 503 athletes (235 women and 268 men; average age 27) undergoing primary, autograft hamstring ACL reconstruction. The surgeries were all performed at a single center by a single surgeon between September through December 2012. Patients were followed for 2 years. Overall, the rate of re-tears was 6% and the mean graft size was 7.9 mm.

Graft size <8 mm and age < 25 years were significantly predictive of re‐tear. Female sex was correlated with re‐tear but was not significant.

After anterior cruciate ligament (ACL) reconstruction, women younger than age 25 with a graft size of <8 mm have an increased change of re-tearing their ACL, according to the results of a study presented at the 2016 annual meeting of the American Orthopedic Society of Sports Medicine.

Researchers studied 503 athletes (235 women and 268 men; average age 27) undergoing primary, autograft hamstring ACL reconstruction. The surgeries were all performed at a single center by a single surgeon between September through December 2012. Patients were followed for 2 years. Overall, the rate of re-tears was 6% and the mean graft size was 7.9 mm.

Graft size <8 mm and age < 25 years were significantly predictive of re‐tear. Female sex was correlated with re‐tear but was not significant.

Although both men and women generally do well after having arthroscopic surgery for hip impingement, patients over age 45, particularly women over 45, don’t fare quite as well, according to a study published May 18 in The Journal of Bone and Joint Surgery.

Researchers examined 150 men and women of various ages, who underwent hip arthroscopy to treat femoroacetabular impingement (FAI). Patients were divided into groups based on age and sex. Outcomes were evaluated based on results from several instruments, include the Hip Outcome Score Activities of Daily Living Subscale, Hip Outcome Score Sport-Specific Subscale, and modified Harris hip score, as well as by clinical improvement at follow-up.

Researchers found that while all patients had significant improvements after hip arthroscopy for FAI, patients under age 45 had better overall results and fewer complications compared with people over age 45. Women older than age 45 had lower outcome scores than their male counterparts.

Although both men and women generally do well after having arthroscopic surgery for hip impingement, patients over age 45, particularly women over 45, don’t fare quite as well, according to a study published May 18 in The Journal of Bone and Joint Surgery.

Researchers examined 150 men and women of various ages, who underwent hip arthroscopy to treat femoroacetabular impingement (FAI). Patients were divided into groups based on age and sex. Outcomes were evaluated based on results from several instruments, include the Hip Outcome Score Activities of Daily Living Subscale, Hip Outcome Score Sport-Specific Subscale, and modified Harris hip score, as well as by clinical improvement at follow-up.

Researchers found that while all patients had significant improvements after hip arthroscopy for FAI, patients under age 45 had better overall results and fewer complications compared with people over age 45. Women older than age 45 had lower outcome scores than their male counterparts.

Although both men and women generally do well after having arthroscopic surgery for hip impingement, patients over age 45, particularly women over 45, don’t fare quite as well, according to a study published May 18 in The Journal of Bone and Joint Surgery.

Researchers examined 150 men and women of various ages, who underwent hip arthroscopy to treat femoroacetabular impingement (FAI). Patients were divided into groups based on age and sex. Outcomes were evaluated based on results from several instruments, include the Hip Outcome Score Activities of Daily Living Subscale, Hip Outcome Score Sport-Specific Subscale, and modified Harris hip score, as well as by clinical improvement at follow-up.

Researchers found that while all patients had significant improvements after hip arthroscopy for FAI, patients under age 45 had better overall results and fewer complications compared with people over age 45. Women older than age 45 had lower outcome scores than their male counterparts.

Nearly 2% of patients who undergo total knee arthroplasty (TKA) or total hip arthroplasty (THA) develop a periprosthetic joint infection (PJI) within 20 years of surgery, and 41% of these infections occur within the first 2 years.¹ PJI is the most common cause of TKA failure and the third leading complication of THA.² The estimated total hospital cost of treating PJI increased from $320 million in 2001 to $566 million in 2009, which can be extrapolated to $1.62 billion in 2020.³ By 2030, the projected increase in demand for TKA and THA will be 673% and 174% of what it was in 2005, respectively.⁴ Treatment of PJI of the knee is estimated to cost 3 to 4 times more than a primary TKA, and the cost of revision THA for PJI is almost $6000 more than that of revision TKA for PJI.³

In this article, we review the numerous preoperative, intraoperative, and postoperative methods of decreasing PJI incidence after total joint arthroplasty (TJA).

Preoperative Risk Prevention

Medical Comorbidities

Preoperative medical optimization is a key element in PJI prevention (Table 1). An American Society of Anesthesiologists classification score of 3 or more has been associated with doubled risk for surgical site infections (SSIs) after THA.5 Autoimmune conditions confer a particularly higher risk. In a retrospective double-cohort study of 924 subjects, Bongartz and colleagues⁶ found that, compared with osteoarthritis, rheumatoid arthritis tripled the risk of PJI. Small case series originally suggested a higher risk of PJI in patients with psoriasis,^7,8 but more recent studies have contradicted that finding.^9,10 Nevertheless, psoriatic plaques have elevated bacterial counts,¹¹ and planned incisions should circumvent these areas.

Diabetes mellitus is a clear risk factor for PJI.^12-16 Regarding whether preoperative glucose control affects risk, findings have been mixed. Mraovic and colleagues¹⁷ showed preoperative hyperglycemia to be an independent risk factor; Jämsen and colleagues,¹⁵ in a single-center analysis of more than 7000 TJAs, suggested preoperative blood glucose levels were not independently associated with PJI; and Iorio and colleagues¹⁶ found no association between surgical infections and hemoglobin A1c levels.

TJA incidence is higher in patients with chronic kidney disease (CKD) than in the general population.¹⁸ Dialysis users have a post-THA PJI rate as high as 13% to 19%.^19,20 Early clinical data suggested that outcomes are improved in dialysis users who undergo renal transplant, but this finding recently has been questioned.^19,21 Deegan and colleagues²² found an increased PJA rate of 3.5% even in low-level CKD (stage 1, 2, or 3), but this may be confounded by the increased association of CKD with other PJI-predisposing comorbidities.

Given a higher incidence of urinary tract infections (UTIs) among patients with PJI, some surgeons think UTIs predispose to PJIs by hematogenous seeding.^12,23,24 Symptomatic UTIs should be cleared before surgery and confirmed on urinalysis. Obstructive symptoms should prompt urologic evaluation. As asymptomatic pyuria and bacteriuria (colony counts, >1 × 105/mL) do not predispose to PJI, patients without symptoms do not require intervention.^25,26 Past history of malignancy may also have a role in PJI. In a case-control study of the Mayo Clinic arthroplasty experience from 1969 to 1991, Berbari and colleagues¹ found an association between malignancy and PJI (odds ratio, 2.4). They theorized the immunosuppressive effects of cancer treatment might be responsible for this increased risk.

Immunocompromising Medications

Immunocompromising medications are modifiable and should be adjusted before surgery. Stopping any disease-modifying antirheumatic drug (DMARD) more than 4 weeks before surgery is not recommended.²⁷

Corticosteroid use can lead to immunosuppression and increased protein catabolism, which impairs soft-tissue healing. To avoid flares or adrenal insufficiency, however, chronic corticosteroid users should continue their regular doses perioperatively.²⁸ On the day of surgery, they should also receive a stress dose of hydrocortisone 50 to 75 mg (for primary arthroplasty) or 100 to 150 mg (for revision arthroplasty), followed by expeditious tapering over 1 to 2 days.²⁹ DMARDs are increasingly used by rheumatologists. One of the most effective DMARDs is methotrexate. Despite its immunocompromising activity, methotrexate should be continued perioperatively, as stopping for even 2 days may increase flare-related complications.³⁰ Hydroxychloroquine can be continued perioperatively and has even been shown, by Johnson and Charnley,³¹ to prevent deep vein thromboses. Sulfasalazine can also be continued perioperatively—but with caution, as it may elevate international normalized ratio (INR) levels in patients receiving warfarin.²⁹ Most other DMARDs should be temporarily discontinued. Leflunomide and interleukin 1 antagonists, such as anakinra, should be stopped 1 to 2 days before surgery and restarted 10 to 14 days after surgery.²⁹ Rituximab should be stopped 1 week before surgery and restarted 10 to 14 days after surgery. Tumor necrosis factor α inhibitors should be discontinued for 2 half-lives before and after surgery.³² Etanercept has a half-life of 3 to 5 days; infliximab, 8 to 10 days; and adalimumab, 10 to 13 days. Most surgeons schedule surgery for the end of a dosing cycle and discontinue these biologic agents for another 10 to 14 days after surgery.

Metabolic Factors

Obese patients are susceptible to longer surgeries, more extensive dissection, poorly vascularized subcutaneous tissue, and higher requirements of weight-adjusted antibiotic dosing.¹³ Body mass index (BMI) of 40 kg/m² or more (morbid obesity) and BMI over 50 kg/m² have been associated with 9 times and 21.3 times increased risk of PJI, respectively.^13,14 Delaying surgery with dietary consultation has been suggested,^33,34 and bariatric surgery before TKA may decrease infection rates by 3.5 times.³⁵

Nutritional markers are considered before arthroplasty. According to most laboratories, a serum transferrin level under 200 mg/dL, albumin level under 3.5 g/dL, and total lymphocyte count under 1500 cells/mm³ indicate malnourishment, which can increase the incidence of wound complications by 5 to 7 times.³⁶ Patients should also have sufficient protein, vitamin, and mineral supplementation, particularly vitamins A and C, zinc, and copper.³⁷Smokers who cease smoking at least 4 to 6 weeks before surgery lower their wound complication rate by up to 26%.^38,39 When nicotine leaves the bloodstream, vasodilation occurs, oxygenation improves, and the immune system recovers.³⁹ Studies have found more SSIs in patients who abuse alcohol,40 and numerous authors have confirmed this finding in the arthroplasty population.^24,41,42 Alcohol inhibits platelet function and may predispose to a postoperative hematoma. In contrast to smoking cessation evidence, evidence regarding alcohol interventions in preventing postoperative infections is less conclusive.^43,44

MRSA Colonization

Methicillin-resistant Staphylococcus aureus (MRSA) is a particularly difficult bacterium to eradicate in PJI. As the mean cost of treating a single case of MRSA-related prosthetic infection is $107,264 vs $68,053 for susceptible strains,45,46 many infection-containment strategies focus on addressing benign MRSA colonization before surgery.

MRSA is present in the nares of 25 million people in the United States. Nasal colonization increases the risk of bacteremia 4-fold⁴⁷ and SSI 2- to 9-fold.^48,49 Nasal swabs are analyzed with either a rapid polymerase chain reaction (PCR) test, which provides results in 2 hours, or a bacterial culture, which provides results in 1 to 4 days. The PCR test is more expensive.

Eradication of MRSA colonization is increasingly prevalent. Several Scandinavian countries have instituted strict practices by which patients are denied elective surgery until negative nasal swabs are obtained.⁴⁹ Nasal decontamination is one method of colonization reduction. Topical mupirocin, which yields eradication in 91% of nasal carriers immediately after treatment and in 87% after 4 weeks,⁵⁰ is effective in reducing SSI rates only when used in conjunction with a body wash, which is used to clean the axilla and groin.⁵¹ There is no consensus on optimal timing, but Bode and colleagues⁵² found a significant decrease in deep SSIs when decontamination occurred just 24 hours before surgery.

Povidone-iodine showers went out of favor with the realization that chlorhexidine gluconate acts longer on the skin surface.^53,54 Preoperative showers involve rinsing with liquid chlorhexidine soap 24 to 48 hours before surgery. However, chlorhexidine binds preferentially to the cotton in washcloths instead of the skin. Edmiston and colleagues^54,55 found that 4% chlorhexidine liquid soaps achieve much lower skin chlorhexidine concentrations than 2% polyester cloths do. Use of these “chlorhexidine wipes” the night before and the day of surgery has decreased PJI after TKA from 2.2% to 0.6%.^56,57

Intraoperative Risk Prevention

Preparation

Which preoperative antibiotic to use is one of the first operative considerations in PJI prophylaxis (Table 2). Cefazolin is recommended as a first-line agent for its excellent soft-tissue penetration, long half-life, and activity against gram-positive bacteria such as skin flora.⁵⁸ Clindamycin may be considered for patients allergic to β-lactam antibiotics. Vancomycin may be considered for adjunctive use with cephalosporins in cases of known MRSA colonization. Vancomycin infusion should be started earlier than infusion with other antibiotics, as vancomycin must be infused slowly and takes longer to become therapeutic.

Antibiotic dosing should be based on local antibiograms, adjusted dosing weight, or BMI.⁵⁹ For revision arthroplasty, preoperative prophylaxis should not be stopped out of fear of affecting operative cultures.⁶⁰ Some surgeons pause antibiotic use if a preoperative joint aspirate has not been obtained. Infusion within 1 hour of incision is part of the pay-for-performance guidelines established by the US Centers for Medicare & Medicaid Services.⁶¹ An antibiotic should be redosed if the operation will take longer than 2 half-lives of the drug.⁵⁹ Surgeons should consider administering a dose every 4 hours or whenever blood loss exceeds 1000 mL.⁶² Engesæter and colleagues⁶³ found that antibiotic prophylaxis was most effective given 4 times perioperatively (1 time before surgery, 3 times after surgery). Postoperative antibiotics should not be administered longer than 24 hours, as prolonged dosing confers no benefit.⁵⁸ Operating room conditions must be optimized for prophylaxis. More people and operating room traffic in nonsterile corridors increase contamination of instruments open to air.⁶⁴ Laminar airflow systems are commonly used. Although there is little dispute that laminar flow decreases the bacterial load of air, there are mixed results regarding its benefit in preventing PJI.^65-68 Skin preparation may address patient risk factors. Hair clipping is preferred to shaving, which may cause microabrasions and increased susceptibility to skin flora.69 Patients should be prepared with antiseptic solution. One randomized controlled trial found that 2% chlorhexidine gluconate mixed with 70% isopropyl alcohol was superior to 10% povidone-iodine in preventing SSIs.⁷⁰ However, a recent cohort study showed a lower rate of superficial wound infections when 1% povidone-iodine (vs 0.5% chlorhexidine) was used with alcohol.⁷¹ This finding may indicate the need for alcohol preparation, higher concentrations of chlorhexidine, or both.

Proper scrubbing and protective gear are needed to reduce surgeon risk factors. Hand washing is a routine part of any surgery. Alcohol-based hand scrubs are as effective as hand scrubbing.65 They reduce local skin flora by 95% immediately and by 99% with repeated applications.⁷² Lidwell and colleagues⁷³ found a 75% reduction in infection when body exhaust suits were used in combination with laminar flow in a multicenter randomized controlled trial of 8052 patients. Sterile draping with impermeable drapes should be done over properly prepared skin. Ioban drapes (3M) are often used as a protective barrier. Interestingly, a Cochrane review found no benefit in using plastic adhesives impregnated with iodine over sterilely prepared skin.⁷⁴

Operative Considerations

Surgical gloves become contaminated in almost one third of cases, half the time during draping.⁷⁵ For this reason, many surgeons change gloves after draping. In addition, double gloving prevents a breech of aseptic technique should the outer glove become perforated.⁷⁶ Demircay and colleagues⁷⁷ assessed double latex gloving in arthroplasty and found the outer and inner gloves perforated in 18.4% and 8.4% of cases, respectively. Punctures are most common along the nondominant index finger, and then the dominant thumb.^77,78 Perforation is more common when 2 latex gloves are worn—vs 1 latex glove plus an outer cloth glove—and the chance of perforation increases with surgery duration. The inner glove may become punctured in up to 100% of operations that last over 3 hours.⁷⁹ Although Dodds and colleagues⁸⁰ found no change in bacterial counts on surgeons’ hands or gloves after perforation, precautions are still recommended. Al-Maiyah and colleagues⁸¹ went as far as to recommend glove changes at 20-minute intervals and before cementation.

Surgical instruments can be sources of contamination. Some authors change the suction tip every hour to minimize the risk of deep wound infection.^82-85 Others change it before femoral canal preparation and prosthesis insertion during THA.⁸⁶ The splash basin is frequently contaminated, and instruments placed in it should not be returned to the operative field.⁸⁷ Hargrove and colleagues⁸⁸ suggested pulsatile lavage decreases PJI more than bulb syringe irrigation does, whereas others argued that high-pressure lavage allows bacteria to penetrate more deeply, which could lead to retention of more bacteria.⁸⁹ Minimizing operating room time was found by Kurtz and colleagues⁹⁰ and Peersman and colleagues⁹¹ to decrease PJI incidence. Carroll and colleagues⁷¹ correlated longer tourniquet use with a higher rate of infection after TKA; proposed mechanisms include local tissue hypoxia and lowered concentrations of prophylactic antibiotics.

Similarly, minimizing blood loss and transfusion needs is another strategy for preventing infection. Allogenic transfusion may increase the risk of PJI 2 times.^23,71,92 The mechanism seems to be immune system modulation by allogenic blood, which impairs microcirculation and oxygen delivery at the surgical site.^23,75 Transfusions should be approached with caution, and consideration given to preoperative optimization and autologous blood donation. Cherian and colleagues⁹³ reviewed different blood management strategies and found preoperative iron therapy, intravenous erythropoietin, and autologous blood donation to be equally effective in reducing the need for allogenic transfusions. Numerous studies of tranexamic acid, thrombin-based hemostatic matrix (Floseal; Baxter Inc), and bipolar sealer with radiofrequency ablation (Aquamantys; Medtronic Inc) have found no alterations in infection rates, but most have used calculated blood loss, not PJI, as the primary endpoint.^94-105 Antibiotic cement also can be used to block infection.^63,106-110 Although liquid gentamicin may weaken bone cement,¹¹¹ most antibiotics, including powdered tobramycin and vancomycin, do not weaken its fatigue strength.^111-114 A recent meta-analysis by Parvizi and colleagues¹¹⁵ revealed that deep infection rates dropped from 2.3% to 1.2% with use of antibiotic cement for primary THAs. Cummins and colleagues,¹¹⁶ however, reported the limited cost-effectiveness of antibiotic cement in primary arthroplasty. Performing povidone-iodine lavage at the end of the case may be a more inexpensive alternative. Brown and colleagues¹¹⁷ found that rinsing with dilute povidone-iodine (.35%) for 3 minutes significantly decreased the incidence of PJI.

Closure techniques and sutures have been a focus of much of the recent literature. Winiarsky and colleagues³⁴ advocated using a longer incision for obese patients and augmenting closure in fattier areas with vertical mattress retention sutures, which are removed after 5 days. A barbed monofilament suture (Quill; Angiotech Inc) is gaining in popularity. Laboratory research has shown that bacteria adhere less to barbed monofilament sutures than to braided sutures.¹¹⁸ Smith and colleagues¹¹⁹ found a statistically nonsignificant higher rate of wound complications with barbed monofilament sutures, whereas Ting and colleagues120 found no difference in complications. These studies were powered to detect differences in time and cost, not postoperative complications. Skin adhesive (Dermabond; Ethicon Inc), also used in closure, may be superior to staples in avoiding superficial skin abscesses.¹²¹ Although expensive, silver-impregnated dressing has antimicrobial activity that reduces PJI incidence by up to 74%.¹²² One brand of this dressing (Aquacel; ConvaTec Inc) has a polyurethane waterproof barrier that allows it to be worn for 7 days.

Three factors commonly mentioned in PJI prevention show little supporting evidence. Drains, which are often used, may create a passage for postoperative infection and are associated with increased transfusion needs.^123,124 Adding antibiotics to irrigation solution¹²⁵ and routinely changing scalpel blades^126-129 also have little supporting evidence. In 2014, the utility of changing scalpel blades after incision was studied by Lee and colleagues,¹³⁰ who reported persistence of Propionibacterium acnes in the dermal layer after skin preparation. Their study, however, was isolated to the upper back region, not the hip or knee.

Postoperative Risk Prevention

Most arthroplasty patients receive anticoagulation after surgery, but it must be used with caution. Large hematomas can predispose to wound complications. Parvizi and colleagues¹³¹ associated wound drainage, hematoma, and subsequent PJI with an INR above 1.5 in the early postoperative period. Therefore, balanced anticoagulation is crucial. Postoperative glucose control is also essential, particularly for patients with diabetes. Although preoperative blood glucose levels may or may not affect PJI risk,^15,17,132 postoperative blood glucose levels of 126 mg/dL or higher are strongly associated with joint infections.¹³³ Even nondiabetic patients with postoperative morning levels over 140 mg/dL are 3 times more likely to develop an infection.¹⁷

Efforts should be made to discharge patients as soon as it is safe to do so. With longer hospital stays, patients are more exposed to nosocomial organisms and increased antibiotic resistance.^5,23,134 Outpatient antibiotics should be considered for dental, gastrointestinal, and genitourinary procedures. Oral antibiotic prophylaxis is controversial, as there is some evidence that dental procedures increase the risk of PJI only minimally.^10,135-138

Conclusion

PJI is a potentially devastating complication of TJA. For this reason, much research has been devoted to proper diagnosis and treatment. Although the literature on PJI prophylaxis is abundant, there is relatively little consensus on appropriate PJI precautions. Preoperative considerations should include medical comorbidities, use of immunocompromising medications, obesity, nutritional factors, smoking, alcohol use, and MRSA colonization. Surgeons must have a consistent intraoperative method of antibiotic administration, skin preparation, scrubbing, draping, gloving, instrument exchange, blood loss management, cementing, and closure. In addition, monitoring of postoperative anticoagulation and blood glucose management is important. Having a thorough understanding of PJI risk factors may help reduce the incidence of this devastating complication.

Nearly 2% of patients who undergo total knee arthroplasty (TKA) or total hip arthroplasty (THA) develop a periprosthetic joint infection (PJI) within 20 years of surgery, and 41% of these infections occur within the first 2 years.¹ PJI is the most common cause of TKA failure and the third leading complication of THA.² The estimated total hospital cost of treating PJI increased from $320 million in 2001 to $566 million in 2009, which can be extrapolated to $1.62 billion in 2020.³ By 2030, the projected increase in demand for TKA and THA will be 673% and 174% of what it was in 2005, respectively.⁴ Treatment of PJI of the knee is estimated to cost 3 to 4 times more than a primary TKA, and the cost of revision THA for PJI is almost $6000 more than that of revision TKA for PJI.³

In this article, we review the numerous preoperative, intraoperative, and postoperative methods of decreasing PJI incidence after total joint arthroplasty (TJA).

Preoperative Risk Prevention

Medical Comorbidities

Preoperative medical optimization is a key element in PJI prevention (Table 1). An American Society of Anesthesiologists classification score of 3 or more has been associated with doubled risk for surgical site infections (SSIs) after THA.5 Autoimmune conditions confer a particularly higher risk. In a retrospective double-cohort study of 924 subjects, Bongartz and colleagues⁶ found that, compared with osteoarthritis, rheumatoid arthritis tripled the risk of PJI. Small case series originally suggested a higher risk of PJI in patients with psoriasis,^7,8 but more recent studies have contradicted that finding.^9,10 Nevertheless, psoriatic plaques have elevated bacterial counts,¹¹ and planned incisions should circumvent these areas.

Diabetes mellitus is a clear risk factor for PJI.^12-16 Regarding whether preoperative glucose control affects risk, findings have been mixed. Mraovic and colleagues¹⁷ showed preoperative hyperglycemia to be an independent risk factor; Jämsen and colleagues,¹⁵ in a single-center analysis of more than 7000 TJAs, suggested preoperative blood glucose levels were not independently associated with PJI; and Iorio and colleagues¹⁶ found no association between surgical infections and hemoglobin A1c levels.

TJA incidence is higher in patients with chronic kidney disease (CKD) than in the general population.¹⁸ Dialysis users have a post-THA PJI rate as high as 13% to 19%.^19,20 Early clinical data suggested that outcomes are improved in dialysis users who undergo renal transplant, but this finding recently has been questioned.^19,21 Deegan and colleagues²² found an increased PJA rate of 3.5% even in low-level CKD (stage 1, 2, or 3), but this may be confounded by the increased association of CKD with other PJI-predisposing comorbidities.

Given a higher incidence of urinary tract infections (UTIs) among patients with PJI, some surgeons think UTIs predispose to PJIs by hematogenous seeding.^12,23,24 Symptomatic UTIs should be cleared before surgery and confirmed on urinalysis. Obstructive symptoms should prompt urologic evaluation. As asymptomatic pyuria and bacteriuria (colony counts, >1 × 105/mL) do not predispose to PJI, patients without symptoms do not require intervention.^25,26 Past history of malignancy may also have a role in PJI. In a case-control study of the Mayo Clinic arthroplasty experience from 1969 to 1991, Berbari and colleagues¹ found an association between malignancy and PJI (odds ratio, 2.4). They theorized the immunosuppressive effects of cancer treatment might be responsible for this increased risk.

Immunocompromising Medications

Immunocompromising medications are modifiable and should be adjusted before surgery. Stopping any disease-modifying antirheumatic drug (DMARD) more than 4 weeks before surgery is not recommended.²⁷

Corticosteroid use can lead to immunosuppression and increased protein catabolism, which impairs soft-tissue healing. To avoid flares or adrenal insufficiency, however, chronic corticosteroid users should continue their regular doses perioperatively.²⁸ On the day of surgery, they should also receive a stress dose of hydrocortisone 50 to 75 mg (for primary arthroplasty) or 100 to 150 mg (for revision arthroplasty), followed by expeditious tapering over 1 to 2 days.²⁹ DMARDs are increasingly used by rheumatologists. One of the most effective DMARDs is methotrexate. Despite its immunocompromising activity, methotrexate should be continued perioperatively, as stopping for even 2 days may increase flare-related complications.³⁰ Hydroxychloroquine can be continued perioperatively and has even been shown, by Johnson and Charnley,³¹ to prevent deep vein thromboses. Sulfasalazine can also be continued perioperatively—but with caution, as it may elevate international normalized ratio (INR) levels in patients receiving warfarin.²⁹ Most other DMARDs should be temporarily discontinued. Leflunomide and interleukin 1 antagonists, such as anakinra, should be stopped 1 to 2 days before surgery and restarted 10 to 14 days after surgery.²⁹ Rituximab should be stopped 1 week before surgery and restarted 10 to 14 days after surgery. Tumor necrosis factor α inhibitors should be discontinued for 2 half-lives before and after surgery.³² Etanercept has a half-life of 3 to 5 days; infliximab, 8 to 10 days; and adalimumab, 10 to 13 days. Most surgeons schedule surgery for the end of a dosing cycle and discontinue these biologic agents for another 10 to 14 days after surgery.

Metabolic Factors

Obese patients are susceptible to longer surgeries, more extensive dissection, poorly vascularized subcutaneous tissue, and higher requirements of weight-adjusted antibiotic dosing.¹³ Body mass index (BMI) of 40 kg/m² or more (morbid obesity) and BMI over 50 kg/m² have been associated with 9 times and 21.3 times increased risk of PJI, respectively.^13,14 Delaying surgery with dietary consultation has been suggested,^33,34 and bariatric surgery before TKA may decrease infection rates by 3.5 times.³⁵

Nutritional markers are considered before arthroplasty. According to most laboratories, a serum transferrin level under 200 mg/dL, albumin level under 3.5 g/dL, and total lymphocyte count under 1500 cells/mm³ indicate malnourishment, which can increase the incidence of wound complications by 5 to 7 times.³⁶ Patients should also have sufficient protein, vitamin, and mineral supplementation, particularly vitamins A and C, zinc, and copper.³⁷Smokers who cease smoking at least 4 to 6 weeks before surgery lower their wound complication rate by up to 26%.^38,39 When nicotine leaves the bloodstream, vasodilation occurs, oxygenation improves, and the immune system recovers.³⁹ Studies have found more SSIs in patients who abuse alcohol,40 and numerous authors have confirmed this finding in the arthroplasty population.^24,41,42 Alcohol inhibits platelet function and may predispose to a postoperative hematoma. In contrast to smoking cessation evidence, evidence regarding alcohol interventions in preventing postoperative infections is less conclusive.^43,44

MRSA Colonization

Methicillin-resistant Staphylococcus aureus (MRSA) is a particularly difficult bacterium to eradicate in PJI. As the mean cost of treating a single case of MRSA-related prosthetic infection is $107,264 vs $68,053 for susceptible strains,45,46 many infection-containment strategies focus on addressing benign MRSA colonization before surgery.

MRSA is present in the nares of 25 million people in the United States. Nasal colonization increases the risk of bacteremia 4-fold⁴⁷ and SSI 2- to 9-fold.^48,49 Nasal swabs are analyzed with either a rapid polymerase chain reaction (PCR) test, which provides results in 2 hours, or a bacterial culture, which provides results in 1 to 4 days. The PCR test is more expensive.

Eradication of MRSA colonization is increasingly prevalent. Several Scandinavian countries have instituted strict practices by which patients are denied elective surgery until negative nasal swabs are obtained.⁴⁹ Nasal decontamination is one method of colonization reduction. Topical mupirocin, which yields eradication in 91% of nasal carriers immediately after treatment and in 87% after 4 weeks,⁵⁰ is effective in reducing SSI rates only when used in conjunction with a body wash, which is used to clean the axilla and groin.⁵¹ There is no consensus on optimal timing, but Bode and colleagues⁵² found a significant decrease in deep SSIs when decontamination occurred just 24 hours before surgery.

Povidone-iodine showers went out of favor with the realization that chlorhexidine gluconate acts longer on the skin surface.^53,54 Preoperative showers involve rinsing with liquid chlorhexidine soap 24 to 48 hours before surgery. However, chlorhexidine binds preferentially to the cotton in washcloths instead of the skin. Edmiston and colleagues^54,55 found that 4% chlorhexidine liquid soaps achieve much lower skin chlorhexidine concentrations than 2% polyester cloths do. Use of these “chlorhexidine wipes” the night before and the day of surgery has decreased PJI after TKA from 2.2% to 0.6%.^56,57

Intraoperative Risk Prevention

Preparation

Which preoperative antibiotic to use is one of the first operative considerations in PJI prophylaxis (Table 2). Cefazolin is recommended as a first-line agent for its excellent soft-tissue penetration, long half-life, and activity against gram-positive bacteria such as skin flora.⁵⁸ Clindamycin may be considered for patients allergic to β-lactam antibiotics. Vancomycin may be considered for adjunctive use with cephalosporins in cases of known MRSA colonization. Vancomycin infusion should be started earlier than infusion with other antibiotics, as vancomycin must be infused slowly and takes longer to become therapeutic.

Antibiotic dosing should be based on local antibiograms, adjusted dosing weight, or BMI.⁵⁹ For revision arthroplasty, preoperative prophylaxis should not be stopped out of fear of affecting operative cultures.⁶⁰ Some surgeons pause antibiotic use if a preoperative joint aspirate has not been obtained. Infusion within 1 hour of incision is part of the pay-for-performance guidelines established by the US Centers for Medicare & Medicaid Services.⁶¹ An antibiotic should be redosed if the operation will take longer than 2 half-lives of the drug.⁵⁹ Surgeons should consider administering a dose every 4 hours or whenever blood loss exceeds 1000 mL.⁶² Engesæter and colleagues⁶³ found that antibiotic prophylaxis was most effective given 4 times perioperatively (1 time before surgery, 3 times after surgery). Postoperative antibiotics should not be administered longer than 24 hours, as prolonged dosing confers no benefit.⁵⁸ Operating room conditions must be optimized for prophylaxis. More people and operating room traffic in nonsterile corridors increase contamination of instruments open to air.⁶⁴ Laminar airflow systems are commonly used. Although there is little dispute that laminar flow decreases the bacterial load of air, there are mixed results regarding its benefit in preventing PJI.^65-68 Skin preparation may address patient risk factors. Hair clipping is preferred to shaving, which may cause microabrasions and increased susceptibility to skin flora.69 Patients should be prepared with antiseptic solution. One randomized controlled trial found that 2% chlorhexidine gluconate mixed with 70% isopropyl alcohol was superior to 10% povidone-iodine in preventing SSIs.⁷⁰ However, a recent cohort study showed a lower rate of superficial wound infections when 1% povidone-iodine (vs 0.5% chlorhexidine) was used with alcohol.⁷¹ This finding may indicate the need for alcohol preparation, higher concentrations of chlorhexidine, or both.

Proper scrubbing and protective gear are needed to reduce surgeon risk factors. Hand washing is a routine part of any surgery. Alcohol-based hand scrubs are as effective as hand scrubbing.65 They reduce local skin flora by 95% immediately and by 99% with repeated applications.⁷² Lidwell and colleagues⁷³ found a 75% reduction in infection when body exhaust suits were used in combination with laminar flow in a multicenter randomized controlled trial of 8052 patients. Sterile draping with impermeable drapes should be done over properly prepared skin. Ioban drapes (3M) are often used as a protective barrier. Interestingly, a Cochrane review found no benefit in using plastic adhesives impregnated with iodine over sterilely prepared skin.⁷⁴

Operative Considerations

Surgical gloves become contaminated in almost one third of cases, half the time during draping.⁷⁵ For this reason, many surgeons change gloves after draping. In addition, double gloving prevents a breech of aseptic technique should the outer glove become perforated.⁷⁶ Demircay and colleagues⁷⁷ assessed double latex gloving in arthroplasty and found the outer and inner gloves perforated in 18.4% and 8.4% of cases, respectively. Punctures are most common along the nondominant index finger, and then the dominant thumb.^77,78 Perforation is more common when 2 latex gloves are worn—vs 1 latex glove plus an outer cloth glove—and the chance of perforation increases with surgery duration. The inner glove may become punctured in up to 100% of operations that last over 3 hours.⁷⁹ Although Dodds and colleagues⁸⁰ found no change in bacterial counts on surgeons’ hands or gloves after perforation, precautions are still recommended. Al-Maiyah and colleagues⁸¹ went as far as to recommend glove changes at 20-minute intervals and before cementation.

Surgical instruments can be sources of contamination. Some authors change the suction tip every hour to minimize the risk of deep wound infection.^82-85 Others change it before femoral canal preparation and prosthesis insertion during THA.⁸⁶ The splash basin is frequently contaminated, and instruments placed in it should not be returned to the operative field.⁸⁷ Hargrove and colleagues⁸⁸ suggested pulsatile lavage decreases PJI more than bulb syringe irrigation does, whereas others argued that high-pressure lavage allows bacteria to penetrate more deeply, which could lead to retention of more bacteria.⁸⁹ Minimizing operating room time was found by Kurtz and colleagues⁹⁰ and Peersman and colleagues⁹¹ to decrease PJI incidence. Carroll and colleagues⁷¹ correlated longer tourniquet use with a higher rate of infection after TKA; proposed mechanisms include local tissue hypoxia and lowered concentrations of prophylactic antibiotics.

Similarly, minimizing blood loss and transfusion needs is another strategy for preventing infection. Allogenic transfusion may increase the risk of PJI 2 times.^23,71,92 The mechanism seems to be immune system modulation by allogenic blood, which impairs microcirculation and oxygen delivery at the surgical site.^23,75 Transfusions should be approached with caution, and consideration given to preoperative optimization and autologous blood donation. Cherian and colleagues⁹³ reviewed different blood management strategies and found preoperative iron therapy, intravenous erythropoietin, and autologous blood donation to be equally effective in reducing the need for allogenic transfusions. Numerous studies of tranexamic acid, thrombin-based hemostatic matrix (Floseal; Baxter Inc), and bipolar sealer with radiofrequency ablation (Aquamantys; Medtronic Inc) have found no alterations in infection rates, but most have used calculated blood loss, not PJI, as the primary endpoint.^94-105 Antibiotic cement also can be used to block infection.^63,106-110 Although liquid gentamicin may weaken bone cement,¹¹¹ most antibiotics, including powdered tobramycin and vancomycin, do not weaken its fatigue strength.^111-114 A recent meta-analysis by Parvizi and colleagues¹¹⁵ revealed that deep infection rates dropped from 2.3% to 1.2% with use of antibiotic cement for primary THAs. Cummins and colleagues,¹¹⁶ however, reported the limited cost-effectiveness of antibiotic cement in primary arthroplasty. Performing povidone-iodine lavage at the end of the case may be a more inexpensive alternative. Brown and colleagues¹¹⁷ found that rinsing with dilute povidone-iodine (.35%) for 3 minutes significantly decreased the incidence of PJI.

Closure techniques and sutures have been a focus of much of the recent literature. Winiarsky and colleagues³⁴ advocated using a longer incision for obese patients and augmenting closure in fattier areas with vertical mattress retention sutures, which are removed after 5 days. A barbed monofilament suture (Quill; Angiotech Inc) is gaining in popularity. Laboratory research has shown that bacteria adhere less to barbed monofilament sutures than to braided sutures.¹¹⁸ Smith and colleagues¹¹⁹ found a statistically nonsignificant higher rate of wound complications with barbed monofilament sutures, whereas Ting and colleagues120 found no difference in complications. These studies were powered to detect differences in time and cost, not postoperative complications. Skin adhesive (Dermabond; Ethicon Inc), also used in closure, may be superior to staples in avoiding superficial skin abscesses.¹²¹ Although expensive, silver-impregnated dressing has antimicrobial activity that reduces PJI incidence by up to 74%.¹²² One brand of this dressing (Aquacel; ConvaTec Inc) has a polyurethane waterproof barrier that allows it to be worn for 7 days.

Three factors commonly mentioned in PJI prevention show little supporting evidence. Drains, which are often used, may create a passage for postoperative infection and are associated with increased transfusion needs.^123,124 Adding antibiotics to irrigation solution¹²⁵ and routinely changing scalpel blades^126-129 also have little supporting evidence. In 2014, the utility of changing scalpel blades after incision was studied by Lee and colleagues,¹³⁰ who reported persistence of Propionibacterium acnes in the dermal layer after skin preparation. Their study, however, was isolated to the upper back region, not the hip or knee.

Postoperative Risk Prevention

Most arthroplasty patients receive anticoagulation after surgery, but it must be used with caution. Large hematomas can predispose to wound complications. Parvizi and colleagues¹³¹ associated wound drainage, hematoma, and subsequent PJI with an INR above 1.5 in the early postoperative period. Therefore, balanced anticoagulation is crucial. Postoperative glucose control is also essential, particularly for patients with diabetes. Although preoperative blood glucose levels may or may not affect PJI risk,^15,17,132 postoperative blood glucose levels of 126 mg/dL or higher are strongly associated with joint infections.¹³³ Even nondiabetic patients with postoperative morning levels over 140 mg/dL are 3 times more likely to develop an infection.¹⁷

Efforts should be made to discharge patients as soon as it is safe to do so. With longer hospital stays, patients are more exposed to nosocomial organisms and increased antibiotic resistance.^5,23,134 Outpatient antibiotics should be considered for dental, gastrointestinal, and genitourinary procedures. Oral antibiotic prophylaxis is controversial, as there is some evidence that dental procedures increase the risk of PJI only minimally.^10,135-138

Conclusion

PJI is a potentially devastating complication of TJA. For this reason, much research has been devoted to proper diagnosis and treatment. Although the literature on PJI prophylaxis is abundant, there is relatively little consensus on appropriate PJI precautions. Preoperative considerations should include medical comorbidities, use of immunocompromising medications, obesity, nutritional factors, smoking, alcohol use, and MRSA colonization. Surgeons must have a consistent intraoperative method of antibiotic administration, skin preparation, scrubbing, draping, gloving, instrument exchange, blood loss management, cementing, and closure. In addition, monitoring of postoperative anticoagulation and blood glucose management is important. Having a thorough understanding of PJI risk factors may help reduce the incidence of this devastating complication.

Nearly 2% of patients who undergo total knee arthroplasty (TKA) or total hip arthroplasty (THA) develop a periprosthetic joint infection (PJI) within 20 years of surgery, and 41% of these infections occur within the first 2 years.¹ PJI is the most common cause of TKA failure and the third leading complication of THA.² The estimated total hospital cost of treating PJI increased from $320 million in 2001 to $566 million in 2009, which can be extrapolated to $1.62 billion in 2020.³ By 2030, the projected increase in demand for TKA and THA will be 673% and 174% of what it was in 2005, respectively.⁴ Treatment of PJI of the knee is estimated to cost 3 to 4 times more than a primary TKA, and the cost of revision THA for PJI is almost $6000 more than that of revision TKA for PJI.³

In this article, we review the numerous preoperative, intraoperative, and postoperative methods of decreasing PJI incidence after total joint arthroplasty (TJA).

Preoperative Risk Prevention

Medical Comorbidities

Preoperative medical optimization is a key element in PJI prevention (Table 1). An American Society of Anesthesiologists classification score of 3 or more has been associated with doubled risk for surgical site infections (SSIs) after THA.5 Autoimmune conditions confer a particularly higher risk. In a retrospective double-cohort study of 924 subjects, Bongartz and colleagues⁶ found that, compared with osteoarthritis, rheumatoid arthritis tripled the risk of PJI. Small case series originally suggested a higher risk of PJI in patients with psoriasis,^7,8 but more recent studies have contradicted that finding.^9,10 Nevertheless, psoriatic plaques have elevated bacterial counts,¹¹ and planned incisions should circumvent these areas.

Diabetes mellitus is a clear risk factor for PJI.^12-16 Regarding whether preoperative glucose control affects risk, findings have been mixed. Mraovic and colleagues¹⁷ showed preoperative hyperglycemia to be an independent risk factor; Jämsen and colleagues,¹⁵ in a single-center analysis of more than 7000 TJAs, suggested preoperative blood glucose levels were not independently associated with PJI; and Iorio and colleagues¹⁶ found no association between surgical infections and hemoglobin A1c levels.

TJA incidence is higher in patients with chronic kidney disease (CKD) than in the general population.¹⁸ Dialysis users have a post-THA PJI rate as high as 13% to 19%.^19,20 Early clinical data suggested that outcomes are improved in dialysis users who undergo renal transplant, but this finding recently has been questioned.^19,21 Deegan and colleagues²² found an increased PJA rate of 3.5% even in low-level CKD (stage 1, 2, or 3), but this may be confounded by the increased association of CKD with other PJI-predisposing comorbidities.

Given a higher incidence of urinary tract infections (UTIs) among patients with PJI, some surgeons think UTIs predispose to PJIs by hematogenous seeding.^12,23,24 Symptomatic UTIs should be cleared before surgery and confirmed on urinalysis. Obstructive symptoms should prompt urologic evaluation. As asymptomatic pyuria and bacteriuria (colony counts, >1 × 105/mL) do not predispose to PJI, patients without symptoms do not require intervention.^25,26 Past history of malignancy may also have a role in PJI. In a case-control study of the Mayo Clinic arthroplasty experience from 1969 to 1991, Berbari and colleagues¹ found an association between malignancy and PJI (odds ratio, 2.4). They theorized the immunosuppressive effects of cancer treatment might be responsible for this increased risk.

Immunocompromising Medications

Immunocompromising medications are modifiable and should be adjusted before surgery. Stopping any disease-modifying antirheumatic drug (DMARD) more than 4 weeks before surgery is not recommended.²⁷

Corticosteroid use can lead to immunosuppression and increased protein catabolism, which impairs soft-tissue healing. To avoid flares or adrenal insufficiency, however, chronic corticosteroid users should continue their regular doses perioperatively.²⁸ On the day of surgery, they should also receive a stress dose of hydrocortisone 50 to 75 mg (for primary arthroplasty) or 100 to 150 mg (for revision arthroplasty), followed by expeditious tapering over 1 to 2 days.²⁹ DMARDs are increasingly used by rheumatologists. One of the most effective DMARDs is methotrexate. Despite its immunocompromising activity, methotrexate should be continued perioperatively, as stopping for even 2 days may increase flare-related complications.³⁰ Hydroxychloroquine can be continued perioperatively and has even been shown, by Johnson and Charnley,³¹ to prevent deep vein thromboses. Sulfasalazine can also be continued perioperatively—but with caution, as it may elevate international normalized ratio (INR) levels in patients receiving warfarin.²⁹ Most other DMARDs should be temporarily discontinued. Leflunomide and interleukin 1 antagonists, such as anakinra, should be stopped 1 to 2 days before surgery and restarted 10 to 14 days after surgery.²⁹ Rituximab should be stopped 1 week before surgery and restarted 10 to 14 days after surgery. Tumor necrosis factor α inhibitors should be discontinued for 2 half-lives before and after surgery.³² Etanercept has a half-life of 3 to 5 days; infliximab, 8 to 10 days; and adalimumab, 10 to 13 days. Most surgeons schedule surgery for the end of a dosing cycle and discontinue these biologic agents for another 10 to 14 days after surgery.

Metabolic Factors

Obese patients are susceptible to longer surgeries, more extensive dissection, poorly vascularized subcutaneous tissue, and higher requirements of weight-adjusted antibiotic dosing.¹³ Body mass index (BMI) of 40 kg/m² or more (morbid obesity) and BMI over 50 kg/m² have been associated with 9 times and 21.3 times increased risk of PJI, respectively.^13,14 Delaying surgery with dietary consultation has been suggested,^33,34 and bariatric surgery before TKA may decrease infection rates by 3.5 times.³⁵

Nutritional markers are considered before arthroplasty. According to most laboratories, a serum transferrin level under 200 mg/dL, albumin level under 3.5 g/dL, and total lymphocyte count under 1500 cells/mm³ indicate malnourishment, which can increase the incidence of wound complications by 5 to 7 times.³⁶ Patients should also have sufficient protein, vitamin, and mineral supplementation, particularly vitamins A and C, zinc, and copper.³⁷Smokers who cease smoking at least 4 to 6 weeks before surgery lower their wound complication rate by up to 26%.^38,39 When nicotine leaves the bloodstream, vasodilation occurs, oxygenation improves, and the immune system recovers.³⁹ Studies have found more SSIs in patients who abuse alcohol,40 and numerous authors have confirmed this finding in the arthroplasty population.^24,41,42 Alcohol inhibits platelet function and may predispose to a postoperative hematoma. In contrast to smoking cessation evidence, evidence regarding alcohol interventions in preventing postoperative infections is less conclusive.^43,44

MRSA Colonization

Methicillin-resistant Staphylococcus aureus (MRSA) is a particularly difficult bacterium to eradicate in PJI. As the mean cost of treating a single case of MRSA-related prosthetic infection is $107,264 vs $68,053 for susceptible strains,45,46 many infection-containment strategies focus on addressing benign MRSA colonization before surgery.

MRSA is present in the nares of 25 million people in the United States. Nasal colonization increases the risk of bacteremia 4-fold⁴⁷ and SSI 2- to 9-fold.^48,49 Nasal swabs are analyzed with either a rapid polymerase chain reaction (PCR) test, which provides results in 2 hours, or a bacterial culture, which provides results in 1 to 4 days. The PCR test is more expensive.

Eradication of MRSA colonization is increasingly prevalent. Several Scandinavian countries have instituted strict practices by which patients are denied elective surgery until negative nasal swabs are obtained.⁴⁹ Nasal decontamination is one method of colonization reduction. Topical mupirocin, which yields eradication in 91% of nasal carriers immediately after treatment and in 87% after 4 weeks,⁵⁰ is effective in reducing SSI rates only when used in conjunction with a body wash, which is used to clean the axilla and groin.⁵¹ There is no consensus on optimal timing, but Bode and colleagues⁵² found a significant decrease in deep SSIs when decontamination occurred just 24 hours before surgery.

Povidone-iodine showers went out of favor with the realization that chlorhexidine gluconate acts longer on the skin surface.^53,54 Preoperative showers involve rinsing with liquid chlorhexidine soap 24 to 48 hours before surgery. However, chlorhexidine binds preferentially to the cotton in washcloths instead of the skin. Edmiston and colleagues^54,55 found that 4% chlorhexidine liquid soaps achieve much lower skin chlorhexidine concentrations than 2% polyester cloths do. Use of these “chlorhexidine wipes” the night before and the day of surgery has decreased PJI after TKA from 2.2% to 0.6%.^56,57

Intraoperative Risk Prevention

Preparation

Which preoperative antibiotic to use is one of the first operative considerations in PJI prophylaxis (Table 2). Cefazolin is recommended as a first-line agent for its excellent soft-tissue penetration, long half-life, and activity against gram-positive bacteria such as skin flora.⁵⁸ Clindamycin may be considered for patients allergic to β-lactam antibiotics. Vancomycin may be considered for adjunctive use with cephalosporins in cases of known MRSA colonization. Vancomycin infusion should be started earlier than infusion with other antibiotics, as vancomycin must be infused slowly and takes longer to become therapeutic.

Antibiotic dosing should be based on local antibiograms, adjusted dosing weight, or BMI.⁵⁹ For revision arthroplasty, preoperative prophylaxis should not be stopped out of fear of affecting operative cultures.⁶⁰ Some surgeons pause antibiotic use if a preoperative joint aspirate has not been obtained. Infusion within 1 hour of incision is part of the pay-for-performance guidelines established by the US Centers for Medicare & Medicaid Services.⁶¹ An antibiotic should be redosed if the operation will take longer than 2 half-lives of the drug.⁵⁹ Surgeons should consider administering a dose every 4 hours or whenever blood loss exceeds 1000 mL.⁶² Engesæter and colleagues⁶³ found that antibiotic prophylaxis was most effective given 4 times perioperatively (1 time before surgery, 3 times after surgery). Postoperative antibiotics should not be administered longer than 24 hours, as prolonged dosing confers no benefit.⁵⁸ Operating room conditions must be optimized for prophylaxis. More people and operating room traffic in nonsterile corridors increase contamination of instruments open to air.⁶⁴ Laminar airflow systems are commonly used. Although there is little dispute that laminar flow decreases the bacterial load of air, there are mixed results regarding its benefit in preventing PJI.^65-68 Skin preparation may address patient risk factors. Hair clipping is preferred to shaving, which may cause microabrasions and increased susceptibility to skin flora.69 Patients should be prepared with antiseptic solution. One randomized controlled trial found that 2% chlorhexidine gluconate mixed with 70% isopropyl alcohol was superior to 10% povidone-iodine in preventing SSIs.⁷⁰ However, a recent cohort study showed a lower rate of superficial wound infections when 1% povidone-iodine (vs 0.5% chlorhexidine) was used with alcohol.⁷¹ This finding may indicate the need for alcohol preparation, higher concentrations of chlorhexidine, or both.

Proper scrubbing and protective gear are needed to reduce surgeon risk factors. Hand washing is a routine part of any surgery. Alcohol-based hand scrubs are as effective as hand scrubbing.65 They reduce local skin flora by 95% immediately and by 99% with repeated applications.⁷² Lidwell and colleagues⁷³ found a 75% reduction in infection when body exhaust suits were used in combination with laminar flow in a multicenter randomized controlled trial of 8052 patients. Sterile draping with impermeable drapes should be done over properly prepared skin. Ioban drapes (3M) are often used as a protective barrier. Interestingly, a Cochrane review found no benefit in using plastic adhesives impregnated with iodine over sterilely prepared skin.⁷⁴

Operative Considerations

Surgical gloves become contaminated in almost one third of cases, half the time during draping.⁷⁵ For this reason, many surgeons change gloves after draping. In addition, double gloving prevents a breech of aseptic technique should the outer glove become perforated.⁷⁶ Demircay and colleagues⁷⁷ assessed double latex gloving in arthroplasty and found the outer and inner gloves perforated in 18.4% and 8.4% of cases, respectively. Punctures are most common along the nondominant index finger, and then the dominant thumb.^77,78 Perforation is more common when 2 latex gloves are worn—vs 1 latex glove plus an outer cloth glove—and the chance of perforation increases with surgery duration. The inner glove may become punctured in up to 100% of operations that last over 3 hours.⁷⁹ Although Dodds and colleagues⁸⁰ found no change in bacterial counts on surgeons’ hands or gloves after perforation, precautions are still recommended. Al-Maiyah and colleagues⁸¹ went as far as to recommend glove changes at 20-minute intervals and before cementation.

Surgical instruments can be sources of contamination. Some authors change the suction tip every hour to minimize the risk of deep wound infection.^82-85 Others change it before femoral canal preparation and prosthesis insertion during THA.⁸⁶ The splash basin is frequently contaminated, and instruments placed in it should not be returned to the operative field.⁸⁷ Hargrove and colleagues⁸⁸ suggested pulsatile lavage decreases PJI more than bulb syringe irrigation does, whereas others argued that high-pressure lavage allows bacteria to penetrate more deeply, which could lead to retention of more bacteria.⁸⁹ Minimizing operating room time was found by Kurtz and colleagues⁹⁰ and Peersman and colleagues⁹¹ to decrease PJI incidence. Carroll and colleagues⁷¹ correlated longer tourniquet use with a higher rate of infection after TKA; proposed mechanisms include local tissue hypoxia and lowered concentrations of prophylactic antibiotics.

Similarly, minimizing blood loss and transfusion needs is another strategy for preventing infection. Allogenic transfusion may increase the risk of PJI 2 times.^23,71,92 The mechanism seems to be immune system modulation by allogenic blood, which impairs microcirculation and oxygen delivery at the surgical site.^23,75 Transfusions should be approached with caution, and consideration given to preoperative optimization and autologous blood donation. Cherian and colleagues⁹³ reviewed different blood management strategies and found preoperative iron therapy, intravenous erythropoietin, and autologous blood donation to be equally effective in reducing the need for allogenic transfusions. Numerous studies of tranexamic acid, thrombin-based hemostatic matrix (Floseal; Baxter Inc), and bipolar sealer with radiofrequency ablation (Aquamantys; Medtronic Inc) have found no alterations in infection rates, but most have used calculated blood loss, not PJI, as the primary endpoint.^94-105 Antibiotic cement also can be used to block infection.^63,106-110 Although liquid gentamicin may weaken bone cement,¹¹¹ most antibiotics, including powdered tobramycin and vancomycin, do not weaken its fatigue strength.^111-114 A recent meta-analysis by Parvizi and colleagues¹¹⁵ revealed that deep infection rates dropped from 2.3% to 1.2% with use of antibiotic cement for primary THAs. Cummins and colleagues,¹¹⁶ however, reported the limited cost-effectiveness of antibiotic cement in primary arthroplasty. Performing povidone-iodine lavage at the end of the case may be a more inexpensive alternative. Brown and colleagues¹¹⁷ found that rinsing with dilute povidone-iodine (.35%) for 3 minutes significantly decreased the incidence of PJI.

Closure techniques and sutures have been a focus of much of the recent literature. Winiarsky and colleagues³⁴ advocated using a longer incision for obese patients and augmenting closure in fattier areas with vertical mattress retention sutures, which are removed after 5 days. A barbed monofilament suture (Quill; Angiotech Inc) is gaining in popularity. Laboratory research has shown that bacteria adhere less to barbed monofilament sutures than to braided sutures.¹¹⁸ Smith and colleagues¹¹⁹ found a statistically nonsignificant higher rate of wound complications with barbed monofilament sutures, whereas Ting and colleagues120 found no difference in complications. These studies were powered to detect differences in time and cost, not postoperative complications. Skin adhesive (Dermabond; Ethicon Inc), also used in closure, may be superior to staples in avoiding superficial skin abscesses.¹²¹ Although expensive, silver-impregnated dressing has antimicrobial activity that reduces PJI incidence by up to 74%.¹²² One brand of this dressing (Aquacel; ConvaTec Inc) has a polyurethane waterproof barrier that allows it to be worn for 7 days.

Three factors commonly mentioned in PJI prevention show little supporting evidence. Drains, which are often used, may create a passage for postoperative infection and are associated with increased transfusion needs.^123,124 Adding antibiotics to irrigation solution¹²⁵ and routinely changing scalpel blades^126-129 also have little supporting evidence. In 2014, the utility of changing scalpel blades after incision was studied by Lee and colleagues,¹³⁰ who reported persistence of Propionibacterium acnes in the dermal layer after skin preparation. Their study, however, was isolated to the upper back region, not the hip or knee.

Postoperative Risk Prevention

Most arthroplasty patients receive anticoagulation after surgery, but it must be used with caution. Large hematomas can predispose to wound complications. Parvizi and colleagues¹³¹ associated wound drainage, hematoma, and subsequent PJI with an INR above 1.5 in the early postoperative period. Therefore, balanced anticoagulation is crucial. Postoperative glucose control is also essential, particularly for patients with diabetes. Although preoperative blood glucose levels may or may not affect PJI risk,^15,17,132 postoperative blood glucose levels of 126 mg/dL or higher are strongly associated with joint infections.¹³³ Even nondiabetic patients with postoperative morning levels over 140 mg/dL are 3 times more likely to develop an infection.¹⁷

Efforts should be made to discharge patients as soon as it is safe to do so. With longer hospital stays, patients are more exposed to nosocomial organisms and increased antibiotic resistance.^5,23,134 Outpatient antibiotics should be considered for dental, gastrointestinal, and genitourinary procedures. Oral antibiotic prophylaxis is controversial, as there is some evidence that dental procedures increase the risk of PJI only minimally.^10,135-138

Conclusion

PJI is a potentially devastating complication of TJA. For this reason, much research has been devoted to proper diagnosis and treatment. Although the literature on PJI prophylaxis is abundant, there is relatively little consensus on appropriate PJI precautions. Preoperative considerations should include medical comorbidities, use of immunocompromising medications, obesity, nutritional factors, smoking, alcohol use, and MRSA colonization. Surgeons must have a consistent intraoperative method of antibiotic administration, skin preparation, scrubbing, draping, gloving, instrument exchange, blood loss management, cementing, and closure. In addition, monitoring of postoperative anticoagulation and blood glucose management is important. Having a thorough understanding of PJI risk factors may help reduce the incidence of this devastating complication.

Although elbow arthroscopy was first described in the 1930s, it has become increasingly popular in the last 30 years.¹ While initially considered as a tool for diagnosis and loose body removal, indications have expanded to include treatment of osteochondritis dissecans (OCD), treatment of lateral epicondylitis, fixation of fractures, and others.^2-5 Miyake and colleagues⁶ found a significant improvement in range of motion, both flexion and extension, and outcome scores when elbow arthroscopy was used to remove impinging osteophytes. Babaqi and colleagues⁷ found significant improvement in pain, satisfaction, and outcome scores in 31 patients who underwent elbow arthroscopy for lateral epicondylitis refractory to nonsurgical management. The technical difficulty of the procedure, lower frequency of pathology amenable to arthroscopic intervention, and potential neurovascular complications make the elbow less frequently evaluated with the arthroscope vs other joints, such as the knee and shoulder.^2,8,9

Geographic distribution of subjects undergoing elbow arthroscopy, the indications used, surgical techniques being performed, and their associated clinical outcomes have received little to no recognition in the peer-reviewed literature.10 Differences in the elbow arthroscopy literature include characteristics related to the patient (age, gender, hand dominance, duration of symptoms), study (level of evidence, number of subjects, number of participating centers, design), indication (lateral epicondylitis, loose bodies, olecranon osteophytes, OCD), surgical technique, and outcome. Evidence-based medicine and clinical practice guidelines direct surgeons in clinical decision-making. Payers investigate the cost of surgical interventions and the value that surgery may provide, while following trends in different surgical techniques. Regulatory agencies and associations emphasize subjective patient-reported outcomes as the primary outcome measured in high-quality trials. Thus, in discussion of complex surgical interventions such as elbow arthroscopy, it is important to characterize the studies, subjects, and surgeries across the world to understand the geographic similarities and differences to optimize care in this clinical situation.

The goal of this study was to perform a systematic review and meta-analysis of elbow arthroscopy literature to identify and compare the characteristics of the studies published, the subjects analyzed, and surgical techniques performed across continents and countries to answer these questions: “Across the world, what demographic of patients are undergoing elbow arthroscopy, what are the most common indications for elbow arthroscopy, and how good is the evidence?” The authors hypothesized that patients who undergo elbow arthroscopy will be largely age <40 years, the most common indication for elbow arthroscopy will be a release/débridement, and the evidence for elbow arthroscopy will be poor. Also, no significant differences will exist in elbow arthroscopy publications, subjects, outcomes, and techniques based on continent/country of publication.

Methods

A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines using a PRISMA checklist.¹¹ Systematic review registration was performed using the International Prospective Register of Ongoing Systematic Reviews (PROSPERO; registration number, CRD42014010580; registration date, July 15, 2014).¹² Two study authors independently conducted the search on June 23, 2014 using the following databases: Medline, Cochrane Central Register of Controlled Trials, SportDiscus, and CINAHL. The electronic search citation algorithm used was: (elbow) AND arthroscopy) NOT shoulder) NOT knee) NOT ankle) NOT wrist) NOT hip) NOT dog) NOT cadaver). English language Level I-IV evidence (2012 update by the Oxford Centre for Evidence-Based Medicine¹³) clinical studies were eligible for inclusion into this study. Abstracts were ineligible for inclusion. All references in selected studies were cross-referenced for inclusion if they were missed during the initial search. Duplicate subject publications within separate unique studies were not reported twice. The study with longer duration follow-up, higher level of evidence, greater number of subjects, or more detailed subject, surgical technique, or outcome reporting was retained for inclusion. Level V evidence reviews, expert opinion articles, letters to the editor, basic science, biomechanical studies, open elbow surgery, imaging, surgical technique, and classification studies were excluded.

All included patients underwent elbow arthroscopy for either intra- or extra-articular elbow pathology (ulnotrochlear osteoarthritis, lateral epicondylitis, rheumatoid arthritis, post-traumatic contracture, osteonecrosis of the capitellum or radial head, osteoid osteoma, and others). There was no minimum follow-up duration or rehabilitation requirement. The study and subject demographic parameters that we analyzed included year of publication, years of subject enrollment, presence of study financial conflict of interest, number of subjects and elbows, elbow dominance, gender, age, body mass index, diagnoses treated, type of anesthesia (block or general), and surgical positioning. Postoperative splint application and pain management, and whether a continuous passive motion machine was used and whether a drain was placed were recorded. Clinical outcome scores were DASH (Disability of the Arm, Shoulder, and Hand), Morrey score, MEPS (Mayo Elbow Performance Score), Andrews-Carson score, Timmerman-Andrews score, LES (Liverpool Elbow Score), Tegner score, HSS (Hospital for Special Surgery Score), VAS (Visual Analog Scale), EFA (Elbow Functional Assessment), Short Form-12 (SF-12), Short Form-36 (SF-36), Kerlan-Jobe Orthopaedic Clinic (KJOC) Shoulder and Elbow Questionnaire, and MAESS (Modified Andrews Elbow Scoring System). Radiographs, computed tomography (CT), computed tomography arthrography (CTA), magnetic resonance imaging (MRI), and magnetic resonance arthrography (MRA) data were extracted when available. Range of motion (flexion, extension, supination, and pronation) and grip strength data, both preoperative and postoperative, were extracted when available. Study methodological quality was evaluated using the Modified Coleman Methodology Score (MCMS).¹⁴

Statistical Analysis

Study descriptive statistics were calculated. Continuous variable data were reported as weighted means ± weighted standard deviations. Categorical variable data were reported as frequencies with percentages. For all statistical analysis either measured and calculated from study data extraction or directly reported from the individual studies, P < .05 was considered statistically significant. Study, subject, and surgical outcomes data were compared using 1-way analysis of variance (ANOVA) tests. Where applicable, study, subject, and surgical outcomes data were also compared using 2-sample and 2-proportion Z-test calculators with α .05 because of the difference in sample sizes between compared groups. To examine trends over time, Pearson’s correlation coefficients were calculated. For the purposes of analysis, the indications of “osteoarthritis,” “arthrofibrosis,” “loose body removal,” “ulnotrochlear osteoarthritis causing stiffness,” “post-traumatic contracture/stiffness,” and “post-operative elbow contracture” were combined into the indication “release and débridement.” For the 3 most common indications for arthroscopy (OCD, lateral epicondylitis, and release and débridement) data were combined into 5-year increments to overcome the smaller sample size within each of these categories, and Pearson’s correlation coefficients were calculated to determine if number of reported cases covaried with year period. Within these 3 diagnoses, ANOVA analyses were performed to determine whether the number of cases differed between continents and countries.

Results

A total of 353 studies were located, and, after implementation of the exclusion criteria, 112 studies were included in the final analysis (Figure 1; 3093 subjects; 3168 elbows; 64% male; mean age, 34.9 ± 14.68 years). There was a mean of 33.4 ± 26.02 months of follow-up, and 75% of surgeries involved the dominant elbow (Table 1). Most studies were level IV evidence (94.6%), had a low MCMS (mean 28.1 ± 8.06; poor rating), and were single-center investigations (94.6%). Most studies did not report financial conflicts of interest (56.3%) (Tables 1 and 2). From 1985 through 2014, the number of publications significantly increased with time (P = .004) among all continents. The MCMS was unchanged over time (P = .247) (Figure 2A), as was the level of evidence (P = .094) (Figure 2B). Conflicts of interest significantly increased with time (P = .025) (Figure 3).

Among continents, North America published the largest number of studies (54), and had the largest number of patients (1395) and elbow surgeries (1425) (Table 1). The United States published the largest number of studies (43%). There were no significant differences between age (P = .331), length of follow-up (P = .403), MCMS (P = .123), and level of evidence (P = .288) between continents. Of the 32 studies that reported the use of preoperative MRI, studies from Asia reported significantly more MRI scans than those from other continents (P = .040); there were no other significant differences between continents in reference to preoperative imaging studies or other demographic information.

The most common surgical indications were OCD (Figure 4), lateral epicondylitis (Figure 5), and release and débridement (Figure 6, Table 3; all studies listed indications). The number of reported cases for these 3 indications significantly increased over time (OCD P = .005, lateral epicondylitis P = .044, release and débridement P = .042) but did not significantly differ between regions (P > .05 in all cases).

Thirty-two (28.6%) studies reported the use of outcome measures (16 different outcome scores were used by the included studies). Asia reported outcome measures in 9 of 23 studies (39%), Europe in 12 of 35 studies (34%) and North America in 11 of 54 (20%) of studies. The MEPS was the most frequently used outcome score in 9.8% of studies, followed by VAS for pain in 5.3% of cases. North American studies reported a significantly higher increase in extension after elbow arthroscopy than Asia (P = .0432) (Figure 7), with no differences in flexion (P = .699), pronation (P = .376), or supination (P = .408). No significant differences were observed between continents in the type of anesthesia chosen (general anesthesia [P = .94] or regional anesthesia [P = .85]). Asia and Europe performed elbow arthroscopy most frequently in the lateral decubitus position, while North American studies most often used the supine position (Table 4).

Twenty (17.9%) studies reported the use of a postoperative splint, 12 (10.7%) studies reported use of a drain, 2 (1.79%) studies reported use of a hinged elbow brace, 9 (8.03%) studies reported use of a continuous passive motion machine postoperatively, and 3 (2.68%) studies reported use of an indwelling axillary catheter for postoperative pain management. Of 130 reported surgical complications (4.1%), the most frequent complication was transient sensory ulnar nerve palsy (1.5%), followed by persistent wound drainage (.76%), and transient sensory radial nerve palsy (.38%). Other reported complications included infection (.22%), transient sensory palsy of the median nerve (.19%), heterotopic ossification (.13%), complete transection of the ulnar nerve (.10%), loose body formation (.06%), hematoma formation (.06%), transient sensory palsy of the posterior interosseous (.06%), or anterior interosseous nerve (.03%), and complete transection of the radial (.03%), or median nerve (.03%).

Discussion

Elbow arthroscopy is an evolving surgical procedure that is used to treat intra- and extra-articular pathologies of the elbow. Outcomes of elbow arthroscopy for certain conditions have generally been reported as good, with improvements seen in pain, functional scores, and range of motion.^6,15-17 The authors’ hypotheses were mostly confirmed in that the average age of patients undergoing elbow arthroscopy was <40 years, release/débridement was one of the most common indications (along with lateral epicondylitis and OCD), and the general evidence for elbow arthroscopy was poor. Also, there were almost no differences between continents/countries related to patient indications, preoperative imaging, anesthesia choice, indications, postoperative protocols, and outcomes (although the number of studies that reported outcomes was low and could have skewed the results), with the exception of a higher number of preoperative MRI scans in Asia. Some of the notable findings of this study included: 1) the number of studies published on elbow arthroscopy is significantly increasing with time, despite a lack of improvement in the level of evidence; 2) the majority of studies on elbow arthroscopy do not report a surgical outcome score; and 3) the number of reported cases for the 3 most common indications significantly increased over time (OCD, P = .005; lateral epicondylitis, P = .044; release and débridement, P = .042) but did not differ between regions (P > .05 in all cases).

The indications for elbow arthroscopy have grown dramatically in the past 2 decades to include both intra- and extra-articular pathologies.¹⁸ Despite this increase in the number of indications for elbow arthroscopy, the study did not find a significant difference between countries/continents in the indications each used for elbow arthroscopy patients. There was a trend towards an increase in OCD cases in all continents, especially Asia (Figure 4), with time. Interestingly, while not statistically significant, there was variation among countries for surgical indications. In North America, removal of loose bodies accounts for 18% of patients, while in Europe this accounted for only 9% and in Asia for 1%. Post-traumatic stiffness was the indication for elbow arthroscopy in Europe in 19% of patients vs 7% in North America and 10% in Asia. In Asia, OCD accounts for 40% of arthroscopies, 7% in Europe, and 14% in North America (Figure 4) (Table 3).

This study demonstrated that the mean increase in elbow extension gained after surgery in North America was significantly greater when compared with studies from Asia, but the gain in flexion, pronation, and supination was similar across continents. The underlying cause of this difference in improvement in elbow extension between nations is unclear, although differences in diagnosis could account for some variation. This study did not examine differences in rehabilitation protocols, and certainly, it is plausible that protocol variations by country could account for some discrepancy. Furthermore, differences in functional needs may vary by continent and could have driven this result.

This study found no routine reporting of outcome scores by elbow arthroscopy studies from any continent, and that when outcome scores are reported, there is substantial inconsistency with regard to the actual scoring system used. No continent reported outcome scores in more than 40% of the studies published from that area, and the variation of outcome scores used, even from a single region, was large. This makes comparing clinical outcomes between studies difficult, even when performing identical procedures for identical indications, because there is no standardized method of reporting outcomes. To allow comparison of studies and generalizability of the results to different populations, a more standardized approach to outcome reporting needs to be instituted in the elbow arthroscopy literature. To date, there is no standardized score that has been validated for reporting clinical outcomes after elbow arthroscopy.19 Hence, it is not surprising that there were 16 different outcome scores reported throughout the 112 studies analyzed in this review, with the most frequent score, the MEPS, reported in a total of 10 studies. As medicine moves towards pay scales that are based on patient outcomes, it will become more important to define a clear outcome score that can be used to assess these patients, and reliably report scores. This will allow comparison of patients across nations to determine the best surgical treatment for different clinical problems. A validation study comparing these outcome scores to determine which score best summarizes the patient’s level of pain and function after surgery would be beneficial, because this could identify 1 score that could be standardized to allow comparison among reported outcomes.

Limitations

This study had several limitations. Despite having 2 authors search independently for studies, some studies could have been missed during the search process, introducing possible selection bias. Including only published studies could have introduced publication bias. Numerous studies did not report all the variables the authors examined. This could have skewed some results, and had additional variables been reported, could have altered the data to show significant differences in some measured variables. Because this study did not compare outcome measures for varying pathologies, conclusions cannot be drawn on the best treatment options for different indications. Case reports could have lowered the MCMS score and the average in studies reporting outcomes. Furthermore, the poor quality of the underlying data used in this study could limit the validity/generalizability of the results because this is a systematic review, and its level of evidence is only as high as the studies it includes. Because the primary aim was to report on demographics, this study did not examine concomitant pathology at the time of surgery or rehabilitation protocols.

Conclusion

The quantity, but not the quality, of arthroscopic elbow publications has significantly increased over time. Most patients undergo elbow arthroscopy for lateral epicondylitis, OCD, and release and débridement. Pathology and indications do not appear to differ geographically with more men undergoing elbow arthroscopy than women.

Although elbow arthroscopy was first described in the 1930s, it has become increasingly popular in the last 30 years.¹ While initially considered as a tool for diagnosis and loose body removal, indications have expanded to include treatment of osteochondritis dissecans (OCD), treatment of lateral epicondylitis, fixation of fractures, and others.^2-5 Miyake and colleagues⁶ found a significant improvement in range of motion, both flexion and extension, and outcome scores when elbow arthroscopy was used to remove impinging osteophytes. Babaqi and colleagues⁷ found significant improvement in pain, satisfaction, and outcome scores in 31 patients who underwent elbow arthroscopy for lateral epicondylitis refractory to nonsurgical management. The technical difficulty of the procedure, lower frequency of pathology amenable to arthroscopic intervention, and potential neurovascular complications make the elbow less frequently evaluated with the arthroscope vs other joints, such as the knee and shoulder.^2,8,9

Geographic distribution of subjects undergoing elbow arthroscopy, the indications used, surgical techniques being performed, and their associated clinical outcomes have received little to no recognition in the peer-reviewed literature.10 Differences in the elbow arthroscopy literature include characteristics related to the patient (age, gender, hand dominance, duration of symptoms), study (level of evidence, number of subjects, number of participating centers, design), indication (lateral epicondylitis, loose bodies, olecranon osteophytes, OCD), surgical technique, and outcome. Evidence-based medicine and clinical practice guidelines direct surgeons in clinical decision-making. Payers investigate the cost of surgical interventions and the value that surgery may provide, while following trends in different surgical techniques. Regulatory agencies and associations emphasize subjective patient-reported outcomes as the primary outcome measured in high-quality trials. Thus, in discussion of complex surgical interventions such as elbow arthroscopy, it is important to characterize the studies, subjects, and surgeries across the world to understand the geographic similarities and differences to optimize care in this clinical situation.

The goal of this study was to perform a systematic review and meta-analysis of elbow arthroscopy literature to identify and compare the characteristics of the studies published, the subjects analyzed, and surgical techniques performed across continents and countries to answer these questions: “Across the world, what demographic of patients are undergoing elbow arthroscopy, what are the most common indications for elbow arthroscopy, and how good is the evidence?” The authors hypothesized that patients who undergo elbow arthroscopy will be largely age <40 years, the most common indication for elbow arthroscopy will be a release/débridement, and the evidence for elbow arthroscopy will be poor. Also, no significant differences will exist in elbow arthroscopy publications, subjects, outcomes, and techniques based on continent/country of publication.

Methods

A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines using a PRISMA checklist.¹¹ Systematic review registration was performed using the International Prospective Register of Ongoing Systematic Reviews (PROSPERO; registration number, CRD42014010580; registration date, July 15, 2014).¹² Two study authors independently conducted the search on June 23, 2014 using the following databases: Medline, Cochrane Central Register of Controlled Trials, SportDiscus, and CINAHL. The electronic search citation algorithm used was: (elbow) AND arthroscopy) NOT shoulder) NOT knee) NOT ankle) NOT wrist) NOT hip) NOT dog) NOT cadaver). English language Level I-IV evidence (2012 update by the Oxford Centre for Evidence-Based Medicine¹³) clinical studies were eligible for inclusion into this study. Abstracts were ineligible for inclusion. All references in selected studies were cross-referenced for inclusion if they were missed during the initial search. Duplicate subject publications within separate unique studies were not reported twice. The study with longer duration follow-up, higher level of evidence, greater number of subjects, or more detailed subject, surgical technique, or outcome reporting was retained for inclusion. Level V evidence reviews, expert opinion articles, letters to the editor, basic science, biomechanical studies, open elbow surgery, imaging, surgical technique, and classification studies were excluded.

All included patients underwent elbow arthroscopy for either intra- or extra-articular elbow pathology (ulnotrochlear osteoarthritis, lateral epicondylitis, rheumatoid arthritis, post-traumatic contracture, osteonecrosis of the capitellum or radial head, osteoid osteoma, and others). There was no minimum follow-up duration or rehabilitation requirement. The study and subject demographic parameters that we analyzed included year of publication, years of subject enrollment, presence of study financial conflict of interest, number of subjects and elbows, elbow dominance, gender, age, body mass index, diagnoses treated, type of anesthesia (block or general), and surgical positioning. Postoperative splint application and pain management, and whether a continuous passive motion machine was used and whether a drain was placed were recorded. Clinical outcome scores were DASH (Disability of the Arm, Shoulder, and Hand), Morrey score, MEPS (Mayo Elbow Performance Score), Andrews-Carson score, Timmerman-Andrews score, LES (Liverpool Elbow Score), Tegner score, HSS (Hospital for Special Surgery Score), VAS (Visual Analog Scale), EFA (Elbow Functional Assessment), Short Form-12 (SF-12), Short Form-36 (SF-36), Kerlan-Jobe Orthopaedic Clinic (KJOC) Shoulder and Elbow Questionnaire, and MAESS (Modified Andrews Elbow Scoring System). Radiographs, computed tomography (CT), computed tomography arthrography (CTA), magnetic resonance imaging (MRI), and magnetic resonance arthrography (MRA) data were extracted when available. Range of motion (flexion, extension, supination, and pronation) and grip strength data, both preoperative and postoperative, were extracted when available. Study methodological quality was evaluated using the Modified Coleman Methodology Score (MCMS).¹⁴

Statistical Analysis

Study descriptive statistics were calculated. Continuous variable data were reported as weighted means ± weighted standard deviations. Categorical variable data were reported as frequencies with percentages. For all statistical analysis either measured and calculated from study data extraction or directly reported from the individual studies, P < .05 was considered statistically significant. Study, subject, and surgical outcomes data were compared using 1-way analysis of variance (ANOVA) tests. Where applicable, study, subject, and surgical outcomes data were also compared using 2-sample and 2-proportion Z-test calculators with α .05 because of the difference in sample sizes between compared groups. To examine trends over time, Pearson’s correlation coefficients were calculated. For the purposes of analysis, the indications of “osteoarthritis,” “arthrofibrosis,” “loose body removal,” “ulnotrochlear osteoarthritis causing stiffness,” “post-traumatic contracture/stiffness,” and “post-operative elbow contracture” were combined into the indication “release and débridement.” For the 3 most common indications for arthroscopy (OCD, lateral epicondylitis, and release and débridement) data were combined into 5-year increments to overcome the smaller sample size within each of these categories, and Pearson’s correlation coefficients were calculated to determine if number of reported cases covaried with year period. Within these 3 diagnoses, ANOVA analyses were performed to determine whether the number of cases differed between continents and countries.

Results

A total of 353 studies were located, and, after implementation of the exclusion criteria, 112 studies were included in the final analysis (Figure 1; 3093 subjects; 3168 elbows; 64% male; mean age, 34.9 ± 14.68 years). There was a mean of 33.4 ± 26.02 months of follow-up, and 75% of surgeries involved the dominant elbow (Table 1). Most studies were level IV evidence (94.6%), had a low MCMS (mean 28.1 ± 8.06; poor rating), and were single-center investigations (94.6%). Most studies did not report financial conflicts of interest (56.3%) (Tables 1 and 2). From 1985 through 2014, the number of publications significantly increased with time (P = .004) among all continents. The MCMS was unchanged over time (P = .247) (Figure 2A), as was the level of evidence (P = .094) (Figure 2B). Conflicts of interest significantly increased with time (P = .025) (Figure 3).

Among continents, North America published the largest number of studies (54), and had the largest number of patients (1395) and elbow surgeries (1425) (Table 1). The United States published the largest number of studies (43%). There were no significant differences between age (P = .331), length of follow-up (P = .403), MCMS (P = .123), and level of evidence (P = .288) between continents. Of the 32 studies that reported the use of preoperative MRI, studies from Asia reported significantly more MRI scans than those from other continents (P = .040); there were no other significant differences between continents in reference to preoperative imaging studies or other demographic information.

The most common surgical indications were OCD (Figure 4), lateral epicondylitis (Figure 5), and release and débridement (Figure 6, Table 3; all studies listed indications). The number of reported cases for these 3 indications significantly increased over time (OCD P = .005, lateral epicondylitis P = .044, release and débridement P = .042) but did not significantly differ between regions (P > .05 in all cases).

Thirty-two (28.6%) studies reported the use of outcome measures (16 different outcome scores were used by the included studies). Asia reported outcome measures in 9 of 23 studies (39%), Europe in 12 of 35 studies (34%) and North America in 11 of 54 (20%) of studies. The MEPS was the most frequently used outcome score in 9.8% of studies, followed by VAS for pain in 5.3% of cases. North American studies reported a significantly higher increase in extension after elbow arthroscopy than Asia (P = .0432) (Figure 7), with no differences in flexion (P = .699), pronation (P = .376), or supination (P = .408). No significant differences were observed between continents in the type of anesthesia chosen (general anesthesia [P = .94] or regional anesthesia [P = .85]). Asia and Europe performed elbow arthroscopy most frequently in the lateral decubitus position, while North American studies most often used the supine position (Table 4).

Twenty (17.9%) studies reported the use of a postoperative splint, 12 (10.7%) studies reported use of a drain, 2 (1.79%) studies reported use of a hinged elbow brace, 9 (8.03%) studies reported use of a continuous passive motion machine postoperatively, and 3 (2.68%) studies reported use of an indwelling axillary catheter for postoperative pain management. Of 130 reported surgical complications (4.1%), the most frequent complication was transient sensory ulnar nerve palsy (1.5%), followed by persistent wound drainage (.76%), and transient sensory radial nerve palsy (.38%). Other reported complications included infection (.22%), transient sensory palsy of the median nerve (.19%), heterotopic ossification (.13%), complete transection of the ulnar nerve (.10%), loose body formation (.06%), hematoma formation (.06%), transient sensory palsy of the posterior interosseous (.06%), or anterior interosseous nerve (.03%), and complete transection of the radial (.03%), or median nerve (.03%).

Discussion

Elbow arthroscopy is an evolving surgical procedure that is used to treat intra- and extra-articular pathologies of the elbow. Outcomes of elbow arthroscopy for certain conditions have generally been reported as good, with improvements seen in pain, functional scores, and range of motion.^6,15-17 The authors’ hypotheses were mostly confirmed in that the average age of patients undergoing elbow arthroscopy was <40 years, release/débridement was one of the most common indications (along with lateral epicondylitis and OCD), and the general evidence for elbow arthroscopy was poor. Also, there were almost no differences between continents/countries related to patient indications, preoperative imaging, anesthesia choice, indications, postoperative protocols, and outcomes (although the number of studies that reported outcomes was low and could have skewed the results), with the exception of a higher number of preoperative MRI scans in Asia. Some of the notable findings of this study included: 1) the number of studies published on elbow arthroscopy is significantly increasing with time, despite a lack of improvement in the level of evidence; 2) the majority of studies on elbow arthroscopy do not report a surgical outcome score; and 3) the number of reported cases for the 3 most common indications significantly increased over time (OCD, P = .005; lateral epicondylitis, P = .044; release and débridement, P = .042) but did not differ between regions (P > .05 in all cases).

The indications for elbow arthroscopy have grown dramatically in the past 2 decades to include both intra- and extra-articular pathologies.¹⁸ Despite this increase in the number of indications for elbow arthroscopy, the study did not find a significant difference between countries/continents in the indications each used for elbow arthroscopy patients. There was a trend towards an increase in OCD cases in all continents, especially Asia (Figure 4), with time. Interestingly, while not statistically significant, there was variation among countries for surgical indications. In North America, removal of loose bodies accounts for 18% of patients, while in Europe this accounted for only 9% and in Asia for 1%. Post-traumatic stiffness was the indication for elbow arthroscopy in Europe in 19% of patients vs 7% in North America and 10% in Asia. In Asia, OCD accounts for 40% of arthroscopies, 7% in Europe, and 14% in North America (Figure 4) (Table 3).

This study demonstrated that the mean increase in elbow extension gained after surgery in North America was significantly greater when compared with studies from Asia, but the gain in flexion, pronation, and supination was similar across continents. The underlying cause of this difference in improvement in elbow extension between nations is unclear, although differences in diagnosis could account for some variation. This study did not examine differences in rehabilitation protocols, and certainly, it is plausible that protocol variations by country could account for some discrepancy. Furthermore, differences in functional needs may vary by continent and could have driven this result.

This study found no routine reporting of outcome scores by elbow arthroscopy studies from any continent, and that when outcome scores are reported, there is substantial inconsistency with regard to the actual scoring system used. No continent reported outcome scores in more than 40% of the studies published from that area, and the variation of outcome scores used, even from a single region, was large. This makes comparing clinical outcomes between studies difficult, even when performing identical procedures for identical indications, because there is no standardized method of reporting outcomes. To allow comparison of studies and generalizability of the results to different populations, a more standardized approach to outcome reporting needs to be instituted in the elbow arthroscopy literature. To date, there is no standardized score that has been validated for reporting clinical outcomes after elbow arthroscopy.19 Hence, it is not surprising that there were 16 different outcome scores reported throughout the 112 studies analyzed in this review, with the most frequent score, the MEPS, reported in a total of 10 studies. As medicine moves towards pay scales that are based on patient outcomes, it will become more important to define a clear outcome score that can be used to assess these patients, and reliably report scores. This will allow comparison of patients across nations to determine the best surgical treatment for different clinical problems. A validation study comparing these outcome scores to determine which score best summarizes the patient’s level of pain and function after surgery would be beneficial, because this could identify 1 score that could be standardized to allow comparison among reported outcomes.

Limitations

This study had several limitations. Despite having 2 authors search independently for studies, some studies could have been missed during the search process, introducing possible selection bias. Including only published studies could have introduced publication bias. Numerous studies did not report all the variables the authors examined. This could have skewed some results, and had additional variables been reported, could have altered the data to show significant differences in some measured variables. Because this study did not compare outcome measures for varying pathologies, conclusions cannot be drawn on the best treatment options for different indications. Case reports could have lowered the MCMS score and the average in studies reporting outcomes. Furthermore, the poor quality of the underlying data used in this study could limit the validity/generalizability of the results because this is a systematic review, and its level of evidence is only as high as the studies it includes. Because the primary aim was to report on demographics, this study did not examine concomitant pathology at the time of surgery or rehabilitation protocols.

Conclusion

The quantity, but not the quality, of arthroscopic elbow publications has significantly increased over time. Most patients undergo elbow arthroscopy for lateral epicondylitis, OCD, and release and débridement. Pathology and indications do not appear to differ geographically with more men undergoing elbow arthroscopy than women.

Although elbow arthroscopy was first described in the 1930s, it has become increasingly popular in the last 30 years.¹ While initially considered as a tool for diagnosis and loose body removal, indications have expanded to include treatment of osteochondritis dissecans (OCD), treatment of lateral epicondylitis, fixation of fractures, and others.^2-5 Miyake and colleagues⁶ found a significant improvement in range of motion, both flexion and extension, and outcome scores when elbow arthroscopy was used to remove impinging osteophytes. Babaqi and colleagues⁷ found significant improvement in pain, satisfaction, and outcome scores in 31 patients who underwent elbow arthroscopy for lateral epicondylitis refractory to nonsurgical management. The technical difficulty of the procedure, lower frequency of pathology amenable to arthroscopic intervention, and potential neurovascular complications make the elbow less frequently evaluated with the arthroscope vs other joints, such as the knee and shoulder.^2,8,9

Geographic distribution of subjects undergoing elbow arthroscopy, the indications used, surgical techniques being performed, and their associated clinical outcomes have received little to no recognition in the peer-reviewed literature.10 Differences in the elbow arthroscopy literature include characteristics related to the patient (age, gender, hand dominance, duration of symptoms), study (level of evidence, number of subjects, number of participating centers, design), indication (lateral epicondylitis, loose bodies, olecranon osteophytes, OCD), surgical technique, and outcome. Evidence-based medicine and clinical practice guidelines direct surgeons in clinical decision-making. Payers investigate the cost of surgical interventions and the value that surgery may provide, while following trends in different surgical techniques. Regulatory agencies and associations emphasize subjective patient-reported outcomes as the primary outcome measured in high-quality trials. Thus, in discussion of complex surgical interventions such as elbow arthroscopy, it is important to characterize the studies, subjects, and surgeries across the world to understand the geographic similarities and differences to optimize care in this clinical situation.

The goal of this study was to perform a systematic review and meta-analysis of elbow arthroscopy literature to identify and compare the characteristics of the studies published, the subjects analyzed, and surgical techniques performed across continents and countries to answer these questions: “Across the world, what demographic of patients are undergoing elbow arthroscopy, what are the most common indications for elbow arthroscopy, and how good is the evidence?” The authors hypothesized that patients who undergo elbow arthroscopy will be largely age <40 years, the most common indication for elbow arthroscopy will be a release/débridement, and the evidence for elbow arthroscopy will be poor. Also, no significant differences will exist in elbow arthroscopy publications, subjects, outcomes, and techniques based on continent/country of publication.

Methods

A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines using a PRISMA checklist.¹¹ Systematic review registration was performed using the International Prospective Register of Ongoing Systematic Reviews (PROSPERO; registration number, CRD42014010580; registration date, July 15, 2014).¹² Two study authors independently conducted the search on June 23, 2014 using the following databases: Medline, Cochrane Central Register of Controlled Trials, SportDiscus, and CINAHL. The electronic search citation algorithm used was: (elbow) AND arthroscopy) NOT shoulder) NOT knee) NOT ankle) NOT wrist) NOT hip) NOT dog) NOT cadaver). English language Level I-IV evidence (2012 update by the Oxford Centre for Evidence-Based Medicine¹³) clinical studies were eligible for inclusion into this study. Abstracts were ineligible for inclusion. All references in selected studies were cross-referenced for inclusion if they were missed during the initial search. Duplicate subject publications within separate unique studies were not reported twice. The study with longer duration follow-up, higher level of evidence, greater number of subjects, or more detailed subject, surgical technique, or outcome reporting was retained for inclusion. Level V evidence reviews, expert opinion articles, letters to the editor, basic science, biomechanical studies, open elbow surgery, imaging, surgical technique, and classification studies were excluded.

All included patients underwent elbow arthroscopy for either intra- or extra-articular elbow pathology (ulnotrochlear osteoarthritis, lateral epicondylitis, rheumatoid arthritis, post-traumatic contracture, osteonecrosis of the capitellum or radial head, osteoid osteoma, and others). There was no minimum follow-up duration or rehabilitation requirement. The study and subject demographic parameters that we analyzed included year of publication, years of subject enrollment, presence of study financial conflict of interest, number of subjects and elbows, elbow dominance, gender, age, body mass index, diagnoses treated, type of anesthesia (block or general), and surgical positioning. Postoperative splint application and pain management, and whether a continuous passive motion machine was used and whether a drain was placed were recorded. Clinical outcome scores were DASH (Disability of the Arm, Shoulder, and Hand), Morrey score, MEPS (Mayo Elbow Performance Score), Andrews-Carson score, Timmerman-Andrews score, LES (Liverpool Elbow Score), Tegner score, HSS (Hospital for Special Surgery Score), VAS (Visual Analog Scale), EFA (Elbow Functional Assessment), Short Form-12 (SF-12), Short Form-36 (SF-36), Kerlan-Jobe Orthopaedic Clinic (KJOC) Shoulder and Elbow Questionnaire, and MAESS (Modified Andrews Elbow Scoring System). Radiographs, computed tomography (CT), computed tomography arthrography (CTA), magnetic resonance imaging (MRI), and magnetic resonance arthrography (MRA) data were extracted when available. Range of motion (flexion, extension, supination, and pronation) and grip strength data, both preoperative and postoperative, were extracted when available. Study methodological quality was evaluated using the Modified Coleman Methodology Score (MCMS).¹⁴

Statistical Analysis

Study descriptive statistics were calculated. Continuous variable data were reported as weighted means ± weighted standard deviations. Categorical variable data were reported as frequencies with percentages. For all statistical analysis either measured and calculated from study data extraction or directly reported from the individual studies, P < .05 was considered statistically significant. Study, subject, and surgical outcomes data were compared using 1-way analysis of variance (ANOVA) tests. Where applicable, study, subject, and surgical outcomes data were also compared using 2-sample and 2-proportion Z-test calculators with α .05 because of the difference in sample sizes between compared groups. To examine trends over time, Pearson’s correlation coefficients were calculated. For the purposes of analysis, the indications of “osteoarthritis,” “arthrofibrosis,” “loose body removal,” “ulnotrochlear osteoarthritis causing stiffness,” “post-traumatic contracture/stiffness,” and “post-operative elbow contracture” were combined into the indication “release and débridement.” For the 3 most common indications for arthroscopy (OCD, lateral epicondylitis, and release and débridement) data were combined into 5-year increments to overcome the smaller sample size within each of these categories, and Pearson’s correlation coefficients were calculated to determine if number of reported cases covaried with year period. Within these 3 diagnoses, ANOVA analyses were performed to determine whether the number of cases differed between continents and countries.

Results

A total of 353 studies were located, and, after implementation of the exclusion criteria, 112 studies were included in the final analysis (Figure 1; 3093 subjects; 3168 elbows; 64% male; mean age, 34.9 ± 14.68 years). There was a mean of 33.4 ± 26.02 months of follow-up, and 75% of surgeries involved the dominant elbow (Table 1). Most studies were level IV evidence (94.6%), had a low MCMS (mean 28.1 ± 8.06; poor rating), and were single-center investigations (94.6%). Most studies did not report financial conflicts of interest (56.3%) (Tables 1 and 2). From 1985 through 2014, the number of publications significantly increased with time (P = .004) among all continents. The MCMS was unchanged over time (P = .247) (Figure 2A), as was the level of evidence (P = .094) (Figure 2B). Conflicts of interest significantly increased with time (P = .025) (Figure 3).

Among continents, North America published the largest number of studies (54), and had the largest number of patients (1395) and elbow surgeries (1425) (Table 1). The United States published the largest number of studies (43%). There were no significant differences between age (P = .331), length of follow-up (P = .403), MCMS (P = .123), and level of evidence (P = .288) between continents. Of the 32 studies that reported the use of preoperative MRI, studies from Asia reported significantly more MRI scans than those from other continents (P = .040); there were no other significant differences between continents in reference to preoperative imaging studies or other demographic information.

The most common surgical indications were OCD (Figure 4), lateral epicondylitis (Figure 5), and release and débridement (Figure 6, Table 3; all studies listed indications). The number of reported cases for these 3 indications significantly increased over time (OCD P = .005, lateral epicondylitis P = .044, release and débridement P = .042) but did not significantly differ between regions (P > .05 in all cases).

Thirty-two (28.6%) studies reported the use of outcome measures (16 different outcome scores were used by the included studies). Asia reported outcome measures in 9 of 23 studies (39%), Europe in 12 of 35 studies (34%) and North America in 11 of 54 (20%) of studies. The MEPS was the most frequently used outcome score in 9.8% of studies, followed by VAS for pain in 5.3% of cases. North American studies reported a significantly higher increase in extension after elbow arthroscopy than Asia (P = .0432) (Figure 7), with no differences in flexion (P = .699), pronation (P = .376), or supination (P = .408). No significant differences were observed between continents in the type of anesthesia chosen (general anesthesia [P = .94] or regional anesthesia [P = .85]). Asia and Europe performed elbow arthroscopy most frequently in the lateral decubitus position, while North American studies most often used the supine position (Table 4).

Twenty (17.9%) studies reported the use of a postoperative splint, 12 (10.7%) studies reported use of a drain, 2 (1.79%) studies reported use of a hinged elbow brace, 9 (8.03%) studies reported use of a continuous passive motion machine postoperatively, and 3 (2.68%) studies reported use of an indwelling axillary catheter for postoperative pain management. Of 130 reported surgical complications (4.1%), the most frequent complication was transient sensory ulnar nerve palsy (1.5%), followed by persistent wound drainage (.76%), and transient sensory radial nerve palsy (.38%). Other reported complications included infection (.22%), transient sensory palsy of the median nerve (.19%), heterotopic ossification (.13%), complete transection of the ulnar nerve (.10%), loose body formation (.06%), hematoma formation (.06%), transient sensory palsy of the posterior interosseous (.06%), or anterior interosseous nerve (.03%), and complete transection of the radial (.03%), or median nerve (.03%).

Discussion

Elbow arthroscopy is an evolving surgical procedure that is used to treat intra- and extra-articular pathologies of the elbow. Outcomes of elbow arthroscopy for certain conditions have generally been reported as good, with improvements seen in pain, functional scores, and range of motion.^6,15-17 The authors’ hypotheses were mostly confirmed in that the average age of patients undergoing elbow arthroscopy was <40 years, release/débridement was one of the most common indications (along with lateral epicondylitis and OCD), and the general evidence for elbow arthroscopy was poor. Also, there were almost no differences between continents/countries related to patient indications, preoperative imaging, anesthesia choice, indications, postoperative protocols, and outcomes (although the number of studies that reported outcomes was low and could have skewed the results), with the exception of a higher number of preoperative MRI scans in Asia. Some of the notable findings of this study included: 1) the number of studies published on elbow arthroscopy is significantly increasing with time, despite a lack of improvement in the level of evidence; 2) the majority of studies on elbow arthroscopy do not report a surgical outcome score; and 3) the number of reported cases for the 3 most common indications significantly increased over time (OCD, P = .005; lateral epicondylitis, P = .044; release and débridement, P = .042) but did not differ between regions (P > .05 in all cases).

The indications for elbow arthroscopy have grown dramatically in the past 2 decades to include both intra- and extra-articular pathologies.¹⁸ Despite this increase in the number of indications for elbow arthroscopy, the study did not find a significant difference between countries/continents in the indications each used for elbow arthroscopy patients. There was a trend towards an increase in OCD cases in all continents, especially Asia (Figure 4), with time. Interestingly, while not statistically significant, there was variation among countries for surgical indications. In North America, removal of loose bodies accounts for 18% of patients, while in Europe this accounted for only 9% and in Asia for 1%. Post-traumatic stiffness was the indication for elbow arthroscopy in Europe in 19% of patients vs 7% in North America and 10% in Asia. In Asia, OCD accounts for 40% of arthroscopies, 7% in Europe, and 14% in North America (Figure 4) (Table 3).

This study demonstrated that the mean increase in elbow extension gained after surgery in North America was significantly greater when compared with studies from Asia, but the gain in flexion, pronation, and supination was similar across continents. The underlying cause of this difference in improvement in elbow extension between nations is unclear, although differences in diagnosis could account for some variation. This study did not examine differences in rehabilitation protocols, and certainly, it is plausible that protocol variations by country could account for some discrepancy. Furthermore, differences in functional needs may vary by continent and could have driven this result.

This study found no routine reporting of outcome scores by elbow arthroscopy studies from any continent, and that when outcome scores are reported, there is substantial inconsistency with regard to the actual scoring system used. No continent reported outcome scores in more than 40% of the studies published from that area, and the variation of outcome scores used, even from a single region, was large. This makes comparing clinical outcomes between studies difficult, even when performing identical procedures for identical indications, because there is no standardized method of reporting outcomes. To allow comparison of studies and generalizability of the results to different populations, a more standardized approach to outcome reporting needs to be instituted in the elbow arthroscopy literature. To date, there is no standardized score that has been validated for reporting clinical outcomes after elbow arthroscopy.19 Hence, it is not surprising that there were 16 different outcome scores reported throughout the 112 studies analyzed in this review, with the most frequent score, the MEPS, reported in a total of 10 studies. As medicine moves towards pay scales that are based on patient outcomes, it will become more important to define a clear outcome score that can be used to assess these patients, and reliably report scores. This will allow comparison of patients across nations to determine the best surgical treatment for different clinical problems. A validation study comparing these outcome scores to determine which score best summarizes the patient’s level of pain and function after surgery would be beneficial, because this could identify 1 score that could be standardized to allow comparison among reported outcomes.

Limitations

This study had several limitations. Despite having 2 authors search independently for studies, some studies could have been missed during the search process, introducing possible selection bias. Including only published studies could have introduced publication bias. Numerous studies did not report all the variables the authors examined. This could have skewed some results, and had additional variables been reported, could have altered the data to show significant differences in some measured variables. Because this study did not compare outcome measures for varying pathologies, conclusions cannot be drawn on the best treatment options for different indications. Case reports could have lowered the MCMS score and the average in studies reporting outcomes. Furthermore, the poor quality of the underlying data used in this study could limit the validity/generalizability of the results because this is a systematic review, and its level of evidence is only as high as the studies it includes. Because the primary aim was to report on demographics, this study did not examine concomitant pathology at the time of surgery or rehabilitation protocols.

Conclusion

The quantity, but not the quality, of arthroscopic elbow publications has significantly increased over time. Most patients undergo elbow arthroscopy for lateral epicondylitis, OCD, and release and débridement. Pathology and indications do not appear to differ geographically with more men undergoing elbow arthroscopy than women.

Although total shoulder arthroplasty (TSA) has proved to be a reliable solution in older patients, treatment in younger patients with glenohumeral arthritis remains controversial, and there are still few reliable long-term surgical options.^1-8 These options include abrasion arthroplasty and arthroscopic management,^9,10 biologic glenoid resurfacing,^11,12 and humeral hemiarthroplasty with¹³ or without^14,15 glenoid treatment and anatomical TSA.

In the younger cohort, 20-year TSA survivorship rates up to 84% have been reported, and unsatisfactory subjective outcomes have been unacceptably high.¹⁶ In addition, there is a paucity of literature addressing the impact of TSA on return to sport. Recommendations on returning to an athletic life style are based largely on surveys of expert opinion^17,18 and heterogeneous studies of either older patients (eg, age >50-55 years) who are active^19-21 or younger patients with no defined level of activity.^{5,7,8,16,22-24}

To our knowledge, no one has evaluated the short-term morbidity and clinical outcomes within a young, high-demand patient population, such as the US military. Therefore, we conducted a study to evaluate the clinical success and complications of TSA performed for glenohumeral arthritis in a young, active population. We hypothesized that patients who had undergone TSA would have a low rate of return to duty, an increased rate of component failure, and a higher reoperation rate because of increased upper extremity demands.

Materials and Methods

After obtaining protocol approval from the William Beaumont Army Medical Center Institutional Review Board, we searched the Military Health System (MHS) Management Analysis and Reporting Tool (M2) database to retrospectively review the cases of all tri-service US military service members who had undergone primary anatomical TSA (Current Procedural Terminology code 23472) between January 1, 2007 and June 31, 2014. This was a multisurgeon, multicenter study. Patient exclusion criteria were nonmilitary or retired status at time of surgery; primary surgery consisting of limited glenohumeral resurfacing procedure, hemiarthroplasty, or reverse TSA; surgery for acute proximal humerus fracture; rotator cuff deficiency diagnosed before or during surgery; and insufficient follow-up (eg, <12 months, unless medically separated beforehand).

The M2 database is an established tool that has been used for clinical outcomes research on treatment of a variety of orthopedic conditions.25,26 The Medical Data Repository, which is operated by MHS, is populated by its military healthcare providers. The MHS, which offers worldwide coverage for all beneficiaries either at Department of Defense facilities or purchased using civilian providers, is among the largest known closed healthcare systems.

All active-duty US military service members are uniformly required to adhere to stringent and regularly evaluated physical fitness standards, which typically exceed those of average civilians. Routine physical training is required in the form of aerobic fitness, weight training, tactical field exercises, and core military tasks, such as the ability to march at least 2 miles while carrying heavy fighting loads. In addition to satisfying required height and weight standards, all service members are subject to semiannual service-specific physical fitness evaluations inclusive of timed push-ups, sit-ups, and an aerobic event. Service members may also be required to maintain a level of physical training above these baseline standards, contingent on their branch of service, rank, and military occupational specialty. If a service member is unable to maintain these standards, medical separation may be initiated.

Demographic and occupational data were extracted from the database. These data included age, sex, military rank, and branch of service. Line-by-line analysis of the Armed Forces Health Longitudinal Technology Application (Version 22; 3M) electronic medical record was then performed to confirm the underlying diagnosis, surgical procedure, and surgery date. Further chart review yielded additional patient-based factors (eg, laterality, hand dominance, presence and type of prior shoulder surgeries) and surgical factors (eg, surgery indication, implant design). We evaluated clinical and functional outcomes as well as perioperative complications, including both major and minor systemic and local complications as previously described^27,28; preoperative and postoperative range of motion (ROM) and self-reported pain score (SRPS, scale 1-10) as measured by physical therapist and surgeon at follow-up; secondary surgical interventions; timing of return to duty; and postoperative deployment history. The primary outcome measures were revision reoperation after index procedure, and military discharge for persistent shoulder-related disability. Clinical failure was defined as component failure or reoperation. Medical Evaluation Board (MEB) is a formal separation from the military in which it is deemed that a service member is no longer able to fulfill his or her duty because of a medical condition.

Statistical Analysis

Continuous variables were compared using statistical means with 95% confidence intervals (CIs) and/or SDs. Categorical data were reported as frequencies or percentages. Univariate analysis was performed to assess the correlation between possible risk factors and the primary outcome measures. P < .05 was considered statistically significant.

Results

Demographics

We identified 24 service members (26 shoulders) who had undergone anatomical TSA during the study period (Table 1). Mean (SD) age was 45.8 (4.5) years (range, 35-54 years), and the cohort was predominately male (25/26 shoulders; 96.2%). Most cohort members were of senior enlisted rank (14, 58.3%), and the US Army was the predominant branch of military service (13, 54.2%). The right side was the operative extremity in 7 cases (26.9%), and the dominant shoulder was involved in 6 cases (23.1%). Two patients (8.3%) underwent staged bilateral TSA. Most patients (76.9%) underwent TSA on the nondominant extremity.

Surgical Variables

TSA was indicated for post-instability arthropathy in 13 cases (50.0%), posttraumatic osteoarthritis in 7 cases (26.9%), and unspecified glenohumeral arthritis, which includes primary glenohumeral osteoarthritis, in 5 cases (19.2%) (Table 2). One case was attributed to iatrogenically induced chondrolysis secondary to intra-articular lidocaine pump. Twelve patients (46.2%) had at least 1 previous surgery. Of the shoulders with instability, 10 (76.9%) had undergone a total of 14 surgical stabilization procedures—10 anterior labral repairs, 2 posterior labral repairs, and 2 capsular plications. The other shoulders had undergone a total of 18 procedures, which included 4 rotator cuff repairs and 3 cartilage restoration procedures.

Clinical Outcomes

Mean (SD) follow-up was 41.0 (21.3) months (range, 11.6-97.6 months). All but 1 shoulder (96.2%) had follow-up of 12 months or more (the only patient with shorter follow-up was because of MEB), and 76.9% of patients had follow-up of 24 months or more (4 of the 6 patients with follow-up under 24 months were medically separated) (Table 3). In all cases, mean ROM improved with respect to flexion, abduction, and external rotation. At final follow-up, mean (SD) ROM was 138° (36°) forward flexion (range, 60°-180°), 125° (39°) abduction (range, 45°-180°), 48° (19°) external rotation at 0° abduction (range, 20°-90°), and 80° (9.4°) external rotation at 90° abduction (range, 70°-90°). Preoperative flexion, abduction, and external rotation at 0° and 90° abduction were all improved at final follow-up. The most improvement in ROM occurred within 6 months after surgery.

Overall patient satisfaction with surgery was 92.3% (n = 24). Ultimately, 18 (72.0%) of 25 shoulders with follow-up of 1 year or more were able to return to active duty within 1 year after surgery, though only 10 (45.5%) of 22 with follow-up of 2 years or more remained active 2 years after surgery. Furthermore, 5 patients (20.8%) were deployed after surgery, and all were still on active duty at final follow-up. By final follow-up, 9 (37.5%) of 24 service members were unable to return to military function; 7 had been medically discharged from the military for persistent shoulder disability, and 2 were in the process of being medically discharged.

In all cases, SRPS improved from before surgery (5.2 out of 10) to final follow-up (1.4). At final follow-up, 22 patients (88.0%) reported mild pain (0-3), and no one had pain above 6.

Complications

Nine patients had a total of 12 postoperative complications (46.2%): 6 component failures (23.1%), 2 neurologic injuries (7.7%; 1 permanent axillary nerve injury, 1 transient brachial plexus neuritis), 2 cases of adhesive capsulitis (7.7%), and 2 episodes of venous thrombosis (7.7%; 1 superficial, 1 deep) (Table 4). There were no documented infections. Six reoperations (23.1%) were performed for the 6 component failures (2 traumatic dislocations of prosthesis resulting in acute glenoid component failure, 3 cases of atraumatic glenoid loosening, 1 case of humeral stem loosening after periprosthetic fracture). Atraumatic glenoid component loosening occurred a mean (SD) of 40.6 (14.2) months after surgery (range, 20.8-54.2 months).

Surgical Failures

Eight service members underwent MEB. Six patients experienced component failure. Factors contributing to both clinical failure and separation from active duty by means of MEB were evaluated with univariate analysis (Table 5). No statistically significant risk factors, including surgical revision and presence of perioperative complications, were identified.

Discussion

We confirmed that our cohort of young service members (mean age, 45.8 years), who had undergone TSA for glenohumeral arthritis, had a relatively higher rate of component failure (23.1%) and a higher reoperation rate (23.1%) with low rates of return to military duty at short-term to midterm follow-up. Our results parallel those of a limited series with a younger cohort (Table 6).^{7,16,19,21,23,24} The high demand and increased life expectancy of the younger patients with glenohumeral arthritis potentiates the risk of complications, component loosening, and ultimate failure.²⁹ To our knowledge, the present article is the first to report clinical and functional outcomes and perioperative risk profiles in a homogenously young, active military cohort after TSA.

The mean age of our study population (46 years) is one of the lowest in the literature. TSA in younger patients (age, <50-55 years) and older, active patients (>55 years) has received increased attention as a result of the expanding indications and growing popularity of TSA in these groups. Other studies have upheld the efficacy of TSA in achieving predictable pain relief and functional improvement in a diverse and predominantly elderly population.^15,30-34 Alternative treatments, including humeral head resurfacing^15,30,35 and soft-tissue interposition,^15,36-40 have also shown inferior short- and long-term results in terms of longevity and degree of clinical or functional improvement.^31-34,41 In addition, the ream-and-run technique has had promising early results by improving glenohumeral kinematics, pain relief, and shoulder function.^13,42,43 However, although implantation of a glenoid component is avoided in young, active people because of reduced longevity and higher rates of component failure, the trade-offs are inadequately treated glenoid disease, suboptimal pain relief, and progression of glenoid arthritis eventually requiring revision. Furthermore, midterm and long-term survivorship of TSA in general is unknown, and there remain few good options for treating end-stage arthritis in young, active patients.

Our cohort had high rates of complications (46.2%) and revisions (23.1%). Two in 5 patients had postoperative complications, most commonly component failure resulting in reoperation. In the literature, complication rates among young patients who underwent TSA are much lower (4.8%-10.9%).^16,23,24 Our cohort’s most common complication was component failure (23.1%), which was most often attributed to atraumatic, aseptic glenoid component loosening and required reoperation. Previously reported revision rates in a young population that underwent TSA (0%-11%)^16,23,24 were also significantly lower than those in the present analysis (23.1%), underscoring the impact of operative indications, postoperative activity levels, and occupational demands on ultimate failure rates. Interestingly, all revisions in our study were for component failure, whereas previous reports have described a higher rate for infection.²² However, the same studies also found glenoid lucency rates as high as 76% at 10-year follow-up.¹⁶ Furthermore, in a review of 136 TSAs with unsatisfactory outcomes, glenoid loosening was the most common reason for presenting to clinic after surgery.⁴⁴ Specifically, our population had a high rate of glenohumeral arthritis secondary to instability (50.0%) and posttraumatic osteoarthritis (26.9%). For many reasons, outcomes were worse in younger patients with a history of glenohumeral instability³³ than in older patients without a high incidence of instability.⁴⁵ This young cohort with higher demands may have had accelerated polyethylene wear patterns caused by repetitive overhead activity, which may have arisen because of a higher functional profile after surgery and greater patient expectations after arthroplasty. In addition, patients with a history of instability may have altered glenohumeral anatomy, especially with previous arthroscopic or open stabilization procedures. Anatomical changes include excessive posterior glenoid wear, internal rotation contracture, patulous capsular tissue, static or dynamic posterior humeral subluxation, and possible overconstraint after prior stabilization procedures. Almost half of our population had a previous surgery; our patients averaged 1.7 previous surgeries each.

Although estimates of component survivorship at a high-volume civilian tertiary-referral center were as high as 97% at 10 years and 84% at 20 years,^7,16 10-year survivorship in patients with a history of instability was only 61%.3 TSA survivorship in our young, active cohort is already foreseeably dramatically reduced, given the 23.1% revision rate at 28.5-month follow-up. This consideration must be addressed during preoperative counseling with the young patient with glenohumeral arthritis and a history of shoulder instability.

Despite the high rates of complications and revisions in our study, 92.3% of patients were satisfied with surgery, 88.0% experienced minimal persistence of pain (mean 3.8-point decrease on SRPS), and 100% maintained improved ROM at final follow-up. Satisfaction in the young population has varied significantly, from 52% to 95%, generally on the basis of physical activity.^16,22-24 The reasonable rate of postoperative satisfaction in the present analysis is comparable to what has been reported in patients of a similar age (Table 6).^7,16,22 However, despite high satisfaction and pain relief, patients were inconsistently able to return to the upper limits of physical activity required of active-duty military service. In addition, we cannot exclude secondary gain motivations for pursuing medical retirement, similar to that seen in patients receiving worker’s compensation.

Other authors have conversely found more favorable functional outcomes and survivorship rates.^23,24 In a retrospective review of 46 TSAs in patients 55 years or younger, Bartelt and colleagues²⁴ found sustained improvements in pain, ROM, and satisfaction at 7-year follow-up.24 Raiss and colleagues²³ conducted a prospective study of TSA outcomes in 21 patients with a mean age of 55 years and a mean follow-up of 7 years and reported no revisions and only 1 minor complication, a transient brachial plexus palsy.²³ The discrepancy between these studies may reflect different activity levels and underlying pathology between cohorts. The present population is unique in that it represents a particularly difficult confluence of factors for shoulder arthroplasty surgeons. The high activity, significant overhead and lifting occupational demands, and discordant patient expectations of this military cohort place a significant functional burden on the implants, the glenoid component in particular. Furthermore, this patient group has a higher incidence of more complex glenohumeral pathology resulting in instability, posttraumatic, or capsulorrhaphy arthropathy, and multiple prior arthroscopic and open stabilization procedures.

At final follow-up, only 33% of our patients were still on activity duty, 37.5% had completed or were completing medical separation from the military after surgery for persistent shoulder disability, and 37.5% were retired from the military. Five patients (20.8%) deployed after surgery. This young, active cohort of service members who had TSA for glenohumeral arthritis faced a unique set of tremendous physical demands. A retrospective case series investigated return to sport in 100 consecutive patients (mean age, 68.9 years) who were participating in recreational and competitive athletics and underwent unilateral TSA.²¹ The patients were engaged most commonly in swimming (20.4%), golf (16.3%), cycling (16.3%), and fitness training (16.3%). The authors found that, at a mean follow-up of 2.8 years, 49 patients (89%) were able to continue in sports, though 36.7% thought their sport activity was restricted after TSA. In another retrospective case series (61 TSAs), McCarty and colleagues¹⁹ found that 48 patients (71%) were improved in their sports participation, and 50% increased their frequency of participation after surgery.

There are no specific recommendations on returning to military service or high-level sport after surgery. Recommendations on returning to sport after TSA have been based largely on small case series involving specific sports^46,47 and surveys of expert opinion.^17,18 In a survey on postoperative physical activity in young patients after TSA conducted by Healy and colleagues,¹⁷ 35 American Shoulder and Elbow Surgeons members recommended avoiding contact and impact sports while permitting return to nonimpact sports, such as swimming, which may still impart significant stress to the glenohumeral joint. In an international survey of 101 shoulder and elbow surgeons, Magnussen and colleagues¹⁸ also found that most recommended avoiding a return to impact sports that require intensive upper extremity demands and permitting full return to sports at preoperative levels. This likely is a result of the perception that most of these patients having TSA are older and have less rigorous involvement in sports at the outset and a lower propensity for adverse patient outcomes. However, these recommendations may place a younger, more high-demand patient at significantly greater risk. The active-duty cohort engages in daily physical training, including push-ups and frequent overhead lifting, which could account for the high failure rates and low incidence of postoperative deployment. Although TSA seems to demonstrate good initial results in terms of return to high-demand activities, the return-to-duty profile in our study highlights the potential pitfalls of TSA in active individuals attempting to return to high-demand preoperative function.

Our analysis was limited by the fact that we used a small patient cohort, contributing to underpowered analysis of the potential risk factors predictive of reoperation and medical discharge. Although our minimum follow-up was 12 months, with the exception of 1 patient who was medically separated at 11.6 months because of shoulder disability, we captured 5 patients (19.2%) who underwent medical separation but who would otherwise be excluded. Therefore, this limitation is not major in that, with a longer minimum follow-up, we would be excluding a significant number of patients with such persistent disability after TSA that they would not be able to return to duty at anywhere near their previous level. In this retrospective study, we were additionally limited to analysis of the data in the medical records and could not control for variables such as surgeon technique, implant choice, and experience. Complete radiographic images were not available, limiting analysis of radiographic outcomes. Given the lack of a standardized preoperative imaging protocol, we could not evaluate glenoid version on axial imaging. It is possible that some patients with early aseptic glenoid loosening had posterior subluxation or a Walch B2 glenoid, which has a higher failure rate.⁴⁸ The strengths of this study include its unique analysis of a homogeneous young, active, high-risk patient cohort within a closed healthcare system. In the military, these patients are subject to intense daily physical and occupational demands. In addition, the clinical and functional outcomes we studied are patient-centered and therefore relevant during preoperative counseling. Further investigations might focus on validated outcome measures and on midterm to long-term TSA outcomes in an active military population vis-à-vis other alternatives for clinical management.

Conclusion

By a mean follow-up of 3.5 years, only a third of the service members had returned to active duty, roughly a third had retired, and more than a third had been medically discharged because of persistent disability attributable to the shoulder. Despite initial improvements in ROM and pain, midterm outcomes were poor. The short-term complication rate (46.2%) and the rate of reoperation for component failure (23.1%) should be emphasized during preoperative counseling.

Although total shoulder arthroplasty (TSA) has proved to be a reliable solution in older patients, treatment in younger patients with glenohumeral arthritis remains controversial, and there are still few reliable long-term surgical options.^1-8 These options include abrasion arthroplasty and arthroscopic management,^9,10 biologic glenoid resurfacing,^11,12 and humeral hemiarthroplasty with¹³ or without^14,15 glenoid treatment and anatomical TSA.

In the younger cohort, 20-year TSA survivorship rates up to 84% have been reported, and unsatisfactory subjective outcomes have been unacceptably high.¹⁶ In addition, there is a paucity of literature addressing the impact of TSA on return to sport. Recommendations on returning to an athletic life style are based largely on surveys of expert opinion^17,18 and heterogeneous studies of either older patients (eg, age >50-55 years) who are active^19-21 or younger patients with no defined level of activity.^{5,7,8,16,22-24}

To our knowledge, no one has evaluated the short-term morbidity and clinical outcomes within a young, high-demand patient population, such as the US military. Therefore, we conducted a study to evaluate the clinical success and complications of TSA performed for glenohumeral arthritis in a young, active population. We hypothesized that patients who had undergone TSA would have a low rate of return to duty, an increased rate of component failure, and a higher reoperation rate because of increased upper extremity demands.

Materials and Methods

After obtaining protocol approval from the William Beaumont Army Medical Center Institutional Review Board, we searched the Military Health System (MHS) Management Analysis and Reporting Tool (M2) database to retrospectively review the cases of all tri-service US military service members who had undergone primary anatomical TSA (Current Procedural Terminology code 23472) between January 1, 2007 and June 31, 2014. This was a multisurgeon, multicenter study. Patient exclusion criteria were nonmilitary or retired status at time of surgery; primary surgery consisting of limited glenohumeral resurfacing procedure, hemiarthroplasty, or reverse TSA; surgery for acute proximal humerus fracture; rotator cuff deficiency diagnosed before or during surgery; and insufficient follow-up (eg, <12 months, unless medically separated beforehand).

The M2 database is an established tool that has been used for clinical outcomes research on treatment of a variety of orthopedic conditions.25,26 The Medical Data Repository, which is operated by MHS, is populated by its military healthcare providers. The MHS, which offers worldwide coverage for all beneficiaries either at Department of Defense facilities or purchased using civilian providers, is among the largest known closed healthcare systems.

All active-duty US military service members are uniformly required to adhere to stringent and regularly evaluated physical fitness standards, which typically exceed those of average civilians. Routine physical training is required in the form of aerobic fitness, weight training, tactical field exercises, and core military tasks, such as the ability to march at least 2 miles while carrying heavy fighting loads. In addition to satisfying required height and weight standards, all service members are subject to semiannual service-specific physical fitness evaluations inclusive of timed push-ups, sit-ups, and an aerobic event. Service members may also be required to maintain a level of physical training above these baseline standards, contingent on their branch of service, rank, and military occupational specialty. If a service member is unable to maintain these standards, medical separation may be initiated.

Demographic and occupational data were extracted from the database. These data included age, sex, military rank, and branch of service. Line-by-line analysis of the Armed Forces Health Longitudinal Technology Application (Version 22; 3M) electronic medical record was then performed to confirm the underlying diagnosis, surgical procedure, and surgery date. Further chart review yielded additional patient-based factors (eg, laterality, hand dominance, presence and type of prior shoulder surgeries) and surgical factors (eg, surgery indication, implant design). We evaluated clinical and functional outcomes as well as perioperative complications, including both major and minor systemic and local complications as previously described^27,28; preoperative and postoperative range of motion (ROM) and self-reported pain score (SRPS, scale 1-10) as measured by physical therapist and surgeon at follow-up; secondary surgical interventions; timing of return to duty; and postoperative deployment history. The primary outcome measures were revision reoperation after index procedure, and military discharge for persistent shoulder-related disability. Clinical failure was defined as component failure or reoperation. Medical Evaluation Board (MEB) is a formal separation from the military in which it is deemed that a service member is no longer able to fulfill his or her duty because of a medical condition.

Statistical Analysis

Continuous variables were compared using statistical means with 95% confidence intervals (CIs) and/or SDs. Categorical data were reported as frequencies or percentages. Univariate analysis was performed to assess the correlation between possible risk factors and the primary outcome measures. P < .05 was considered statistically significant.

Results

Demographics

We identified 24 service members (26 shoulders) who had undergone anatomical TSA during the study period (Table 1). Mean (SD) age was 45.8 (4.5) years (range, 35-54 years), and the cohort was predominately male (25/26 shoulders; 96.2%). Most cohort members were of senior enlisted rank (14, 58.3%), and the US Army was the predominant branch of military service (13, 54.2%). The right side was the operative extremity in 7 cases (26.9%), and the dominant shoulder was involved in 6 cases (23.1%). Two patients (8.3%) underwent staged bilateral TSA. Most patients (76.9%) underwent TSA on the nondominant extremity.

Surgical Variables

TSA was indicated for post-instability arthropathy in 13 cases (50.0%), posttraumatic osteoarthritis in 7 cases (26.9%), and unspecified glenohumeral arthritis, which includes primary glenohumeral osteoarthritis, in 5 cases (19.2%) (Table 2). One case was attributed to iatrogenically induced chondrolysis secondary to intra-articular lidocaine pump. Twelve patients (46.2%) had at least 1 previous surgery. Of the shoulders with instability, 10 (76.9%) had undergone a total of 14 surgical stabilization procedures—10 anterior labral repairs, 2 posterior labral repairs, and 2 capsular plications. The other shoulders had undergone a total of 18 procedures, which included 4 rotator cuff repairs and 3 cartilage restoration procedures.

Clinical Outcomes

Mean (SD) follow-up was 41.0 (21.3) months (range, 11.6-97.6 months). All but 1 shoulder (96.2%) had follow-up of 12 months or more (the only patient with shorter follow-up was because of MEB), and 76.9% of patients had follow-up of 24 months or more (4 of the 6 patients with follow-up under 24 months were medically separated) (Table 3). In all cases, mean ROM improved with respect to flexion, abduction, and external rotation. At final follow-up, mean (SD) ROM was 138° (36°) forward flexion (range, 60°-180°), 125° (39°) abduction (range, 45°-180°), 48° (19°) external rotation at 0° abduction (range, 20°-90°), and 80° (9.4°) external rotation at 90° abduction (range, 70°-90°). Preoperative flexion, abduction, and external rotation at 0° and 90° abduction were all improved at final follow-up. The most improvement in ROM occurred within 6 months after surgery.

Overall patient satisfaction with surgery was 92.3% (n = 24). Ultimately, 18 (72.0%) of 25 shoulders with follow-up of 1 year or more were able to return to active duty within 1 year after surgery, though only 10 (45.5%) of 22 with follow-up of 2 years or more remained active 2 years after surgery. Furthermore, 5 patients (20.8%) were deployed after surgery, and all were still on active duty at final follow-up. By final follow-up, 9 (37.5%) of 24 service members were unable to return to military function; 7 had been medically discharged from the military for persistent shoulder disability, and 2 were in the process of being medically discharged.

In all cases, SRPS improved from before surgery (5.2 out of 10) to final follow-up (1.4). At final follow-up, 22 patients (88.0%) reported mild pain (0-3), and no one had pain above 6.

Complications

Nine patients had a total of 12 postoperative complications (46.2%): 6 component failures (23.1%), 2 neurologic injuries (7.7%; 1 permanent axillary nerve injury, 1 transient brachial plexus neuritis), 2 cases of adhesive capsulitis (7.7%), and 2 episodes of venous thrombosis (7.7%; 1 superficial, 1 deep) (Table 4). There were no documented infections. Six reoperations (23.1%) were performed for the 6 component failures (2 traumatic dislocations of prosthesis resulting in acute glenoid component failure, 3 cases of atraumatic glenoid loosening, 1 case of humeral stem loosening after periprosthetic fracture). Atraumatic glenoid component loosening occurred a mean (SD) of 40.6 (14.2) months after surgery (range, 20.8-54.2 months).

Surgical Failures

Eight service members underwent MEB. Six patients experienced component failure. Factors contributing to both clinical failure and separation from active duty by means of MEB were evaluated with univariate analysis (Table 5). No statistically significant risk factors, including surgical revision and presence of perioperative complications, were identified.

Discussion

We confirmed that our cohort of young service members (mean age, 45.8 years), who had undergone TSA for glenohumeral arthritis, had a relatively higher rate of component failure (23.1%) and a higher reoperation rate (23.1%) with low rates of return to military duty at short-term to midterm follow-up. Our results parallel those of a limited series with a younger cohort (Table 6).^{7,16,19,21,23,24} The high demand and increased life expectancy of the younger patients with glenohumeral arthritis potentiates the risk of complications, component loosening, and ultimate failure.²⁹ To our knowledge, the present article is the first to report clinical and functional outcomes and perioperative risk profiles in a homogenously young, active military cohort after TSA.

The mean age of our study population (46 years) is one of the lowest in the literature. TSA in younger patients (age, <50-55 years) and older, active patients (>55 years) has received increased attention as a result of the expanding indications and growing popularity of TSA in these groups. Other studies have upheld the efficacy of TSA in achieving predictable pain relief and functional improvement in a diverse and predominantly elderly population.^15,30-34 Alternative treatments, including humeral head resurfacing^15,30,35 and soft-tissue interposition,^15,36-40 have also shown inferior short- and long-term results in terms of longevity and degree of clinical or functional improvement.^31-34,41 In addition, the ream-and-run technique has had promising early results by improving glenohumeral kinematics, pain relief, and shoulder function.^13,42,43 However, although implantation of a glenoid component is avoided in young, active people because of reduced longevity and higher rates of component failure, the trade-offs are inadequately treated glenoid disease, suboptimal pain relief, and progression of glenoid arthritis eventually requiring revision. Furthermore, midterm and long-term survivorship of TSA in general is unknown, and there remain few good options for treating end-stage arthritis in young, active patients.

Our cohort had high rates of complications (46.2%) and revisions (23.1%). Two in 5 patients had postoperative complications, most commonly component failure resulting in reoperation. In the literature, complication rates among young patients who underwent TSA are much lower (4.8%-10.9%).^16,23,24 Our cohort’s most common complication was component failure (23.1%), which was most often attributed to atraumatic, aseptic glenoid component loosening and required reoperation. Previously reported revision rates in a young population that underwent TSA (0%-11%)^16,23,24 were also significantly lower than those in the present analysis (23.1%), underscoring the impact of operative indications, postoperative activity levels, and occupational demands on ultimate failure rates. Interestingly, all revisions in our study were for component failure, whereas previous reports have described a higher rate for infection.²² However, the same studies also found glenoid lucency rates as high as 76% at 10-year follow-up.¹⁶ Furthermore, in a review of 136 TSAs with unsatisfactory outcomes, glenoid loosening was the most common reason for presenting to clinic after surgery.⁴⁴ Specifically, our population had a high rate of glenohumeral arthritis secondary to instability (50.0%) and posttraumatic osteoarthritis (26.9%). For many reasons, outcomes were worse in younger patients with a history of glenohumeral instability³³ than in older patients without a high incidence of instability.⁴⁵ This young cohort with higher demands may have had accelerated polyethylene wear patterns caused by repetitive overhead activity, which may have arisen because of a higher functional profile after surgery and greater patient expectations after arthroplasty. In addition, patients with a history of instability may have altered glenohumeral anatomy, especially with previous arthroscopic or open stabilization procedures. Anatomical changes include excessive posterior glenoid wear, internal rotation contracture, patulous capsular tissue, static or dynamic posterior humeral subluxation, and possible overconstraint after prior stabilization procedures. Almost half of our population had a previous surgery; our patients averaged 1.7 previous surgeries each.

Although estimates of component survivorship at a high-volume civilian tertiary-referral center were as high as 97% at 10 years and 84% at 20 years,^7,16 10-year survivorship in patients with a history of instability was only 61%.3 TSA survivorship in our young, active cohort is already foreseeably dramatically reduced, given the 23.1% revision rate at 28.5-month follow-up. This consideration must be addressed during preoperative counseling with the young patient with glenohumeral arthritis and a history of shoulder instability.

Despite the high rates of complications and revisions in our study, 92.3% of patients were satisfied with surgery, 88.0% experienced minimal persistence of pain (mean 3.8-point decrease on SRPS), and 100% maintained improved ROM at final follow-up. Satisfaction in the young population has varied significantly, from 52% to 95%, generally on the basis of physical activity.^16,22-24 The reasonable rate of postoperative satisfaction in the present analysis is comparable to what has been reported in patients of a similar age (Table 6).^7,16,22 However, despite high satisfaction and pain relief, patients were inconsistently able to return to the upper limits of physical activity required of active-duty military service. In addition, we cannot exclude secondary gain motivations for pursuing medical retirement, similar to that seen in patients receiving worker’s compensation.

Other authors have conversely found more favorable functional outcomes and survivorship rates.^23,24 In a retrospective review of 46 TSAs in patients 55 years or younger, Bartelt and colleagues²⁴ found sustained improvements in pain, ROM, and satisfaction at 7-year follow-up.24 Raiss and colleagues²³ conducted a prospective study of TSA outcomes in 21 patients with a mean age of 55 years and a mean follow-up of 7 years and reported no revisions and only 1 minor complication, a transient brachial plexus palsy.²³ The discrepancy between these studies may reflect different activity levels and underlying pathology between cohorts. The present population is unique in that it represents a particularly difficult confluence of factors for shoulder arthroplasty surgeons. The high activity, significant overhead and lifting occupational demands, and discordant patient expectations of this military cohort place a significant functional burden on the implants, the glenoid component in particular. Furthermore, this patient group has a higher incidence of more complex glenohumeral pathology resulting in instability, posttraumatic, or capsulorrhaphy arthropathy, and multiple prior arthroscopic and open stabilization procedures.

At final follow-up, only 33% of our patients were still on activity duty, 37.5% had completed or were completing medical separation from the military after surgery for persistent shoulder disability, and 37.5% were retired from the military. Five patients (20.8%) deployed after surgery. This young, active cohort of service members who had TSA for glenohumeral arthritis faced a unique set of tremendous physical demands. A retrospective case series investigated return to sport in 100 consecutive patients (mean age, 68.9 years) who were participating in recreational and competitive athletics and underwent unilateral TSA.²¹ The patients were engaged most commonly in swimming (20.4%), golf (16.3%), cycling (16.3%), and fitness training (16.3%). The authors found that, at a mean follow-up of 2.8 years, 49 patients (89%) were able to continue in sports, though 36.7% thought their sport activity was restricted after TSA. In another retrospective case series (61 TSAs), McCarty and colleagues¹⁹ found that 48 patients (71%) were improved in their sports participation, and 50% increased their frequency of participation after surgery.

There are no specific recommendations on returning to military service or high-level sport after surgery. Recommendations on returning to sport after TSA have been based largely on small case series involving specific sports^46,47 and surveys of expert opinion.^17,18 In a survey on postoperative physical activity in young patients after TSA conducted by Healy and colleagues,¹⁷ 35 American Shoulder and Elbow Surgeons members recommended avoiding contact and impact sports while permitting return to nonimpact sports, such as swimming, which may still impart significant stress to the glenohumeral joint. In an international survey of 101 shoulder and elbow surgeons, Magnussen and colleagues¹⁸ also found that most recommended avoiding a return to impact sports that require intensive upper extremity demands and permitting full return to sports at preoperative levels. This likely is a result of the perception that most of these patients having TSA are older and have less rigorous involvement in sports at the outset and a lower propensity for adverse patient outcomes. However, these recommendations may place a younger, more high-demand patient at significantly greater risk. The active-duty cohort engages in daily physical training, including push-ups and frequent overhead lifting, which could account for the high failure rates and low incidence of postoperative deployment. Although TSA seems to demonstrate good initial results in terms of return to high-demand activities, the return-to-duty profile in our study highlights the potential pitfalls of TSA in active individuals attempting to return to high-demand preoperative function.

Our analysis was limited by the fact that we used a small patient cohort, contributing to underpowered analysis of the potential risk factors predictive of reoperation and medical discharge. Although our minimum follow-up was 12 months, with the exception of 1 patient who was medically separated at 11.6 months because of shoulder disability, we captured 5 patients (19.2%) who underwent medical separation but who would otherwise be excluded. Therefore, this limitation is not major in that, with a longer minimum follow-up, we would be excluding a significant number of patients with such persistent disability after TSA that they would not be able to return to duty at anywhere near their previous level. In this retrospective study, we were additionally limited to analysis of the data in the medical records and could not control for variables such as surgeon technique, implant choice, and experience. Complete radiographic images were not available, limiting analysis of radiographic outcomes. Given the lack of a standardized preoperative imaging protocol, we could not evaluate glenoid version on axial imaging. It is possible that some patients with early aseptic glenoid loosening had posterior subluxation or a Walch B2 glenoid, which has a higher failure rate.⁴⁸ The strengths of this study include its unique analysis of a homogeneous young, active, high-risk patient cohort within a closed healthcare system. In the military, these patients are subject to intense daily physical and occupational demands. In addition, the clinical and functional outcomes we studied are patient-centered and therefore relevant during preoperative counseling. Further investigations might focus on validated outcome measures and on midterm to long-term TSA outcomes in an active military population vis-à-vis other alternatives for clinical management.

Conclusion

By a mean follow-up of 3.5 years, only a third of the service members had returned to active duty, roughly a third had retired, and more than a third had been medically discharged because of persistent disability attributable to the shoulder. Despite initial improvements in ROM and pain, midterm outcomes were poor. The short-term complication rate (46.2%) and the rate of reoperation for component failure (23.1%) should be emphasized during preoperative counseling.

Although total shoulder arthroplasty (TSA) has proved to be a reliable solution in older patients, treatment in younger patients with glenohumeral arthritis remains controversial, and there are still few reliable long-term surgical options.^1-8 These options include abrasion arthroplasty and arthroscopic management,^9,10 biologic glenoid resurfacing,^11,12 and humeral hemiarthroplasty with¹³ or without^14,15 glenoid treatment and anatomical TSA.

In the younger cohort, 20-year TSA survivorship rates up to 84% have been reported, and unsatisfactory subjective outcomes have been unacceptably high.¹⁶ In addition, there is a paucity of literature addressing the impact of TSA on return to sport. Recommendations on returning to an athletic life style are based largely on surveys of expert opinion^17,18 and heterogeneous studies of either older patients (eg, age >50-55 years) who are active^19-21 or younger patients with no defined level of activity.^{5,7,8,16,22-24}

To our knowledge, no one has evaluated the short-term morbidity and clinical outcomes within a young, high-demand patient population, such as the US military. Therefore, we conducted a study to evaluate the clinical success and complications of TSA performed for glenohumeral arthritis in a young, active population. We hypothesized that patients who had undergone TSA would have a low rate of return to duty, an increased rate of component failure, and a higher reoperation rate because of increased upper extremity demands.

Materials and Methods

After obtaining protocol approval from the William Beaumont Army Medical Center Institutional Review Board, we searched the Military Health System (MHS) Management Analysis and Reporting Tool (M2) database to retrospectively review the cases of all tri-service US military service members who had undergone primary anatomical TSA (Current Procedural Terminology code 23472) between January 1, 2007 and June 31, 2014. This was a multisurgeon, multicenter study. Patient exclusion criteria were nonmilitary or retired status at time of surgery; primary surgery consisting of limited glenohumeral resurfacing procedure, hemiarthroplasty, or reverse TSA; surgery for acute proximal humerus fracture; rotator cuff deficiency diagnosed before or during surgery; and insufficient follow-up (eg, <12 months, unless medically separated beforehand).

The M2 database is an established tool that has been used for clinical outcomes research on treatment of a variety of orthopedic conditions.25,26 The Medical Data Repository, which is operated by MHS, is populated by its military healthcare providers. The MHS, which offers worldwide coverage for all beneficiaries either at Department of Defense facilities or purchased using civilian providers, is among the largest known closed healthcare systems.

All active-duty US military service members are uniformly required to adhere to stringent and regularly evaluated physical fitness standards, which typically exceed those of average civilians. Routine physical training is required in the form of aerobic fitness, weight training, tactical field exercises, and core military tasks, such as the ability to march at least 2 miles while carrying heavy fighting loads. In addition to satisfying required height and weight standards, all service members are subject to semiannual service-specific physical fitness evaluations inclusive of timed push-ups, sit-ups, and an aerobic event. Service members may also be required to maintain a level of physical training above these baseline standards, contingent on their branch of service, rank, and military occupational specialty. If a service member is unable to maintain these standards, medical separation may be initiated.

Demographic and occupational data were extracted from the database. These data included age, sex, military rank, and branch of service. Line-by-line analysis of the Armed Forces Health Longitudinal Technology Application (Version 22; 3M) electronic medical record was then performed to confirm the underlying diagnosis, surgical procedure, and surgery date. Further chart review yielded additional patient-based factors (eg, laterality, hand dominance, presence and type of prior shoulder surgeries) and surgical factors (eg, surgery indication, implant design). We evaluated clinical and functional outcomes as well as perioperative complications, including both major and minor systemic and local complications as previously described^27,28; preoperative and postoperative range of motion (ROM) and self-reported pain score (SRPS, scale 1-10) as measured by physical therapist and surgeon at follow-up; secondary surgical interventions; timing of return to duty; and postoperative deployment history. The primary outcome measures were revision reoperation after index procedure, and military discharge for persistent shoulder-related disability. Clinical failure was defined as component failure or reoperation. Medical Evaluation Board (MEB) is a formal separation from the military in which it is deemed that a service member is no longer able to fulfill his or her duty because of a medical condition.

Statistical Analysis

Continuous variables were compared using statistical means with 95% confidence intervals (CIs) and/or SDs. Categorical data were reported as frequencies or percentages. Univariate analysis was performed to assess the correlation between possible risk factors and the primary outcome measures. P < .05 was considered statistically significant.

Results

Demographics

We identified 24 service members (26 shoulders) who had undergone anatomical TSA during the study period (Table 1). Mean (SD) age was 45.8 (4.5) years (range, 35-54 years), and the cohort was predominately male (25/26 shoulders; 96.2%). Most cohort members were of senior enlisted rank (14, 58.3%), and the US Army was the predominant branch of military service (13, 54.2%). The right side was the operative extremity in 7 cases (26.9%), and the dominant shoulder was involved in 6 cases (23.1%). Two patients (8.3%) underwent staged bilateral TSA. Most patients (76.9%) underwent TSA on the nondominant extremity.

Surgical Variables

TSA was indicated for post-instability arthropathy in 13 cases (50.0%), posttraumatic osteoarthritis in 7 cases (26.9%), and unspecified glenohumeral arthritis, which includes primary glenohumeral osteoarthritis, in 5 cases (19.2%) (Table 2). One case was attributed to iatrogenically induced chondrolysis secondary to intra-articular lidocaine pump. Twelve patients (46.2%) had at least 1 previous surgery. Of the shoulders with instability, 10 (76.9%) had undergone a total of 14 surgical stabilization procedures—10 anterior labral repairs, 2 posterior labral repairs, and 2 capsular plications. The other shoulders had undergone a total of 18 procedures, which included 4 rotator cuff repairs and 3 cartilage restoration procedures.

Clinical Outcomes

Mean (SD) follow-up was 41.0 (21.3) months (range, 11.6-97.6 months). All but 1 shoulder (96.2%) had follow-up of 12 months or more (the only patient with shorter follow-up was because of MEB), and 76.9% of patients had follow-up of 24 months or more (4 of the 6 patients with follow-up under 24 months were medically separated) (Table 3). In all cases, mean ROM improved with respect to flexion, abduction, and external rotation. At final follow-up, mean (SD) ROM was 138° (36°) forward flexion (range, 60°-180°), 125° (39°) abduction (range, 45°-180°), 48° (19°) external rotation at 0° abduction (range, 20°-90°), and 80° (9.4°) external rotation at 90° abduction (range, 70°-90°). Preoperative flexion, abduction, and external rotation at 0° and 90° abduction were all improved at final follow-up. The most improvement in ROM occurred within 6 months after surgery.

Overall patient satisfaction with surgery was 92.3% (n = 24). Ultimately, 18 (72.0%) of 25 shoulders with follow-up of 1 year or more were able to return to active duty within 1 year after surgery, though only 10 (45.5%) of 22 with follow-up of 2 years or more remained active 2 years after surgery. Furthermore, 5 patients (20.8%) were deployed after surgery, and all were still on active duty at final follow-up. By final follow-up, 9 (37.5%) of 24 service members were unable to return to military function; 7 had been medically discharged from the military for persistent shoulder disability, and 2 were in the process of being medically discharged.

In all cases, SRPS improved from before surgery (5.2 out of 10) to final follow-up (1.4). At final follow-up, 22 patients (88.0%) reported mild pain (0-3), and no one had pain above 6.

Complications

Nine patients had a total of 12 postoperative complications (46.2%): 6 component failures (23.1%), 2 neurologic injuries (7.7%; 1 permanent axillary nerve injury, 1 transient brachial plexus neuritis), 2 cases of adhesive capsulitis (7.7%), and 2 episodes of venous thrombosis (7.7%; 1 superficial, 1 deep) (Table 4). There were no documented infections. Six reoperations (23.1%) were performed for the 6 component failures (2 traumatic dislocations of prosthesis resulting in acute glenoid component failure, 3 cases of atraumatic glenoid loosening, 1 case of humeral stem loosening after periprosthetic fracture). Atraumatic glenoid component loosening occurred a mean (SD) of 40.6 (14.2) months after surgery (range, 20.8-54.2 months).

Surgical Failures

Eight service members underwent MEB. Six patients experienced component failure. Factors contributing to both clinical failure and separation from active duty by means of MEB were evaluated with univariate analysis (Table 5). No statistically significant risk factors, including surgical revision and presence of perioperative complications, were identified.

Discussion

We confirmed that our cohort of young service members (mean age, 45.8 years), who had undergone TSA for glenohumeral arthritis, had a relatively higher rate of component failure (23.1%) and a higher reoperation rate (23.1%) with low rates of return to military duty at short-term to midterm follow-up. Our results parallel those of a limited series with a younger cohort (Table 6).^{7,16,19,21,23,24} The high demand and increased life expectancy of the younger patients with glenohumeral arthritis potentiates the risk of complications, component loosening, and ultimate failure.²⁹ To our knowledge, the present article is the first to report clinical and functional outcomes and perioperative risk profiles in a homogenously young, active military cohort after TSA.

The mean age of our study population (46 years) is one of the lowest in the literature. TSA in younger patients (age, <50-55 years) and older, active patients (>55 years) has received increased attention as a result of the expanding indications and growing popularity of TSA in these groups. Other studies have upheld the efficacy of TSA in achieving predictable pain relief and functional improvement in a diverse and predominantly elderly population.^15,30-34 Alternative treatments, including humeral head resurfacing^15,30,35 and soft-tissue interposition,^15,36-40 have also shown inferior short- and long-term results in terms of longevity and degree of clinical or functional improvement.^31-34,41 In addition, the ream-and-run technique has had promising early results by improving glenohumeral kinematics, pain relief, and shoulder function.^13,42,43 However, although implantation of a glenoid component is avoided in young, active people because of reduced longevity and higher rates of component failure, the trade-offs are inadequately treated glenoid disease, suboptimal pain relief, and progression of glenoid arthritis eventually requiring revision. Furthermore, midterm and long-term survivorship of TSA in general is unknown, and there remain few good options for treating end-stage arthritis in young, active patients.

Our cohort had high rates of complications (46.2%) and revisions (23.1%). Two in 5 patients had postoperative complications, most commonly component failure resulting in reoperation. In the literature, complication rates among young patients who underwent TSA are much lower (4.8%-10.9%).^16,23,24 Our cohort’s most common complication was component failure (23.1%), which was most often attributed to atraumatic, aseptic glenoid component loosening and required reoperation. Previously reported revision rates in a young population that underwent TSA (0%-11%)^16,23,24 were also significantly lower than those in the present analysis (23.1%), underscoring the impact of operative indications, postoperative activity levels, and occupational demands on ultimate failure rates. Interestingly, all revisions in our study were for component failure, whereas previous reports have described a higher rate for infection.²² However, the same studies also found glenoid lucency rates as high as 76% at 10-year follow-up.¹⁶ Furthermore, in a review of 136 TSAs with unsatisfactory outcomes, glenoid loosening was the most common reason for presenting to clinic after surgery.⁴⁴ Specifically, our population had a high rate of glenohumeral arthritis secondary to instability (50.0%) and posttraumatic osteoarthritis (26.9%). For many reasons, outcomes were worse in younger patients with a history of glenohumeral instability³³ than in older patients without a high incidence of instability.⁴⁵ This young cohort with higher demands may have had accelerated polyethylene wear patterns caused by repetitive overhead activity, which may have arisen because of a higher functional profile after surgery and greater patient expectations after arthroplasty. In addition, patients with a history of instability may have altered glenohumeral anatomy, especially with previous arthroscopic or open stabilization procedures. Anatomical changes include excessive posterior glenoid wear, internal rotation contracture, patulous capsular tissue, static or dynamic posterior humeral subluxation, and possible overconstraint after prior stabilization procedures. Almost half of our population had a previous surgery; our patients averaged 1.7 previous surgeries each.

Although estimates of component survivorship at a high-volume civilian tertiary-referral center were as high as 97% at 10 years and 84% at 20 years,^7,16 10-year survivorship in patients with a history of instability was only 61%.3 TSA survivorship in our young, active cohort is already foreseeably dramatically reduced, given the 23.1% revision rate at 28.5-month follow-up. This consideration must be addressed during preoperative counseling with the young patient with glenohumeral arthritis and a history of shoulder instability.

Despite the high rates of complications and revisions in our study, 92.3% of patients were satisfied with surgery, 88.0% experienced minimal persistence of pain (mean 3.8-point decrease on SRPS), and 100% maintained improved ROM at final follow-up. Satisfaction in the young population has varied significantly, from 52% to 95%, generally on the basis of physical activity.^16,22-24 The reasonable rate of postoperative satisfaction in the present analysis is comparable to what has been reported in patients of a similar age (Table 6).^7,16,22 However, despite high satisfaction and pain relief, patients were inconsistently able to return to the upper limits of physical activity required of active-duty military service. In addition, we cannot exclude secondary gain motivations for pursuing medical retirement, similar to that seen in patients receiving worker’s compensation.

Other authors have conversely found more favorable functional outcomes and survivorship rates.^23,24 In a retrospective review of 46 TSAs in patients 55 years or younger, Bartelt and colleagues²⁴ found sustained improvements in pain, ROM, and satisfaction at 7-year follow-up.24 Raiss and colleagues²³ conducted a prospective study of TSA outcomes in 21 patients with a mean age of 55 years and a mean follow-up of 7 years and reported no revisions and only 1 minor complication, a transient brachial plexus palsy.²³ The discrepancy between these studies may reflect different activity levels and underlying pathology between cohorts. The present population is unique in that it represents a particularly difficult confluence of factors for shoulder arthroplasty surgeons. The high activity, significant overhead and lifting occupational demands, and discordant patient expectations of this military cohort place a significant functional burden on the implants, the glenoid component in particular. Furthermore, this patient group has a higher incidence of more complex glenohumeral pathology resulting in instability, posttraumatic, or capsulorrhaphy arthropathy, and multiple prior arthroscopic and open stabilization procedures.

At final follow-up, only 33% of our patients were still on activity duty, 37.5% had completed or were completing medical separation from the military after surgery for persistent shoulder disability, and 37.5% were retired from the military. Five patients (20.8%) deployed after surgery. This young, active cohort of service members who had TSA for glenohumeral arthritis faced a unique set of tremendous physical demands. A retrospective case series investigated return to sport in 100 consecutive patients (mean age, 68.9 years) who were participating in recreational and competitive athletics and underwent unilateral TSA.²¹ The patients were engaged most commonly in swimming (20.4%), golf (16.3%), cycling (16.3%), and fitness training (16.3%). The authors found that, at a mean follow-up of 2.8 years, 49 patients (89%) were able to continue in sports, though 36.7% thought their sport activity was restricted after TSA. In another retrospective case series (61 TSAs), McCarty and colleagues¹⁹ found that 48 patients (71%) were improved in their sports participation, and 50% increased their frequency of participation after surgery.

There are no specific recommendations on returning to military service or high-level sport after surgery. Recommendations on returning to sport after TSA have been based largely on small case series involving specific sports^46,47 and surveys of expert opinion.^17,18 In a survey on postoperative physical activity in young patients after TSA conducted by Healy and colleagues,¹⁷ 35 American Shoulder and Elbow Surgeons members recommended avoiding contact and impact sports while permitting return to nonimpact sports, such as swimming, which may still impart significant stress to the glenohumeral joint. In an international survey of 101 shoulder and elbow surgeons, Magnussen and colleagues¹⁸ also found that most recommended avoiding a return to impact sports that require intensive upper extremity demands and permitting full return to sports at preoperative levels. This likely is a result of the perception that most of these patients having TSA are older and have less rigorous involvement in sports at the outset and a lower propensity for adverse patient outcomes. However, these recommendations may place a younger, more high-demand patient at significantly greater risk. The active-duty cohort engages in daily physical training, including push-ups and frequent overhead lifting, which could account for the high failure rates and low incidence of postoperative deployment. Although TSA seems to demonstrate good initial results in terms of return to high-demand activities, the return-to-duty profile in our study highlights the potential pitfalls of TSA in active individuals attempting to return to high-demand preoperative function.

Our analysis was limited by the fact that we used a small patient cohort, contributing to underpowered analysis of the potential risk factors predictive of reoperation and medical discharge. Although our minimum follow-up was 12 months, with the exception of 1 patient who was medically separated at 11.6 months because of shoulder disability, we captured 5 patients (19.2%) who underwent medical separation but who would otherwise be excluded. Therefore, this limitation is not major in that, with a longer minimum follow-up, we would be excluding a significant number of patients with such persistent disability after TSA that they would not be able to return to duty at anywhere near their previous level. In this retrospective study, we were additionally limited to analysis of the data in the medical records and could not control for variables such as surgeon technique, implant choice, and experience. Complete radiographic images were not available, limiting analysis of radiographic outcomes. Given the lack of a standardized preoperative imaging protocol, we could not evaluate glenoid version on axial imaging. It is possible that some patients with early aseptic glenoid loosening had posterior subluxation or a Walch B2 glenoid, which has a higher failure rate.⁴⁸ The strengths of this study include its unique analysis of a homogeneous young, active, high-risk patient cohort within a closed healthcare system. In the military, these patients are subject to intense daily physical and occupational demands. In addition, the clinical and functional outcomes we studied are patient-centered and therefore relevant during preoperative counseling. Further investigations might focus on validated outcome measures and on midterm to long-term TSA outcomes in an active military population vis-à-vis other alternatives for clinical management.

Conclusion

By a mean follow-up of 3.5 years, only a third of the service members had returned to active duty, roughly a third had retired, and more than a third had been medically discharged because of persistent disability attributable to the shoulder. Despite initial improvements in ROM and pain, midterm outcomes were poor. The short-term complication rate (46.2%) and the rate of reoperation for component failure (23.1%) should be emphasized during preoperative counseling.

The humeral avulsion of glenohumeral ligament (HAGL) lesion has been recognized as a cause of recurrent shoulder instability. In 1942, Nicola¹ was the first to describe this lesion, in a small case series of avulsions of the anterior band of the inferior glenohumeral ligament from the humeral neck secondary to a dislocation injury. In 1988, Bach and colleagues² described it in 2 patients with recurrent anterior dislocations. Wolf and colleagues³ were the first to apply the term HAGL to the injury, in 1995.

HAGL lesion incidence ranges from 1% to 9%, but many authors think the lesion is underdiagnosed.^3-5 It occurs in isolation or in combination with other injuries, and it is commonly identified on recurrence of instability. Bui-Mansfield and colleagues⁶ found that 11% of patients with a diagnosis of HAGL lesion previously had surgery on the same shoulder, whereas for 62% the lesion was associated with other, concurrent lesions, including labral tears (18, 25%), rotator cuff tears (16, 23%), and Hill-Sachs deformities (12, 17%).

Most young athletes who undergo nonoperative therapy for a HAGL lesion continue to experience pain and/or instability that then requires surgical intervention.⁴ To our knowledge, there are no reports of return to full function in young competitive athletes or return to manual labor after nonoperative management of a HAGL lesion.

In this article, we report the case of a US Navy SEAL who sustained a traction injury causing an axillary nerve injury and a HAGL lesion. Successful nonoperative management allowed him to return to full duty. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

An otherwise healthy 26-year-old Navy SEAL presented with pain and significant weakness in the right (dominant) upper extremity after an injury in a training exercise. The shoulder sustained a traction injury when the man’s fast-moving marine attack craft was in a collision and he was trying not to be thrown off. He reported having a sense of dislocation yet never required a reduction.

Physical examination revealed severe weakness with shoulder abduction, external rotation, and forward flexion; inability to contract the deltoid muscle; and complete numbness along the cutaneous distribution of the axillary nerve. On neurovascular examination, the right upper extremity was otherwise intact. The patient had complete passive range of motion (ROM) with apprehension in abduction with external rotation along with anterior laxity and normal posterior stability.

Standard shoulder radiographs showed no bony abnormalities and a concentrically reduced glenohumeral joint. Magnetic resonance imaging (MRI), reviewed by a staff musculoskeletal radiologist and a sports fellowship–trained orthopedic surgeon, showed a greater tuberosity contusion, a partial tear of the infraspinatus, and a HAGL lesion (Figure 1).

The patient was counseled toward surgical intervention to prevent symptoms of recurrent instability. A detailed discussion ensued about whether to proceed with surgery immediately or to pursue temporary nonoperative treatment to allow for assessment and return of deltoid function. Patient and surgeon decided to delay operative intervention because of concerns about the patient’s ability to effectively rehabilitate while still having a compromised axillary nerve after surgery. The recommendation was to delay initial electromyographic (EMG) and nerve conduction velocity testing at least 4 weeks to allow for completion of Wallerian degeneration and more accurate assessment of the axillary nerve.⁷ Physical therapy for gentle ROM (excluding external rotation) and isometric rotator cuff exercises were initiated.

Five weeks after injury, the patient left the area to attend a 2-month nonphysical training course and continued rehabilitation and orthopedic follow-up at another military medical facility. Six weeks after injury, initial EMG testing revealed the expected axillary neuropraxia. In addition, some marginal improvement in ROM was noted, but deltoid function was still very limited.

Ten weeks after injury, clinical inspection revealed deltoid wasting. Active shoulder ROM was limited, and deltoid strength was 3/5, though the patient was able to perform a standard push-up without difficulty and showed no sign of laxity or apprehension on shoulder examination. Repeat EMG testing revealed axillary nerve denervation with no sign of regeneration. Twelve weeks after injury, MRA showed reorganization and partial healing of the HAGL lesion relative to the prior study (Figure 2).

On the patient’s return from training, 15 weeks after injury, he had improved active ROM and 4+/5 deltoid strength. Axillary nerve sensation was still decreased but markedly improved. Physical examination revealed no significant shoulder laxity or apprehension, and the patient denied feelings of instability. Activities were advanced to include an organized strengthening program.

Six months after injury, the patient was cleared to return to his unit with only mild physical restriction. Function continued to steadily improve. After 9 months, he was cleared for full, unrestricted duty. Although he still demonstrated slight asymmetric weakness in the right deltoid with continued muscular atrophy, examination findings were otherwise normal, and he was back to full activities without significant symptoms.

Eleven months after injury, MRI showed healing of the HAGL lesion (Figure 3). At 17 months, EMG testing revealed significant interval improvement in axillary motor unit potentials but still about a 50% decrement compared with the noninjured side. The patient denied any motor or sensory deficits and any instability events since his injury. He continued with full function as an active-duty Navy SEAL.

Discussion

Nonoperative management has been used for injuries to the inferior glenohumeral ligament complex when there is no humeral detachment but generally has been reserved for low-demand patients and patients who cannot tolerate surgical intervention.⁴ Detached lesions may initially be managed nonoperatively with physical therapy and rehabilitation, but the rate of recurrent instability after nonoperative management of a known HAGL lesion remains unknown.⁴ Most active young people are expected to have persistent pain and/or instability and require surgical intervention. Both arthroscopic and open methods have been used successfully.^3,8-15 Persistent instability is often the primary complaint leading to a diagnosis of a HAGL lesion.⁴ The patient in this case report neither demonstrated nor reported any instability event after his 6-month period of nonoperative management, despite his young age and elite physical requirements.

To our knowledge, there are no reports of successful nonoperative management of a known symptomatic HAGL lesion in a high-demand athlete. Although we do not routinely recommend nonoperative treatment for cases such as the one reported here, the decision to delay this Navy SEAL’s surgical management was made out of concern about potential complications of postoperative rehabilitation given the concurrent axillary nerve injury.

With anterior shoulder dislocations, multiple concomitant shoulder injuries, including a HAGL lesion, are not uncommon.^6,16 With HAGL lesions, associated rotator cuff injuries occur at a rate as high as 23%.⁶ Our patient had a concurrent partial rotator cuff tear but also an axillary nerve traction injury. To our knowledge, the literature has not described axillary nerve injury specifically in association with a HAGL lesion, though it is well documented and maintained as a possible concurrent injury with anterior shoulder instability events.¹⁷ Robinson and colleagues¹⁶ found a 5.8% incidence of a clinically apparent neurologic deficit after traumatic anterior shoulder dislocation in 3633 dislocations, about 75% of which were isolated axillary nerve injuries. They also reported a 25.7% rate of rotator cuff tear or greater tuberosity fracture, either of which significantly increased the likelihood of a neurologic deficit in their study.

When nerve continuity remains, functional recovery occurs after 3 to 6 months, or within weeks in some cases.^18-20 Nerve injuries in continuity but with persistent, severe clinical deficits may require surgical exploration with subsequent neurolysis and/or repair.^19-21 Our patient showed gradual axillary nerve recovery from a clinical standpoint. By 6 months after injury, despite continued muscle atrophy and decreased axillary nerve sensation, he had returned to full duty as a Navy SEAL. By 17 months, atrophy was markedly improved, and strength and ROM had subjectively returned, despite there being significant conduction amplitude losses, up to 50% of the contralateral side, on EMG testing.

This case represents a scenario in which likely initial surgical management was precluded by a concomitant injury, and the patient had a serendipitous outcome. It is possible the axillary neuropraxia and subsequent temporary deltoid dysfunction provided a unique environment that was conducive to the healing of the HAGL lesion. With classic Bankart lesions, many surgeons prefer to use aggressive early surgical treatment in first-time dislocators, especially elite athletes, in an attempt to avoid recurrent instability.^22-26 However, some have suggested that initial immobilization after acute injury may lead to successful nonoperative management.²⁷ Perhaps our case report raises the question as to whether a prolonged period of initial immobilization can prove successful in management of a HAGL lesion. Prospective studies comparing early surgical and nonoperative treatment of these challenging lesions are warranted.

We have reported a case of successful nonoperative management of a HAGL lesion in an active-duty Navy SEAL with concomitant shoulder injuries. This case could suggest that a trial of initial nonoperative management should be considered for injuries that involve a HAGL lesion when there are concerns about the patient’s ability to complete functional rehabilitation because of the combined injuries of the shoulder.

The humeral avulsion of glenohumeral ligament (HAGL) lesion has been recognized as a cause of recurrent shoulder instability. In 1942, Nicola¹ was the first to describe this lesion, in a small case series of avulsions of the anterior band of the inferior glenohumeral ligament from the humeral neck secondary to a dislocation injury. In 1988, Bach and colleagues² described it in 2 patients with recurrent anterior dislocations. Wolf and colleagues³ were the first to apply the term HAGL to the injury, in 1995.

HAGL lesion incidence ranges from 1% to 9%, but many authors think the lesion is underdiagnosed.^3-5 It occurs in isolation or in combination with other injuries, and it is commonly identified on recurrence of instability. Bui-Mansfield and colleagues⁶ found that 11% of patients with a diagnosis of HAGL lesion previously had surgery on the same shoulder, whereas for 62% the lesion was associated with other, concurrent lesions, including labral tears (18, 25%), rotator cuff tears (16, 23%), and Hill-Sachs deformities (12, 17%).

Most young athletes who undergo nonoperative therapy for a HAGL lesion continue to experience pain and/or instability that then requires surgical intervention.⁴ To our knowledge, there are no reports of return to full function in young competitive athletes or return to manual labor after nonoperative management of a HAGL lesion.

In this article, we report the case of a US Navy SEAL who sustained a traction injury causing an axillary nerve injury and a HAGL lesion. Successful nonoperative management allowed him to return to full duty. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

An otherwise healthy 26-year-old Navy SEAL presented with pain and significant weakness in the right (dominant) upper extremity after an injury in a training exercise. The shoulder sustained a traction injury when the man’s fast-moving marine attack craft was in a collision and he was trying not to be thrown off. He reported having a sense of dislocation yet never required a reduction.

Physical examination revealed severe weakness with shoulder abduction, external rotation, and forward flexion; inability to contract the deltoid muscle; and complete numbness along the cutaneous distribution of the axillary nerve. On neurovascular examination, the right upper extremity was otherwise intact. The patient had complete passive range of motion (ROM) with apprehension in abduction with external rotation along with anterior laxity and normal posterior stability.

Standard shoulder radiographs showed no bony abnormalities and a concentrically reduced glenohumeral joint. Magnetic resonance imaging (MRI), reviewed by a staff musculoskeletal radiologist and a sports fellowship–trained orthopedic surgeon, showed a greater tuberosity contusion, a partial tear of the infraspinatus, and a HAGL lesion (Figure 1).

The patient was counseled toward surgical intervention to prevent symptoms of recurrent instability. A detailed discussion ensued about whether to proceed with surgery immediately or to pursue temporary nonoperative treatment to allow for assessment and return of deltoid function. Patient and surgeon decided to delay operative intervention because of concerns about the patient’s ability to effectively rehabilitate while still having a compromised axillary nerve after surgery. The recommendation was to delay initial electromyographic (EMG) and nerve conduction velocity testing at least 4 weeks to allow for completion of Wallerian degeneration and more accurate assessment of the axillary nerve.⁷ Physical therapy for gentle ROM (excluding external rotation) and isometric rotator cuff exercises were initiated.

Five weeks after injury, the patient left the area to attend a 2-month nonphysical training course and continued rehabilitation and orthopedic follow-up at another military medical facility. Six weeks after injury, initial EMG testing revealed the expected axillary neuropraxia. In addition, some marginal improvement in ROM was noted, but deltoid function was still very limited.

Ten weeks after injury, clinical inspection revealed deltoid wasting. Active shoulder ROM was limited, and deltoid strength was 3/5, though the patient was able to perform a standard push-up without difficulty and showed no sign of laxity or apprehension on shoulder examination. Repeat EMG testing revealed axillary nerve denervation with no sign of regeneration. Twelve weeks after injury, MRA showed reorganization and partial healing of the HAGL lesion relative to the prior study (Figure 2).

On the patient’s return from training, 15 weeks after injury, he had improved active ROM and 4+/5 deltoid strength. Axillary nerve sensation was still decreased but markedly improved. Physical examination revealed no significant shoulder laxity or apprehension, and the patient denied feelings of instability. Activities were advanced to include an organized strengthening program.

Six months after injury, the patient was cleared to return to his unit with only mild physical restriction. Function continued to steadily improve. After 9 months, he was cleared for full, unrestricted duty. Although he still demonstrated slight asymmetric weakness in the right deltoid with continued muscular atrophy, examination findings were otherwise normal, and he was back to full activities without significant symptoms.

Eleven months after injury, MRI showed healing of the HAGL lesion (Figure 3). At 17 months, EMG testing revealed significant interval improvement in axillary motor unit potentials but still about a 50% decrement compared with the noninjured side. The patient denied any motor or sensory deficits and any instability events since his injury. He continued with full function as an active-duty Navy SEAL.

Discussion

Nonoperative management has been used for injuries to the inferior glenohumeral ligament complex when there is no humeral detachment but generally has been reserved for low-demand patients and patients who cannot tolerate surgical intervention.⁴ Detached lesions may initially be managed nonoperatively with physical therapy and rehabilitation, but the rate of recurrent instability after nonoperative management of a known HAGL lesion remains unknown.⁴ Most active young people are expected to have persistent pain and/or instability and require surgical intervention. Both arthroscopic and open methods have been used successfully.^3,8-15 Persistent instability is often the primary complaint leading to a diagnosis of a HAGL lesion.⁴ The patient in this case report neither demonstrated nor reported any instability event after his 6-month period of nonoperative management, despite his young age and elite physical requirements.

To our knowledge, there are no reports of successful nonoperative management of a known symptomatic HAGL lesion in a high-demand athlete. Although we do not routinely recommend nonoperative treatment for cases such as the one reported here, the decision to delay this Navy SEAL’s surgical management was made out of concern about potential complications of postoperative rehabilitation given the concurrent axillary nerve injury.

With anterior shoulder dislocations, multiple concomitant shoulder injuries, including a HAGL lesion, are not uncommon.^6,16 With HAGL lesions, associated rotator cuff injuries occur at a rate as high as 23%.⁶ Our patient had a concurrent partial rotator cuff tear but also an axillary nerve traction injury. To our knowledge, the literature has not described axillary nerve injury specifically in association with a HAGL lesion, though it is well documented and maintained as a possible concurrent injury with anterior shoulder instability events.¹⁷ Robinson and colleagues¹⁶ found a 5.8% incidence of a clinically apparent neurologic deficit after traumatic anterior shoulder dislocation in 3633 dislocations, about 75% of which were isolated axillary nerve injuries. They also reported a 25.7% rate of rotator cuff tear or greater tuberosity fracture, either of which significantly increased the likelihood of a neurologic deficit in their study.

When nerve continuity remains, functional recovery occurs after 3 to 6 months, or within weeks in some cases.^18-20 Nerve injuries in continuity but with persistent, severe clinical deficits may require surgical exploration with subsequent neurolysis and/or repair.^19-21 Our patient showed gradual axillary nerve recovery from a clinical standpoint. By 6 months after injury, despite continued muscle atrophy and decreased axillary nerve sensation, he had returned to full duty as a Navy SEAL. By 17 months, atrophy was markedly improved, and strength and ROM had subjectively returned, despite there being significant conduction amplitude losses, up to 50% of the contralateral side, on EMG testing.

This case represents a scenario in which likely initial surgical management was precluded by a concomitant injury, and the patient had a serendipitous outcome. It is possible the axillary neuropraxia and subsequent temporary deltoid dysfunction provided a unique environment that was conducive to the healing of the HAGL lesion. With classic Bankart lesions, many surgeons prefer to use aggressive early surgical treatment in first-time dislocators, especially elite athletes, in an attempt to avoid recurrent instability.^22-26 However, some have suggested that initial immobilization after acute injury may lead to successful nonoperative management.²⁷ Perhaps our case report raises the question as to whether a prolonged period of initial immobilization can prove successful in management of a HAGL lesion. Prospective studies comparing early surgical and nonoperative treatment of these challenging lesions are warranted.

We have reported a case of successful nonoperative management of a HAGL lesion in an active-duty Navy SEAL with concomitant shoulder injuries. This case could suggest that a trial of initial nonoperative management should be considered for injuries that involve a HAGL lesion when there are concerns about the patient’s ability to complete functional rehabilitation because of the combined injuries of the shoulder.

The humeral avulsion of glenohumeral ligament (HAGL) lesion has been recognized as a cause of recurrent shoulder instability. In 1942, Nicola¹ was the first to describe this lesion, in a small case series of avulsions of the anterior band of the inferior glenohumeral ligament from the humeral neck secondary to a dislocation injury. In 1988, Bach and colleagues² described it in 2 patients with recurrent anterior dislocations. Wolf and colleagues³ were the first to apply the term HAGL to the injury, in 1995.

HAGL lesion incidence ranges from 1% to 9%, but many authors think the lesion is underdiagnosed.^3-5 It occurs in isolation or in combination with other injuries, and it is commonly identified on recurrence of instability. Bui-Mansfield and colleagues⁶ found that 11% of patients with a diagnosis of HAGL lesion previously had surgery on the same shoulder, whereas for 62% the lesion was associated with other, concurrent lesions, including labral tears (18, 25%), rotator cuff tears (16, 23%), and Hill-Sachs deformities (12, 17%).

Most young athletes who undergo nonoperative therapy for a HAGL lesion continue to experience pain and/or instability that then requires surgical intervention.⁴ To our knowledge, there are no reports of return to full function in young competitive athletes or return to manual labor after nonoperative management of a HAGL lesion.

In this article, we report the case of a US Navy SEAL who sustained a traction injury causing an axillary nerve injury and a HAGL lesion. Successful nonoperative management allowed him to return to full duty. The patient provided written informed consent for print and electronic publication of this case report.

Case Report

An otherwise healthy 26-year-old Navy SEAL presented with pain and significant weakness in the right (dominant) upper extremity after an injury in a training exercise. The shoulder sustained a traction injury when the man’s fast-moving marine attack craft was in a collision and he was trying not to be thrown off. He reported having a sense of dislocation yet never required a reduction.

Physical examination revealed severe weakness with shoulder abduction, external rotation, and forward flexion; inability to contract the deltoid muscle; and complete numbness along the cutaneous distribution of the axillary nerve. On neurovascular examination, the right upper extremity was otherwise intact. The patient had complete passive range of motion (ROM) with apprehension in abduction with external rotation along with anterior laxity and normal posterior stability.

Standard shoulder radiographs showed no bony abnormalities and a concentrically reduced glenohumeral joint. Magnetic resonance imaging (MRI), reviewed by a staff musculoskeletal radiologist and a sports fellowship–trained orthopedic surgeon, showed a greater tuberosity contusion, a partial tear of the infraspinatus, and a HAGL lesion (Figure 1).

The patient was counseled toward surgical intervention to prevent symptoms of recurrent instability. A detailed discussion ensued about whether to proceed with surgery immediately or to pursue temporary nonoperative treatment to allow for assessment and return of deltoid function. Patient and surgeon decided to delay operative intervention because of concerns about the patient’s ability to effectively rehabilitate while still having a compromised axillary nerve after surgery. The recommendation was to delay initial electromyographic (EMG) and nerve conduction velocity testing at least 4 weeks to allow for completion of Wallerian degeneration and more accurate assessment of the axillary nerve.⁷ Physical therapy for gentle ROM (excluding external rotation) and isometric rotator cuff exercises were initiated.

Five weeks after injury, the patient left the area to attend a 2-month nonphysical training course and continued rehabilitation and orthopedic follow-up at another military medical facility. Six weeks after injury, initial EMG testing revealed the expected axillary neuropraxia. In addition, some marginal improvement in ROM was noted, but deltoid function was still very limited.

Ten weeks after injury, clinical inspection revealed deltoid wasting. Active shoulder ROM was limited, and deltoid strength was 3/5, though the patient was able to perform a standard push-up without difficulty and showed no sign of laxity or apprehension on shoulder examination. Repeat EMG testing revealed axillary nerve denervation with no sign of regeneration. Twelve weeks after injury, MRA showed reorganization and partial healing of the HAGL lesion relative to the prior study (Figure 2).

On the patient’s return from training, 15 weeks after injury, he had improved active ROM and 4+/5 deltoid strength. Axillary nerve sensation was still decreased but markedly improved. Physical examination revealed no significant shoulder laxity or apprehension, and the patient denied feelings of instability. Activities were advanced to include an organized strengthening program.

Six months after injury, the patient was cleared to return to his unit with only mild physical restriction. Function continued to steadily improve. After 9 months, he was cleared for full, unrestricted duty. Although he still demonstrated slight asymmetric weakness in the right deltoid with continued muscular atrophy, examination findings were otherwise normal, and he was back to full activities without significant symptoms.

Eleven months after injury, MRI showed healing of the HAGL lesion (Figure 3). At 17 months, EMG testing revealed significant interval improvement in axillary motor unit potentials but still about a 50% decrement compared with the noninjured side. The patient denied any motor or sensory deficits and any instability events since his injury. He continued with full function as an active-duty Navy SEAL.

Discussion

Nonoperative management has been used for injuries to the inferior glenohumeral ligament complex when there is no humeral detachment but generally has been reserved for low-demand patients and patients who cannot tolerate surgical intervention.⁴ Detached lesions may initially be managed nonoperatively with physical therapy and rehabilitation, but the rate of recurrent instability after nonoperative management of a known HAGL lesion remains unknown.⁴ Most active young people are expected to have persistent pain and/or instability and require surgical intervention. Both arthroscopic and open methods have been used successfully.^3,8-15 Persistent instability is often the primary complaint leading to a diagnosis of a HAGL lesion.⁴ The patient in this case report neither demonstrated nor reported any instability event after his 6-month period of nonoperative management, despite his young age and elite physical requirements.

To our knowledge, there are no reports of successful nonoperative management of a known symptomatic HAGL lesion in a high-demand athlete. Although we do not routinely recommend nonoperative treatment for cases such as the one reported here, the decision to delay this Navy SEAL’s surgical management was made out of concern about potential complications of postoperative rehabilitation given the concurrent axillary nerve injury.

With anterior shoulder dislocations, multiple concomitant shoulder injuries, including a HAGL lesion, are not uncommon.^6,16 With HAGL lesions, associated rotator cuff injuries occur at a rate as high as 23%.⁶ Our patient had a concurrent partial rotator cuff tear but also an axillary nerve traction injury. To our knowledge, the literature has not described axillary nerve injury specifically in association with a HAGL lesion, though it is well documented and maintained as a possible concurrent injury with anterior shoulder instability events.¹⁷ Robinson and colleagues¹⁶ found a 5.8% incidence of a clinically apparent neurologic deficit after traumatic anterior shoulder dislocation in 3633 dislocations, about 75% of which were isolated axillary nerve injuries. They also reported a 25.7% rate of rotator cuff tear or greater tuberosity fracture, either of which significantly increased the likelihood of a neurologic deficit in their study.

When nerve continuity remains, functional recovery occurs after 3 to 6 months, or within weeks in some cases.^18-20 Nerve injuries in continuity but with persistent, severe clinical deficits may require surgical exploration with subsequent neurolysis and/or repair.^19-21 Our patient showed gradual axillary nerve recovery from a clinical standpoint. By 6 months after injury, despite continued muscle atrophy and decreased axillary nerve sensation, he had returned to full duty as a Navy SEAL. By 17 months, atrophy was markedly improved, and strength and ROM had subjectively returned, despite there being significant conduction amplitude losses, up to 50% of the contralateral side, on EMG testing.

This case represents a scenario in which likely initial surgical management was precluded by a concomitant injury, and the patient had a serendipitous outcome. It is possible the axillary neuropraxia and subsequent temporary deltoid dysfunction provided a unique environment that was conducive to the healing of the HAGL lesion. With classic Bankart lesions, many surgeons prefer to use aggressive early surgical treatment in first-time dislocators, especially elite athletes, in an attempt to avoid recurrent instability.^22-26 However, some have suggested that initial immobilization after acute injury may lead to successful nonoperative management.²⁷ Perhaps our case report raises the question as to whether a prolonged period of initial immobilization can prove successful in management of a HAGL lesion. Prospective studies comparing early surgical and nonoperative treatment of these challenging lesions are warranted.

We have reported a case of successful nonoperative management of a HAGL lesion in an active-duty Navy SEAL with concomitant shoulder injuries. This case could suggest that a trial of initial nonoperative management should be considered for injuries that involve a HAGL lesion when there are concerns about the patient’s ability to complete functional rehabilitation because of the combined injuries of the shoulder.